JP2006188672A - Radical formation inhibitor - Google Patents
Radical formation inhibitor Download PDFInfo
- Publication number
- JP2006188672A JP2006188672A JP2005351866A JP2005351866A JP2006188672A JP 2006188672 A JP2006188672 A JP 2006188672A JP 2005351866 A JP2005351866 A JP 2005351866A JP 2005351866 A JP2005351866 A JP 2005351866A JP 2006188672 A JP2006188672 A JP 2006188672A
- Authority
- JP
- Japan
- Prior art keywords
- radical
- trehalose
- production inhibitor
- acid
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940081611 Radical formation inhibitor Drugs 0.000 title description 6
- 239000003112 inhibitor Substances 0.000 claims abstract description 148
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 108
- 239000000203 mixture Substances 0.000 claims abstract description 83
- 238000000034 method Methods 0.000 claims abstract description 81
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 19
- 238000002156 mixing Methods 0.000 claims abstract description 18
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 9
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 235
- 238000004519 manufacturing process Methods 0.000 claims description 137
- -1 α-glucosyl α, α-trehalose Chemical compound 0.000 claims description 112
- 150000001720 carbohydrates Chemical class 0.000 claims description 107
- 150000001719 carbohydrate derivatives Chemical class 0.000 claims description 102
- 239000000126 substance Substances 0.000 claims description 67
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 56
- 150000001875 compounds Chemical class 0.000 claims description 54
- 230000001603 reducing effect Effects 0.000 claims description 45
- 239000002537 cosmetic Substances 0.000 claims description 30
- 150000002632 lipids Chemical class 0.000 claims description 30
- 239000002516 radical scavenger Substances 0.000 claims description 28
- 229960005070 ascorbic acid Drugs 0.000 claims description 27
- 238000002845 discoloration Methods 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 25
- 235000013305 food Nutrition 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 22
- 239000000194 fatty acid Substances 0.000 claims description 22
- 229930195729 fatty acid Natural products 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 21
- 108090000790 Enzymes Proteins 0.000 claims description 21
- 150000005846 sugar alcohols Chemical class 0.000 claims description 20
- 150000004665 fatty acids Chemical class 0.000 claims description 18
- 239000003205 fragrance Substances 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 15
- 235000010323 ascorbic acid Nutrition 0.000 claims description 14
- 239000011668 ascorbic acid Substances 0.000 claims description 14
- 150000002978 peroxides Chemical class 0.000 claims description 14
- 235000019640 taste Nutrition 0.000 claims description 14
- 239000011248 coating agent Substances 0.000 claims description 13
- 239000003973 paint Substances 0.000 claims description 13
- 208000035985 Body Odor Diseases 0.000 claims description 12
- 206010040904 Skin odour abnormal Diseases 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 12
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 12
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 claims description 12
- 230000001629 suppression Effects 0.000 claims description 12
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims description 11
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 11
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 11
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims description 11
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims description 11
- 229940025878 hesperidin Drugs 0.000 claims description 11
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims description 11
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims description 11
- 150000003505 terpenes Chemical class 0.000 claims description 11
- 235000007586 terpenes Nutrition 0.000 claims description 11
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 10
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 10
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 10
- 235000005493 rutin Nutrition 0.000 claims description 10
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 10
- 229960004555 rutoside Drugs 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 7
- 235000005487 catechin Nutrition 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 239000000049 pigment Substances 0.000 claims description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 7
- 235000013824 polyphenols Nutrition 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- 229920001059 synthetic polymer Polymers 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- 229950001002 cianidanol Drugs 0.000 claims description 6
- 229930003935 flavonoid Natural products 0.000 claims description 6
- 150000002215 flavonoids Chemical class 0.000 claims description 6
- 235000017173 flavonoids Nutrition 0.000 claims description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 claims description 5
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 5
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims description 5
- 229920002079 Ellagic acid Polymers 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 229930014669 anthocyanidin Natural products 0.000 claims description 5
- 235000008758 anthocyanidins Nutrition 0.000 claims description 5
- 229960002852 ellagic acid Drugs 0.000 claims description 5
- 235000004132 ellagic acid Nutrition 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims description 5
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 claims description 5
- 229930019673 naringin Natural products 0.000 claims description 5
- 229940052490 naringin Drugs 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 4
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 4
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 4
- 229940074393 chlorogenic acid Drugs 0.000 claims description 4
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 4
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims description 4
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 4
- 150000007965 phenolic acids Chemical class 0.000 claims description 4
- 235000018553 tannin Nutrition 0.000 claims description 4
- 229920001864 tannin Polymers 0.000 claims description 4
- 239000001648 tannin Substances 0.000 claims description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 3
- 229930182470 glycoside Natural products 0.000 claims description 3
- 150000002338 glycosides Chemical class 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 235000019583 umami taste Nutrition 0.000 claims description 3
- 239000000058 anti acne agent Substances 0.000 claims description 2
- 229940124340 antiacne agent Drugs 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 229920002770 condensed tannin Polymers 0.000 claims 3
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 claims 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 229940110767 coenzyme Q10 Drugs 0.000 claims 2
- 229940097362 cyclodextrins Drugs 0.000 claims 1
- 239000012676 herbal extract Substances 0.000 claims 1
- 235000009048 phenolic acids Nutrition 0.000 claims 1
- 235000013599 spices Nutrition 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 abstract description 43
- 230000006866 deterioration Effects 0.000 abstract description 15
- 230000008569 process Effects 0.000 abstract description 5
- 150000003254 radicals Chemical class 0.000 description 224
- 239000000047 product Substances 0.000 description 115
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 69
- 239000000243 solution Substances 0.000 description 68
- 235000014633 carbohydrates Nutrition 0.000 description 57
- 238000006243 chemical reaction Methods 0.000 description 44
- 239000000306 component Substances 0.000 description 42
- 239000000796 flavoring agent Substances 0.000 description 31
- 239000000284 extract Substances 0.000 description 30
- 238000007796 conventional method Methods 0.000 description 28
- 230000000694 effects Effects 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 229920002472 Starch Polymers 0.000 description 26
- 238000002474 experimental method Methods 0.000 description 26
- 239000000843 powder Substances 0.000 description 25
- 239000008107 starch Substances 0.000 description 25
- 235000019698 starch Nutrition 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 24
- 150000008064 anhydrides Chemical class 0.000 description 23
- 239000007864 aqueous solution Substances 0.000 description 23
- 239000008213 purified water Substances 0.000 description 22
- 229920005989 resin Polymers 0.000 description 22
- 239000011347 resin Substances 0.000 description 22
- 238000003860 storage Methods 0.000 description 22
- 235000019645 odor Nutrition 0.000 description 21
- 235000018102 proteins Nutrition 0.000 description 21
- 230000009471 action Effects 0.000 description 20
- 239000008103 glucose Substances 0.000 description 20
- 229940088598 enzyme Drugs 0.000 description 19
- 230000004048 modification Effects 0.000 description 19
- 238000012986 modification Methods 0.000 description 19
- 230000002265 prevention Effects 0.000 description 19
- 239000007788 liquid Substances 0.000 description 18
- 239000006188 syrup Substances 0.000 description 18
- 235000020357 syrup Nutrition 0.000 description 18
- 239000013078 crystal Substances 0.000 description 17
- 235000001727 glucose Nutrition 0.000 description 17
- 230000005764 inhibitory process Effects 0.000 description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 16
- 206010061218 Inflammation Diseases 0.000 description 16
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 16
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 16
- 238000004925 denaturation Methods 0.000 description 16
- 230000036425 denaturation Effects 0.000 description 16
- 238000004040 coloring Methods 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 238000009472 formulation Methods 0.000 description 15
- 230000004054 inflammatory process Effects 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- 239000000975 dye Substances 0.000 description 14
- 239000002211 L-ascorbic acid Substances 0.000 description 13
- 235000000069 L-ascorbic acid Nutrition 0.000 description 13
- 239000002253 acid Substances 0.000 description 13
- 239000003925 fat Substances 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- 229930006000 Sucrose Natural products 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000005720 sucrose Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 208000002874 Acne Vulgaris Diseases 0.000 description 11
- 206010000496 acne Diseases 0.000 description 11
- 239000000839 emulsion Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 210000004209 hair Anatomy 0.000 description 11
- 239000006210 lotion Substances 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 11
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 10
- 238000000354 decomposition reaction Methods 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 150000002894 organic compounds Chemical class 0.000 description 10
- 230000009759 skin aging Effects 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 201000004624 Dermatitis Diseases 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 230000015556 catabolic process Effects 0.000 description 9
- 238000006731 degradation reaction Methods 0.000 description 9
- 210000000056 organ Anatomy 0.000 description 9
- 235000015927 pasta Nutrition 0.000 description 9
- 150000008163 sugars Chemical class 0.000 description 9
- 239000012085 test solution Substances 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 240000007594 Oryza sativa Species 0.000 description 8
- 206010070834 Sensitisation Diseases 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 230000005713 exacerbation Effects 0.000 description 8
- 239000000976 ink Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 230000008313 sensitization Effects 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 7
- 206010040880 Skin irritation Diseases 0.000 description 7
- 206010042496 Sunburn Diseases 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 229920000180 alkyd Polymers 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000007803 itching Effects 0.000 description 7
- 239000002304 perfume Substances 0.000 description 7
- 235000009566 rice Nutrition 0.000 description 7
- 230000036556 skin irritation Effects 0.000 description 7
- 231100000475 skin irritation Toxicity 0.000 description 7
- 239000000344 soap Substances 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- 208000012657 Atopic disease Diseases 0.000 description 6
- 208000034656 Contusions Diseases 0.000 description 6
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 6
- 240000008620 Fagopyrum esculentum Species 0.000 description 6
- 102000006992 Interferon-alpha Human genes 0.000 description 6
- 108010047761 Interferon-alpha Proteins 0.000 description 6
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 6
- 239000007868 Raney catalyst Substances 0.000 description 6
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 6
- 229910000564 Raney nickel Inorganic materials 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 6
- 108090000637 alpha-Amylases Proteins 0.000 description 6
- 208000034526 bruise Diseases 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000011033 desalting Methods 0.000 description 6
- 238000001362 electron spin resonance spectrum Methods 0.000 description 6
- 238000005562 fading Methods 0.000 description 6
- 238000007710 freezing Methods 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 238000012423 maintenance Methods 0.000 description 6
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 6
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 6
- 230000019612 pigmentation Effects 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 6
- HJRJRUMKQCMYDL-UHFFFAOYSA-N 1-chloro-2,4,6-trinitrobenzene Chemical compound [O-][N+](=O)C1=CC([N+]([O-])=O)=C(Cl)C([N+]([O-])=O)=C1 HJRJRUMKQCMYDL-UHFFFAOYSA-N 0.000 description 5
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 5
- 244000144725 Amygdalus communis Species 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 5
- 108010065511 Amylases Proteins 0.000 description 5
- 102000013142 Amylases Human genes 0.000 description 5
- 206010012438 Dermatitis atopic Diseases 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 239000004373 Pullulan Substances 0.000 description 5
- 229920001218 Pullulan Polymers 0.000 description 5
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 5
- 229930003316 Vitamin D Natural products 0.000 description 5
- 125000003158 alcohol group Chemical group 0.000 description 5
- 235000020224 almond Nutrition 0.000 description 5
- 102000004139 alpha-Amylases Human genes 0.000 description 5
- 229940024171 alpha-amylase Drugs 0.000 description 5
- 235000019418 amylase Nutrition 0.000 description 5
- 230000001153 anti-wrinkle effect Effects 0.000 description 5
- 201000008937 atopic dermatitis Diseases 0.000 description 5
- 238000001723 curing Methods 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 235000019688 fish Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 239000003456 ion exchange resin Substances 0.000 description 5
- 229920003303 ion-exchange polymer Polymers 0.000 description 5
- 239000000845 maltitol Substances 0.000 description 5
- 235000010449 maltitol Nutrition 0.000 description 5
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 5
- 229940035436 maltitol Drugs 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000003504 photosensitizing agent Substances 0.000 description 5
- 235000019423 pullulan Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 229940083542 sodium Drugs 0.000 description 5
- 235000019465 surimi Nutrition 0.000 description 5
- 235000019166 vitamin D Nutrition 0.000 description 5
- 239000011710 vitamin D Substances 0.000 description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 description 5
- 229940046008 vitamin d Drugs 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 4
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 4
- VCUVETGKTILCLC-UHFFFAOYSA-N 5,5-dimethyl-1-pyrroline N-oxide Chemical compound CC1(C)CCC=[N+]1[O-] VCUVETGKTILCLC-UHFFFAOYSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 241000186063 Arthrobacter Species 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 108010028688 Isoamylase Proteins 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 4
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000003889 eye drop Substances 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000000118 hair dye Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine group Chemical group N1=CCC2=CC=CC=C12 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 4
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 239000006072 paste Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 150000008494 α-glucosides Chemical class 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000234282 Allium Species 0.000 description 3
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 208000019300 CLIPPERS Diseases 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 240000008415 Lactuca sativa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 3
- 244000203593 Piper nigrum Species 0.000 description 3
- 235000008184 Piper nigrum Nutrition 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 241001504592 Trachurus trachurus Species 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 description 3
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 230000003255 anti-acne Effects 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 235000019606 astringent taste Nutrition 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229960000686 benzalkonium chloride Drugs 0.000 description 3
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 229940012356 eye drops Drugs 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 229940087559 grape seed Drugs 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 description 3
- 239000008268 mayonnaise Substances 0.000 description 3
- 235000010746 mayonnaise Nutrition 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 235000002949 phytic acid Nutrition 0.000 description 3
- 239000000467 phytic acid Substances 0.000 description 3
- 229940068041 phytic acid Drugs 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 235000015277 pork Nutrition 0.000 description 3
- 229920001592 potato starch Polymers 0.000 description 3
- 235000008476 powdered milk Nutrition 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000002510 pyrogen Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 235000021067 refined food Nutrition 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 235000014102 seafood Nutrition 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000019832 sodium triphosphate Nutrition 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 125000005504 styryl group Chemical group 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- AWFYPPSBLUWMFQ-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=C2 AWFYPPSBLUWMFQ-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 2
- 206010013774 Dry eye Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- 244000061408 Eugenia caryophyllata Species 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 235000019501 Lemon oil Nutrition 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical group O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 244000183278 Nephelium litchi Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000011795 alpha-carotene Substances 0.000 description 2
- 235000003903 alpha-carotene Nutrition 0.000 description 2
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- ZZTCCAPMZLDHFM-UHFFFAOYSA-N ammonium thioglycolate Chemical compound [NH4+].[O-]C(=O)CS ZZTCCAPMZLDHFM-UHFFFAOYSA-N 0.000 description 2
- 229940075861 ammonium thioglycolate Drugs 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000003788 bath preparation Substances 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000004566 building material Substances 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 239000008278 cosmetic cream Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- JGFBRKRYDCGYKD-UHFFFAOYSA-N dibutyl(oxo)tin Chemical compound CCCC[Sn](=O)CCCC JGFBRKRYDCGYKD-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 235000015071 dressings Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 229940029982 garlic powder Drugs 0.000 description 2
- 150000002327 glycerophospholipids Chemical class 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229920003049 isoprene rubber Polymers 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000010501 lemon oil Substances 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000002960 lipid emulsion Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 2
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 150000004291 polyenes Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002952 polymeric resin Substances 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 235000014438 salad dressings Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- DWZAJFZEYZIHPO-UHFFFAOYSA-N santin Chemical compound C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(O)C(OC)=C(O)C=C2O1 DWZAJFZEYZIHPO-UHFFFAOYSA-N 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229920003051 synthetic elastomer Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000005061 synthetic rubber Substances 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 229920005992 thermoplastic resin Polymers 0.000 description 2
- 229920001187 thermosetting polymer Polymers 0.000 description 2
- 235000010215 titanium dioxide Nutrition 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical group CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical group [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- LAYAKLSFVAPMEL-UHFFFAOYSA-N 1-ethenoxydodecane Chemical compound CCCCCCCCCCCCOC=C LAYAKLSFVAPMEL-UHFFFAOYSA-N 0.000 description 1
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- NLMOYOROJZUUMN-UHFFFAOYSA-N 2,3-dihydroxypropyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO NLMOYOROJZUUMN-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 description 1
- BYACHAOCSIPLCM-UHFFFAOYSA-N 2-[2-[bis(2-hydroxyethyl)amino]ethyl-(2-hydroxyethyl)amino]ethanol Chemical compound OCCN(CCO)CCN(CCO)CCO BYACHAOCSIPLCM-UHFFFAOYSA-N 0.000 description 1
- QOPUBSBYMCLLKW-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]-4-hydroxybutanoic acid Chemical compound OCCC(C(O)=O)N(CC(O)=O)CCN(CC(O)=O)CC(O)=O QOPUBSBYMCLLKW-UHFFFAOYSA-N 0.000 description 1
- RNMCCPMYXUKHAZ-UHFFFAOYSA-N 2-[3,3-diamino-1,2,2-tris(carboxymethyl)cyclohexyl]acetic acid Chemical compound NC1(N)CCCC(CC(O)=O)(CC(O)=O)C1(CC(O)=O)CC(O)=O RNMCCPMYXUKHAZ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- JMMZCWZIJXAGKW-UHFFFAOYSA-N 2-methylpent-2-ene Chemical compound CCC=C(C)C JMMZCWZIJXAGKW-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UWRBFYBQPCJRRL-UHFFFAOYSA-N 3-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)CCN(CC(O)=O)CC(O)=O UWRBFYBQPCJRRL-UHFFFAOYSA-N 0.000 description 1
- DQYSALLXMHVJAV-UHFFFAOYSA-M 3-heptyl-2-[(3-heptyl-4-methyl-1,3-thiazol-3-ium-2-yl)methylidene]-4-methyl-1,3-thiazole;iodide Chemical compound [I-].CCCCCCCN1C(C)=CS\C1=C\C1=[N+](CCCCCCC)C(C)=CS1 DQYSALLXMHVJAV-UHFFFAOYSA-M 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- LXEKPEMOWBOYRF-QDBORUFSSA-N AAPH Chemical compound Cl.Cl.NC(=N)C(C)(C)\N=N\C(C)(C)C(N)=N LXEKPEMOWBOYRF-QDBORUFSSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000242757 Anthozoa Species 0.000 description 1
- 240000006914 Aspalathus linearis Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000269333 Caudata Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- 206010015943 Eye inflammation Diseases 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 229940124726 Japanese encephalitis vaccine Drugs 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 description 1
- 102100037791 Macrophage migration inhibitory factor Human genes 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- MFBDBXAVPLFMNJ-UHFFFAOYSA-M N,N-Bis(2-hydroxyethyl)glycine sodium salt Chemical compound [Na+].OCCN(CCO)CC([O-])=O MFBDBXAVPLFMNJ-UHFFFAOYSA-M 0.000 description 1
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 1
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 1
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241001098054 Pollachius pollachius Species 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 229920001991 Proanthocyanidin Polymers 0.000 description 1
- 102100024819 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000785681 Sander vitreus Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 108010074506 Transfer Factor Proteins 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 235000021322 Vaccenic acid Nutrition 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- VENIIVIRETXKSV-BQYQJAHWSA-N Ximenynic acid Chemical compound CCCCCC\C=C\C#CCCCCCCCC(O)=O VENIIVIRETXKSV-BQYQJAHWSA-N 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 1
- BPOZQWVXHGWPPO-UHFFFAOYSA-J [Na+].[Na+].[Na+].[Na+].C(CCC(=O)[O-])(=O)ONOC(CCC(=O)[O-])=O.N(OC(CCC(=O)[O-])=O)OC(CCC(=O)[O-])=O Chemical compound [Na+].[Na+].[Na+].[Na+].C(CCC(=O)[O-])(=O)ONOC(CCC(=O)[O-])=O.N(OC(CCC(=O)[O-])=O)OC(CCC(=O)[O-])=O BPOZQWVXHGWPPO-UHFFFAOYSA-J 0.000 description 1
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 1
- RXDLGFMMQFNVLI-UHFFFAOYSA-N [Na].[Na].[Ca] Chemical compound [Na].[Na].[Ca] RXDLGFMMQFNVLI-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000011354 acetal resin Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000000475 acetylene derivatives Chemical class 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 229940117913 acrylamide Drugs 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- CAKGLMPBYAPFCR-UHFFFAOYSA-N alpha-maltosyl alpha-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 CAKGLMPBYAPFCR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 229940010048 aluminum sulfate Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- AGXUVMPSUKZYDT-UHFFFAOYSA-L barium(2+);octadecanoate Chemical compound [Ba+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O AGXUVMPSUKZYDT-UHFFFAOYSA-L 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-NCFXGAEVSA-N beta,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-NCFXGAEVSA-N 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000012813 breadcrumbs Nutrition 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- QHIWVLPBUQWDMQ-UHFFFAOYSA-N butyl prop-2-enoate;methyl 2-methylprop-2-enoate;prop-2-enoic acid Chemical compound OC(=O)C=C.COC(=O)C(C)=C.CCCCOC(=O)C=C QHIWVLPBUQWDMQ-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960000958 deferoxamine Drugs 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 1
- KYQODXQIAJFKPH-UHFFFAOYSA-N diazanium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [NH4+].[NH4+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O KYQODXQIAJFKPH-UHFFFAOYSA-N 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940090960 diethylenetriamine pentamethylene phosphonic acid Drugs 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- WQABCVAJNWAXTE-UHFFFAOYSA-N dimercaprol Chemical compound OCC(S)CS WQABCVAJNWAXTE-UHFFFAOYSA-N 0.000 description 1
- 229960001051 dimercaprol Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- BXLLINKJZLDGOX-UHFFFAOYSA-N dimethoxyphosphorylmethanamine Chemical compound COP(=O)(CN)OC BXLLINKJZLDGOX-UHFFFAOYSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- OPGYRRGJRBEUFK-UHFFFAOYSA-L disodium;diacetate Chemical compound [Na+].[Na+].CC([O-])=O.CC([O-])=O OPGYRRGJRBEUFK-UHFFFAOYSA-L 0.000 description 1
- PXBZPVFAAVSLKY-UHFFFAOYSA-L disodium;hydroxy-[2-[hydroxy(oxido)phosphoryl]azepan-2-yl]phosphinate Chemical compound [Na+].[Na+].OP([O-])(=O)C1(P(O)([O-])=O)CCCCCN1 PXBZPVFAAVSLKY-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002828 effect on organs or tissue Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- BDWFYHUDXIDTIU-UHFFFAOYSA-N ethanol;propane-1,2,3-triol Chemical compound CCO.OCC(O)CO BDWFYHUDXIDTIU-UHFFFAOYSA-N 0.000 description 1
- GLVVKKSPKXTQRB-UHFFFAOYSA-N ethenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC=C GLVVKKSPKXTQRB-UHFFFAOYSA-N 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 229940009626 etidronate Drugs 0.000 description 1
- 229940045995 etidronate tetrasodium Drugs 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000035611 feeding Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000007914 freezing tolerance Effects 0.000 description 1
- 239000007849 furan resin Substances 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- ZFSXZJXLKAJIGS-UHFFFAOYSA-N halocarban Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=CC(Cl)=CC=2)=C1 ZFSXZJXLKAJIGS-UHFFFAOYSA-N 0.000 description 1
- 229950006625 halocarban Drugs 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 229960001388 interferon-beta Drugs 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940113915 isostearyl palmitate Drugs 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 229940041323 measles vaccine Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000002759 monoacylglycerols Chemical class 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- APNPVBXEWGCCLU-QNRZBPGKSA-N mycomycin Chemical compound OC(=O)C\C=C\C=C/C=C=CC#CC#C APNPVBXEWGCCLU-QNRZBPGKSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- OASRDXXKKGHDJZ-UHFFFAOYSA-N octadec-17-en-9,11-diynoic acid Chemical compound OC(=O)CCCCCCCC#CC#CCCCCC=C OASRDXXKKGHDJZ-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000021542 oral nutrition Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940023462 paste product Drugs 0.000 description 1
- 235000019831 pentapotassium triphosphate Nutrition 0.000 description 1
- ATGAWOHQWWULNK-UHFFFAOYSA-I pentapotassium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [K+].[K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O ATGAWOHQWWULNK-UHFFFAOYSA-I 0.000 description 1
- QPTMDBQLCWRDCK-UHFFFAOYSA-I pentasodium;[2-[bis[[hydroxy(oxido)phosphoryl]methyl]amino]ethyl-(phosphonatomethyl)amino]methyl-hydroxyphosphinate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].OP([O-])(=O)CN(CP(O)([O-])=O)CCN(CP(O)([O-])=O)CP([O-])([O-])=O QPTMDBQLCWRDCK-UHFFFAOYSA-I 0.000 description 1
- OSBMVGFXROCQIZ-UHFFFAOYSA-I pentasodium;[bis(phosphonatomethyl)amino]methyl-hydroxyphosphinate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].OP([O-])(=O)CN(CP([O-])([O-])=O)CP([O-])([O-])=O OSBMVGFXROCQIZ-UHFFFAOYSA-I 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- 229940067082 pentetate Drugs 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000001931 piper nigrum l. white Substances 0.000 description 1
- 239000002281 placental hormone Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 235000019828 potassium polyphosphate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940010310 propylene glycol dioleate Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000003303 reheating Methods 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000018040 scab formation Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- ABTOQLMXBSRXSM-UHFFFAOYSA-N silicon tetrafluoride Chemical compound F[Si](F)(F)F ABTOQLMXBSRXSM-UHFFFAOYSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940083982 sodium phytate Drugs 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 1
- XSDNATYZLSRAKQ-UHFFFAOYSA-N sodium;2,7,9,14-tetraoxa-1,8-diazabicyclo[6.6.2]hexadecane-3,6,10,13-tetrone Chemical compound [Na].[Na].[Na].C1CN2OC(=O)CCC(=O)ON1OC(=O)CCC(=O)O2 XSDNATYZLSRAKQ-UHFFFAOYSA-N 0.000 description 1
- HLWRUJAIJJEZDL-UHFFFAOYSA-M sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC([O-])=O HLWRUJAIJJEZDL-UHFFFAOYSA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 150000003535 tetraterpenes Chemical class 0.000 description 1
- 235000009657 tetraterpenes Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 125000000647 trehalose group Chemical group 0.000 description 1
- 150000003625 trehaloses Chemical class 0.000 description 1
- JREYOWJEWZVAOR-UHFFFAOYSA-N triazanium;[3-methylbut-3-enoxy(oxido)phosphoryl] phosphate Chemical compound [NH4+].[NH4+].[NH4+].CC(=C)CCOP([O-])(=O)OP([O-])([O-])=O JREYOWJEWZVAOR-UHFFFAOYSA-N 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 229920006337 unsaturated polyester resin Polymers 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
Description
本発明は、新規なラジカル生成抑制剤、ラジカル生成抑制方法及びその用途、より詳細には、α,α−トレハロースの糖質誘導体或いはこれを含有する糖質を有効成分とする新規なラジカル生成抑制剤、該抑制剤を組成物に配合することを特徴とするラジカル生成抑制方法及びその用途に関するものである。 The present invention relates to a novel radical production inhibitor, a radical production inhibition method and its use, and more specifically, a novel radical production inhibition containing a carbohydrate derivative of α, α-trehalose or a carbohydrate containing the same as an active ingredient. The present invention relates to a radical generation inhibiting method characterized by blending an agent, the inhibitor into a composition, and its use.
脂質、染料、合成高分子をはじめとする有機化合物を主体とする製品が、その保存中に異臭の発生、変色・退色、硬化、分解、変性などにより品質劣化や機能低下を起こすことはよく知られている。また、飲食品や医薬品などの場合には、ラジカル生成により生じる過酸化物が、タンパク質、ペプチド及び/又はアミノ酸などの不飽和化合物以外の成分を変性させ、該製品の品質や機能の一層の低下をもたらすことが知られている。しかも、近年、ラジカル生成及びそれに引き続く一連の化学反応により生じる過酸化物は、細胞、組織に対する傷害作用があることから、皮膚の老化、生活習慣病、炎症性疾患、悪性新生物等の各種疾患の発症や増悪の主要原因の一つとされている。 It is well known that products mainly composed of organic compounds such as lipids, dyes and synthetic polymers cause quality deterioration and functional deterioration due to generation of strange odor, discoloration / discoloration, curing, decomposition, modification during storage. It has been. In addition, in the case of foods and drinks, pharmaceuticals, etc., the peroxide generated by radical generation denatures components other than unsaturated compounds such as proteins, peptides and / or amino acids, and further deteriorates the quality and function of the product. It is known to bring Moreover, in recent years, peroxides produced by radical generation and subsequent series of chemical reactions have damaging effects on cells and tissues, so various diseases such as skin aging, lifestyle-related diseases, inflammatory diseases, malignant neoplasms, etc. It is considered to be one of the main causes of onset and exacerbations.
このような品質劣化、機能の低下やヒトの健康に害を及ぼすとさえいわれる成分の生成をもたらす主要な反応は、有機化合物が無触媒下に起こす化学反応である。つまり、ラジカル化し易い有機化合物ほど上記のような品質劣化、すなわち化学的変化を起こし易いといえる。そして、ラジカル化のし易さは、分子内に不飽和結合が存在するか否か、ならびに、その存在様式と密接に関連しているといわれている。更に、有機化合物のラジカルが何らかの原因で一旦生成すると、該ラジカルとその近傍に存在する他の未反応の分子や分子状酸素との間で多様な反応が連鎖的に進行し、より大きな品質劣化や機能低下を引き起こすこととなる。有機化合物からのラジカル生成は、光照射や加温など日常的に起こり得る環境条件下で容易に誘発されるため、ラジカル生成及びそれに引き続き、連鎖的に進行する一連の化学反応反応(以下、本明細書ではこれらの反応を合わせて「ラジカル生成」という。)による製品の化学的変化は、食品分野、化粧品分野、医薬品分野、化学工業品分野などの広範な分野で起こり得る問題である。このため、ラジカル生成を阻止、抑制することは、特定の分野に限らず、製品の品質や機能の保持、ヒトの健康維持の上で極めて重要な課題のひとつである。 The main reactions that lead to such quality degradation, reduced function and the generation of components that are said to be harmful to human health are chemical reactions that occur in the absence of catalysts by organic compounds. That is, it can be said that an organic compound that is easily radicalized is more likely to cause the above-described quality deterioration, that is, chemical change. The easiness of radicalization is said to be closely related to whether or not there is an unsaturated bond in the molecule and the manner of its existence. Furthermore, once an organic compound radical is generated for some reason, a variety of reactions proceed in a chain between the radical and other unreacted molecules and molecular oxygen present in the vicinity, resulting in greater quality degradation. It will cause deterioration of function. Since radical generation from organic compounds is easily induced under environmental conditions that can occur on a daily basis, such as light irradiation and heating, radical generation and subsequent series of chemical reaction reactions (hereinafter referred to as this) In the specification, these reactions are collectively referred to as “radical generation”), and the chemical change of a product is a problem that can occur in a wide range of fields such as the food field, cosmetic field, pharmaceutical field, and chemical industry field. For this reason, prevention and suppression of radical generation is not only a specific field, but one of the extremely important issues in maintaining product quality and function and maintaining human health.
この課題を解決するための手段として、現在のところ、各分野において最も汎用されている手段は、一般にラジカルスカベンジャーと呼ばれる物質、すなわち、既に存在しているラジカルと反応し、それ自体が化学的に変化することによりラジカルの反応性を阻止ないしは抑制する物質を、製品又はその原料に配合する方法である。しかしながら、ラジカルスカベンジャーによるラジカルの抑制効果は長期間持続するものではないという欠点がある。 At present, as a means for solving this problem, the most widely used means in each field reacts with a substance generally called a radical scavenger, that is, an already existing radical, and itself is chemically. This is a method of blending a product or its raw material with a substance that prevents or suppresses the reactivity of radicals by changing. However, there is a drawback that the radical suppressing effect by the radical scavenger does not last for a long time.
このような状況をふまえて、例えば、特許文献1には、α,α−トレハロース及び/又はマルチトールを配合することにより、脂肪酸類からの揮発性アルデヒドの産生を抑制する方法が提案されている。しかしながら、現在の多様な食生活に対応するためには、継続的に摂取しても、食品の味、香り、食感などの風味の低下をもたらすことがなく、しかも、安全なラジカル生成抑制効果を有する機能性に優れた食品素材のさらなる開発が望まれている。 In view of such a situation, for example, Patent Document 1 proposes a method for suppressing the production of volatile aldehydes from fatty acids by blending α, α-trehalose and / or maltitol. . However, in order to cope with the current diverse diet, even if it is continuously consumed, it does not cause a decrease in the taste, aroma, texture, etc. of the food, and it has a safe radical production inhibitory effect. Further development of a food material with excellent functionality and having a high functionality is desired.
一方、本発明者らは、特許文献2〜7において、α,α−トレハロースの糖質誘導体やそれを含む糖質が、飲食品の褐変などを起こさないこと、脂質の酸化防止効果、及び、タンパク質の変性抑制効果を有することを開示したものの、その抑制メカニズムの実体については依然として不明であり、また、これら特許文献1〜7には、α,α−トレハロースの糖質誘導体やそれを含む糖質が、不飽和化合物からのラジカルを抑制することについてはなんら記載されていない。 On the other hand, the present inventors in Patent Documents 2 to 7, the α, α-trehalose saccharide derivative and the saccharide containing the same do not cause browning of food and drink, the lipid antioxidant effect, and Although disclosed that it has a protein denaturation inhibitory effect, the substance of the suppression mechanism is still unclear, and these Patent Documents 1 to 7 include α, α-trehalose carbohydrate derivatives and sugars containing the same. There is no mention of quality inhibiting radicals from unsaturated compounds.
本発明は、組成物中に含まれる不飽和化合物などの有機化合物からのラジカルの生成、このラジカルの生成による該組成物の保存中の異臭、褐変、退色、硬化、分解、変性などの発生、さらには、これらの反応により生成する過酸化物による該組成物中の脂質、タンパク質、ペプチド、アミノ酸などの成分の修飾などに起因する、該組成物の品質や機能の低下を抑制するために、ラジカルの生成(過酸化物などの生成や、さらに、この過酸化物が共存する脂質、タンパク質、ペプチド類、アミノ酸類などの成分を修飾、変性させる反応も含む)を抑制、阻止するために、ラジカル生成抑制剤を提供することを第一の課題とし、該ラジカル生成抑制剤を用いた有機化合物のラジカルの生成を抑制する方法を提供することを第二の課題として、該ラジカル生成抑制剤を含有するラジカル生成が抑制された組成物を提供することを第三の課題とするものである。 The present invention relates to generation of radicals from organic compounds such as unsaturated compounds contained in the composition, generation of off-flavors, browning, fading, curing, decomposition, modification, and the like during storage of the composition due to the generation of these radicals. Furthermore, in order to suppress degradation of the quality and function of the composition due to the modification of components such as lipids, proteins, peptides, and amino acids in the composition by peroxide generated by these reactions, In order to suppress or prevent the generation of radicals (including reactions that modify and modify lipids, proteins, peptides, amino acids, etc., in which peroxides coexist), A first problem is to provide a radical generation inhibitor, and a second problem is to provide a method for suppressing radical generation of an organic compound using the radical generation inhibitor. It is an third challenge that radical containing radical production inhibitor provides a composition which is suppressed.
本発明者らは、上記の課題を解決する目的で、糖質を用いるラジカルの生成の抑制、並びに、タンパク質や脂質の変性抑制の方法について長年にわたり研究を進めてきた。その結果、α,α−トレハロースの糖質誘導体、又は、これを含有する糖質が、不飽和化合物のラジカル生成の抑制に強く働くこと、さらには、これらの糖質が、該ラジカル生成により生じた過酸化物による脂質、タンパク質をはじめとする種々の成分の修飾乃至変性を抑制することを新たに見いだし、ラジカル生成抑制剤を確立するとともに、それを用いたラジカルの生成抑制方法を確立し、更に、ラジカル生成抑制剤を配合した組成物を確立することにより、本発明を完成するに至った。即ち、α,α−トレハロースの糖質誘導体、又は、これを含有する糖質がラジカルの生成を抑制できることを明らかにし、α,α−トレハロースの糖質誘導体、又は、これを含有する糖質を有効成分として含有するラジカル生成抑制剤を確立し、ラジカル生成が起こる前、又は、起きている有機の不飽和化合物を含む反応系に上記のラジカル生成抑制剤を配合させることで、ラジカル生成を抑制する方法を確立し、更に、不飽和化合物を含有する飲食品、化粧品、医薬部外品、医薬品、化学工業品などにラジカル生成抑制剤を配合した組成物を確立することにより、本発明を完成するに至った。 In order to solve the above-mentioned problems, the present inventors have been conducting research for many years on methods for suppressing the generation of radicals using carbohydrates and methods for suppressing the denaturation of proteins and lipids. As a result, the carbohydrate derivative of α, α-trehalose or a carbohydrate containing this strongly acts on the suppression of radical generation of unsaturated compounds, and furthermore, these carbohydrates are generated by the radical generation. Newly found to suppress the modification or denaturation of various components such as lipids and proteins caused by peroxides, and established a radical production inhibitor, and established a radical production inhibition method using it, Furthermore, the present invention has been completed by establishing a composition containing a radical production inhibitor. That is, it is clarified that a carbohydrate derivative of α, α-trehalose or a carbohydrate containing it can suppress the production of radicals, and a carbohydrate derivative of α, α-trehalose or a carbohydrate containing the same is added. Establish radical generation inhibitor contained as an active ingredient and suppress radical generation before radical generation occurs or by adding the above radical generation inhibitor to a reaction system containing an organic unsaturated compound. In addition, the present invention was completed by establishing a composition in which a radical generation inhibitor was blended with foods and drinks, cosmetics, quasi drugs, pharmaceuticals, and chemical industrial products containing unsaturated compounds. It came to do.
本発明は、ラジカルの生成により不飽和化合物の分解が進行すること、さらには、不飽和化合物の過酸化物による脂質、タンパク質などの修飾、変性をも抑制するために、グルコースを構成糖とする非還元性糖質であるα,α−トレハロースの糖質誘導体が、ラジカルの生成抑制作用が強いことを見出し、ラジカル生成が起こる前、又は、起きている有機の不飽和化合物を含む反応系に上記のα,α−トレハロースの糖質誘導体、又は、これを含有する糖質を有効成分とするラジカル生成抑制剤を配合させることで、不飽和化合物のラジカル生成を抑制し、さらには、発生した過酸化物によるタンパク質などの修飾、変性をも抑制するものである。 In the present invention, glucose is used as a constituent sugar in order to suppress the degradation of unsaturated compounds by the generation of radicals, and also to suppress the modification and denaturation of lipids and proteins due to the peroxides of unsaturated compounds. The α, α-trehalose saccharide derivative, a non-reducing saccharide, has been found to have a strong radical-inhibiting action and can be used before a radical is generated or in a reaction system containing an organic unsaturated compound. Incorporating the above-mentioned α, α-trehalose saccharide derivative or a radical generation inhibitor containing a saccharide containing this as an active ingredient suppresses radical generation of unsaturated compounds, and further occurs. It also suppresses modification and denaturation of proteins by peroxides.
本発明で使用するα、α−トレハロースの糖質誘導体は、ラジカル生成を抑制できるものであればよく、α、α−トレハロースの糖質誘導体或いはこれを含有するシラップ、マスキット、非晶質粉末、含密結晶粉末、結晶などが有利に利用できる。α、α−トレハロースの糖質誘導体は、具体的には、分子内にα,α−トレハロース構造を有する3個以上のグルコースからなる非還元性オリゴ糖から選ばれる1種又は2種以上の糖質であれば、いずれでもよく、より具体的には、α,α−トレハロース分子の少なくとも一方のグルコースに、モノ−グルコース、ジ−グルコース、トリ−グルコース及びテトラ−グルコースから選ばれるいずれかが結合したものをいう。例えば、先に、本出願人が特許文献2などにおいて開示した、α−グルコシルα,α−トレハロース(別名α−マルトシルα−グルコシド)、α−イソマルトシルα−グルコシドなどのモノ−グルコシルα,α−トレハロースや、α−マルトシルα,α−トレハロース(別名α−マルトトリオシルα−グルコシド)、α−マルトシルα−マルトシド、α−イソマルトシルα−マルトシド、α−イソマルトシルα−イソマルトシドなどのジ−グルコシルα,α−トレハロース、α−マルトトリオシルα,α−トレハロース(別名α−マルトテトラオシルα−グルコシド)、α−マルトシルα−マルトトリオシド、α−パノシルα−マルトシドなどのトリ−グルコシルα,α−トレハロース、α−マルトテトラオシルα,α−トレハロース(別名α−マルトペンタオシルα−グルコシド)、α−マルトトリオシルα−マルトトリオシド、α−パノシルα−マルトトリオシドなどのテトラ−グルコシルα,α−トレハロースなど、グルコース重合度が3乃至6からなるα,α−トレハロースの糖質誘導体が好ましい。 The carbohydrate derivative of α, α-trehalose used in the present invention is not limited as long as it can suppress radical generation, and α, α-trehalose carbohydrate derivative or syrup, mass kit, amorphous powder containing the same, Impregnated crystal powder, crystals, etc. can be advantageously used. Specifically, the carbohydrate derivative of α, α-trehalose is one or more sugars selected from non-reducing oligosaccharides composed of 3 or more glucoses having an α, α-trehalose structure in the molecule. And more specifically, any one selected from mono-glucose, di-glucose, tri-glucose and tetra-glucose is bound to at least one glucose of the α, α-trehalose molecule. What you did. For example, mono-glucosyl α, α-, such as α-glucosyl α, α-trehalose (also known as α-maltosyl α-glucoside) and α-isomaltosyl α-glucoside, previously disclosed by the present applicant in Patent Document 2 and the like. Di-glucosyl α such as trehalose, α-maltosyl α, α-trehalose (also known as α-maltotriosyl α-glucoside), α-maltosyl α-maltoside, α-isomaltosyl α-maltoside, α-isomaltosyl α-isomaltoside, etc. Tri-glucosyl α, α such as α-trehalose, α-maltotriosyl α, α-trehalose (also known as α-maltotetraosyl α-glucoside), α-maltosyl α-maltotrioside, α-panosyl α-maltoside -Trehalose, α-maltotetraosyl α, α-trehalose (also known as α-maltopentaosyl α- Glucoside), α-maltotriosyl α-maltotrioside, α-panosyl α-maltotrioside and other tetra-glucosyl α, α-trehalose, etc. Quality derivatives are preferred.
これらのα,α−トレハロースの糖質誘導体は、その由来や製法は問わず、発酵法、酵素法、有機合成法などにより製造されたものでもよい。例えば、本出願人が、特許文献2で開示した酵素法により澱粉や澱粉の部分加水分解物から直接製造してもよく、或いは、特許文献2で開示したマルトテトラオース生成アミラーゼや、特公平7−14962号公報で開示したマルトペンタオースを高率に生成するα−アミラーゼ或いは特開平7−236478号公報で開示したマルトヘキサオース・マルトヘプタオース生成アミラーゼなどを使用して、澱粉からマルトテトラオース、マルトペンタオース、マルトヘキサオース、マルトヘプタオースなどの特定のオリゴ糖の含量を高めた澱粉部分加水分解物を調製し、これに特許文献2で開示した非還元性糖質生成酵素を作用させて製造することも随意である。また、澱粉、或いは、澱粉の部分加水分解物とα,α−トレハロースとを含有する溶液にシクロデキストリングルカノトランスフェラーゼなどのグリコシル基の転移能を有する酵素を作用させて調製することも随意である。これらの方法により得られる反応液は、α,α−トレハロースの糖質誘導体を含有する糖質を含む溶液として、そのままで、又は、部分精製して、或いは、高純度に精製して使用することも、さらには、これらの糖質の製造工程において共存する還元性の糖質を水素添加して、糖アルコールにしたものを使用することも可能である。これらの製造方法は、豊富で安価な澱粉質を原料とし、高効率かつ安価にα,α−トレハロースの糖質誘導体を製造できることから、工業的に有利に利用できる。また、上記方法により製造された市販のシラップ状のα,α−トレハロースの糖質誘導体含有糖質(株式会社林原商事販売、商品名「ハローデックス」や、これを水素添加して共存する還元性糖質をその糖アルコールに変換した糖質(株式会社林原生物化学研究所販売、商品名「トルナーレ」)を使用することも有利に実施できる。 These carbohydrate derivatives of α, α-trehalose may be produced by fermentation, enzymatic methods, organic synthesis methods, etc., regardless of their origin or production method. For example, the present applicant may directly produce starch or a partially hydrolyzed starch by the enzyme method disclosed in Patent Document 2, or maltotetraose-producing amylase disclosed in Patent Document 2 or The α-amylase that produces maltopentaose disclosed in Japanese Patent No. 14962 at a high rate or the maltohexaose maltoheptaose-producing amylase disclosed in Japanese Patent Application Laid-Open No. 7-236478 is used to make maltotetraose from starch. , A partial hydrolyzate of starch having an increased content of specific oligosaccharides such as maltopentaose, maltohexaose, maltoheptaose and the like, and a non-reducing saccharide-forming enzyme disclosed in Patent Document 2 acting thereon It is also optional to manufacture. It is also optional to prepare starch or a solution containing starch partial hydrolyzate and α, α-trehalose by allowing an enzyme having a glycosyl group transfer ability such as cyclodextrin glucanotransferase to act. . The reaction solution obtained by these methods should be used as it is, as a solution containing a saccharide derivative containing a saccharide derivative of α, α-trehalose, as it is or after partial purification or purification to a high purity. Furthermore, it is also possible to use a sugar alcohol obtained by hydrogenating a reducing sugar coexisting in the sugar production process. These production methods can be advantageously used industrially because a saccharide derivative of α, α-trehalose can be produced with high efficiency and low cost by using abundant and inexpensive starch as a raw material. Also, a commercially available syrup-like α, α-trehalose saccharide derivative-containing saccharide produced by the above method (trade name “Hellodex” sold by Hayashibara Shoji Co., Ltd.) The use of a saccharide obtained by converting a saccharide into its sugar alcohol (sales by Hayashibara Biochemical Laboratories, Inc., trade name “Tornale”) can also be advantageously performed.
上記のα,α−トレハロースの糖質誘導体のうち、とりわけ、α−グルコシルα,α−トレハロース、α−マルトシルα,α−トレハロース、α−マルトトリオシルα,α−トレハロース及びα−マルトテトラオシルα,α−トレハロースなど、分子の末端にトレハロース構造を持つ糖質が、ラジカル生成の抑制作用が強く、本発明に有利に利用できる。この糖質の一例としては、特許文献2に開示されたα−マルトシルα,α−トレハロースを主成分として含有し、他に、α−グルコシルα,α−トレハロース、α−マルトトリオシルα,α−トレハロース、α−グリコシルα−グルコースから選ばれる1種又は2種以上を含有する糖質が望ましく、とりわけ、α−マルトシルα,α−トレハロースを、無水物換算で、約5質量%(以下、本明細書では特に断らない限り、「質量%」を単に「%」と表記する。)以上、望ましくは約10%以上、さらに望ましくは約30%以上含有する糖質が望ましい。また、本発明のラジカル生成抑制剤は、ラジカル生成抑制作用の強さの点からすると、α,α−トレハロースの糖質誘導体のいずれか2種以上を、少なくとも、α,α−トレハロースの糖質誘導体の全量に対して、無水物換算で各々5%以上含有する糖質の方が、そのいずれか1種のみを含有するものよりも望ましい。 Among the above carbohydrate derivatives of α, α-trehalose, among others, α-glucosyl α, α-trehalose, α-maltosyl α, α-trehalose, α-maltotriosyl α, α-trehalose and α-maltotetrao A carbohydrate having a trehalose structure at the end of the molecule, such as syl α, α-trehalose, has a strong radical-inhibiting action and can be advantageously used in the present invention. As an example of this carbohydrate, α-maltosyl α, α-trehalose disclosed in Patent Document 2 is contained as a main component, and in addition, α-glucosyl α, α-trehalose, α-maltotriosyl α, α -A saccharide containing one or more selected from trehalose and α-glycosyl α-glucose is desirable, and in particular, α-maltosyl α, α-trehalose is about 5% by mass (hereinafter referred to as “anhydride”). In the present specification, unless otherwise specified, “mass%” is simply expressed as “%”.) More preferably, a carbohydrate containing about 10% or more, more preferably about 30% or more is desirable. In addition, the radical production inhibitor of the present invention is characterized in that any two or more of α, α-trehalose saccharide derivatives and at least α, α-trehalose saccharide are used from the viewpoint of the strength of the radical production inhibitory action. Carbohydrates containing 5% or more each in terms of anhydride are more preferable than those containing only one of them relative to the total amount of the derivative.
また、本発明のラジカル生成抑制剤を使用する組成物が、アミノ酸などのように分子内にアミノ基を有する物質を含む場合には、グルコースをはじめとする還元性糖類が混在するとメーラード反応などにより該組成物中の有効成分及び/又は該組成物自体の品質低下が特に問題となることが予想されるので、本発明のラジカル生成抑制剤として、α,α−トレハロースの糖質誘導体を、98%以上、望ましく99%以上、さらに望ましくは99.5%以上含有するものや、α,α−トレハロースの糖質誘導体と共存する還元性の糖質に水素添加して、その還元性を低減したものが好適である。また、α,α−トレハロースの糖質誘導体は安定な糖質なので、本発明のラジカル生成抑制剤を使用する組成物の品質を低下させない限り、必要に応じて、ラジカルスカベンジャーの他、分散性を高めたり、増量などの目的に応じて、還元性糖質類、α,α−トレハロースの糖質誘導体以外の非還元性糖質類、糖蜜、糖アルコール類、ヒアルロン酸やコンドロイチンなどのムコ多糖類を含む水溶性多糖類、無機塩類、アデノシンモノホスフェイト(AMP)などの核酸関連物質、乳化剤、動植物の由来の成分、酸化防止剤及びキレート作用を有する物質から選ばれる1種又は2種以上と併用することも随意である。さらに必要であれば、公知の着色料、着香料、保存料、安定剤などを適量併用することも随意である。 In addition, when the composition using the radical production inhibitor of the present invention contains a substance having an amino group in the molecule such as an amino acid, when reducing sugars such as glucose are mixed, it is caused by a Maillard reaction or the like. Since it is anticipated that deterioration of the quality of the active ingredient in the composition and / or the composition itself will be a particular problem, a carbohydrate derivative of α, α-trehalose is used as the radical production inhibitor of the present invention. % Or more, preferably 99% or more, more preferably 99.5% or more, or reducing carbohydrates coexisting with carbohydrate derivatives of α, α-trehalose to reduce the reducing properties. Those are preferred. In addition, since the saccharide derivatives of α, α-trehalose are stable saccharides, as long as the quality of the composition using the radical production inhibitor of the present invention is not deteriorated, in addition to the radical scavenger, the dispersibility can be improved. Depending on the purpose such as increasing or increasing the amount, reducing carbohydrates, non-reducing carbohydrates other than carbohydrate derivatives of α, α-trehalose, molasses, sugar alcohols, mucopolysaccharides such as hyaluronic acid and chondroitin 1 type or 2 or more types selected from water-soluble polysaccharides, inorganic salts, nucleic acid-related substances such as adenosine monophosphate (AMP), emulsifiers, ingredients derived from animals and plants, antioxidants and substances having a chelating action Use in combination is also optional. Furthermore, if necessary, it is optional to use known amounts of coloring agents, flavoring agents, preservatives, stabilizers and the like in appropriate amounts.
また、本発明のラジカル生成抑制剤と併用される非還元性糖類としては、トレハロース(α,α−トレハロース、α,β−トレハロース或いはβ,β−トレハロースの1種又は2種以上の組み合わせ)や、同じ特許出願人による国際公開WO 02/10361号明細書或いは特開2005−95148号公報(特願2004−174880号明細書)などに記載の環状四糖が、又、糖アルコール類としてはマルチトールが、いずれも優れたラシカル産生抑制効果、脂質の変敗抑制効果や脂質からのアルデヒド類の生成抑制効果を有する点から望ましく、中でもα,α−トレハロースや環状四糖は、それらの効果が極めて高いことから、特に望ましい。 Examples of the non-reducing saccharide used in combination with the radical production inhibitor of the present invention include trehalose (α, α-trehalose, α, β-trehalose or one or a combination of two or more of β, β-trehalose) and The cyclic tetrasaccharides described in International Publication WO 02/10361 or Japanese Patent Application Laid-Open No. 2005-95148 (Japanese Patent Application No. 2004-174880) and the like by the same patent applicant are also available as sugar alcohols. Tolls are desirable because they all have excellent radical production inhibitory effects, lipid degradation inhibitory effects, and aldehydes production inhibitory effects from lipids. Among them, α, α-trehalose and cyclic tetrasaccharides have these effects. It is particularly desirable because it is very expensive.
本発明のラジカル生成抑制剤は、その各々の使用分野において通常使用される酸化防止方法と組み合わせて用いることにより、単独の使用よりも更に効率的にラジカル生成を抑制することができる。酸化防止方法としては、例えば、抗酸化剤、脱酸素剤、ラジカルスカベンジャー、カルボン酸、オキシカルボン酸、アミノカルボン酸、ホスホン酸、アミノホスホン酸、ポリリン酸やこれらの塩類をはじめとする金属のキレート剤との併用や、本発明のラジカル生成抑制剤を含有する組成物を、カプセルへ封入したり、コーティング処理、密封容器での保存、不活性ガスの封入などにより酸素との接触の遮断、さらには、遮光、低温保存などから選ばれる1種又は2種以上の方法を適宜組み合わせて利用することができる。 By using the radical generation inhibitor of the present invention in combination with an antioxidant method usually used in each field of use, radical generation can be more efficiently suppressed than when used alone. Examples of the antioxidant method include chelating metals such as antioxidants, oxygen scavengers, radical scavengers, carboxylic acids, oxycarboxylic acids, aminocarboxylic acids, phosphonic acids, aminophosphonic acids, polyphosphoric acids and salts thereof. In combination with an agent, the composition containing the radical generation inhibitor of the present invention is sealed in a capsule, coated, stored in a sealed container, sealed with an inert gas, etc., to block contact with oxygen, and Can be used by appropriately combining one or more methods selected from light-shielding and low-temperature storage.
本発明でいうラジカルスカベンジャーとは、反応中に生じるラジカルや活性酸素を効率的に捉えて消去するために使用される化合物であれば、いずれでもよく、ラジカル生成抑制剤の使途に応じて1種又2種以上が、適宜選択される。例えば、アスコルビン酸、アスコルビン酸2−グルコシドなどのアスコルビン酸誘導体、ビタミンB2、ビタミンB2誘導体、ヘスペリジン、ルチン、ナリンジン、ケルセチンなどのビタミンP類或いは糖転移ヘスペリジン、糖転移ルチン、糖転移ナリンジン、糖転移ケルセチンをはじめとするビタミンP類の誘導体などのビタミン類、コエンザイムQ10(CoQ10)を含むユビキノン類・ヒドロキノン類・レゾルシノール類やそれらの誘導体、β−カロチン、α−カロチン、ルテイン、リコピン、アスタキサンチンをはじめとするカロチノイド、カテキン、エピガロカテキン、エピガロカテキンガレート、フラバンジェノール、アントシアニジン、プロアントシアニジン、タンニン、クロロゲン酸、エラグ酸、フェノール酸、アスタキサンチンをはじめとするポリフェノール類などのフラボノイド類や、これらの配糖体をはじめとする誘導体、ジブチルヒドロキシトルエン、没食子酸プロピル、ジフェニルピクリルヒドラジル、ガルビノキシル、ハイドロキノン、ハイドロキノン誘導体、チオタウリン、アイエキス、アマチャエキス、アマモエキス、ウコンエキス、エイジツエキス、オウゴンエキス、オトギリソウエキス、ゴバイシエキス、ゲンノショウコウエキス、コンフリーエキス、サンショウエキス、シソエキス、シャクヤクエキス、チャエキス、チョウジエキス、ビワエキス、ボタンエキス、マロニエエキス、ユキノシタエキス、ルイボスエキス、ローズマリーエキス、クロレラエキス、ドナリエラエキスをはじめとするフラボノイド類やテルペン類を含有する植物エキス類(プロポリスエキスを含む)、レイシエキス、鹿角レイシエキスなどを挙げることができ、また、前記不飽和化合物の中からも、例えば、ビタミンA、ビタミンEやそれらの誘導体などに代表されるテルペン類、ドコサペンタエン酸、ドコサヘキサエン酸などに代表される不飽和脂肪酸のようなラジカル消去能を有する化合物を、その用途に応じて適宜使用することも自由である。 The radical scavenger referred to in the present invention may be any compound as long as it is a compound used for efficiently capturing and erasing radicals and active oxygen generated during the reaction, and one kind is used depending on the use of the radical production inhibitor. Two or more kinds are appropriately selected. For example, ascorbic acid, ascorbic acid derivatives such as ascorbic acid 2-glucoside, vitamin B 2 , vitamin B 2 derivatives, vitamin Ps such as hesperidin, rutin, naringin, quercetin or sugar-transferred hesperidin, sugar-transferred rutin, sugar-transferred naringin, Vitamins such as derivatives of vitamin P including sugar transfer quercetin, ubiquinones / hydroquinones / resorcinols including coenzyme Q10 (CoQ10) and derivatives thereof, β-carotene, α-carotene, lutein, lycopene, astaxanthin Carotenoids such as catechin, epigallocatechin, epigallocatechin gallate, flavangenol, anthocyanidin, proanthocyanidin, tannin, chlorogenic acid, ellagic acid, phenolic acid, astaki Flavonoids such as polyphenols including santin, derivatives including these glycosides, dibutylhydroxytoluene, propyl gallate, diphenylpicrylhydrazyl, galvinoxyl, hydroquinone, hydroquinone derivatives, thiotaurine, eye extract, Achacha extract, Amamo extract, Turmeric extract, Ages extract, Ogon extract, Hypericum extract, Gobaishi extract, Genpoku extract, Comfrey extract, Salamander extract, Perilla extract, Peonies extract, Cha extract, Clove extract, Biwa extract, Button extract, Maronnier extract, Plants that contain flavonoids and terpenes, including yukinoshita extract, rooibos extract, rosemary extract, chlorella extract, donariella extract Examples include kisses (including propolis extract), litchi extract, and kakukaku litchi extract. Among the unsaturated compounds, for example, terpenes represented by vitamin A, vitamin E, and derivatives thereof A compound having radical scavenging ability such as an unsaturated fatty acid typified by catechol, docosapentaenoic acid, docosahexaenoic acid and the like can be used as appropriate depending on the application.
また、α,α−トレハロースの糖質誘導体は、前記ラジカルスカベンジャーの持つ独特の、苦味、渋味、生臭味などの不快味や不快臭を効果的にマスクし、さらには、ラジカルスカベンジャー自身の酸化やメーラード反応などに起因する褐変や変色を抑制することから、ラジカルスカベンジャーを併用しても、それに由来する不快味や不快臭が抑制され、着色や変色も抑制された高品質の飲食品、医薬品、医薬部外品などを製造することができる。この場合の、ラジカルスカベンジャーの添加量に特に制限は無く、通常、組成物の約0.001〜20%が望ましく、0.01〜10%が特に望ましい。また、α,α−トレハロースの糖質誘導体の添加量は、対象とする組成物の物性や品質に影響を及ぼさない限り特に制限はないものの、例えば、茶飲料などのように甘味を持たない組成物の場合には、組成物の約5%或いはそれ以下の量が望ましい。この場合、α,α−トレハロース、国際公開WO 02/10361号明細書や特開2005−95148号公報(特願2004−174880号明細書)などに記載の環状四糖、L−アスコルビン酸2−グルコシドから選ばれる何れか1種又は2種以上とを併用することにより、これらの物質の持つ不快味及び/又は不快臭の抑制効果がさらに増強され、ラジカルスカベンジャーの不快味及び/又は不快臭を効果的に低減することができる。 In addition, the carbohydrate derivative of α, α-trehalose effectively masks the unpleasant taste and unpleasant odor such as the bitterness, astringency and raw odor of the radical scavenger. Because it suppresses browning and discoloration due to oxidation, Maillard reaction, etc., even when used together with radical scavengers, high-quality food and drink that suppresses unpleasant taste and unpleasant odor derived from it, and also suppresses coloring and discoloration, Pharmaceuticals, quasi drugs, etc. can be manufactured. In this case, the amount of radical scavenger added is not particularly limited, and is usually preferably about 0.001 to 20%, and particularly preferably 0.01 to 10% of the composition. The amount of the α, α-trehalose saccharide derivative added is not particularly limited as long as it does not affect the physical properties and quality of the target composition. For example, a composition having no sweetness such as a tea beverage In the case of products, an amount of about 5% or less of the composition is desirable. In this case, α, α-trehalose, cyclic tetrasaccharides described in WO 02/10361 and JP-A-2005-95148 (Japanese Patent Application No. 2004-174880), L-ascorbic acid 2- By using any one or more selected from glucoside in combination, the effect of suppressing the unpleasant taste and / or unpleasant odor of these substances is further enhanced, and the unpleasant taste and / or unpleasant odor of the radical scavenger is reduced. It can be effectively reduced.
本発明でいう、α,α−トレハロースの糖質誘導体、又は、これを含有する糖質を含んでなるラジカル生成抑制剤を含有させるとは、当該成分とそれ以外の成分が直接接触できるように、その利用目的に応じて、原料の段階から製品の段階に至るまでの適宜の工程、或いは、既存の製品に対して、例えば、混和、混捏、溶解、融解、分散、懸濁、乳化、浸漬、浸透、散布、塗布、被覆、噴霧、注入、晶出、固化、逆ミセル化などの1種又は2種以上の方法を適宜組み合わせて接触させることを意味し、これらの方法を、常圧条件下ではもとより、高圧条件下、減圧条件下、さらには、超臨界流体を利用して超臨界条件下で実施することも随意である。また、本発明で使用するα,α−トレハロースの糖質誘導体、又は、これを含有する糖質の形態に特に制限はなく、例えば、シラップ、マスキット、ペースト、固状物、粉末、結晶、顆粒、錠剤などのいずれでもよく、そのままで、又は、必要に応じて、増量剤、賦形剤、結合剤などと混合して、顆粒、球状、短棒状、板状、立方体、錠剤などの各種形状に成形して使用することも随意である。 In the present invention, the inclusion of a saccharide derivative of α, α-trehalose or a radical production inhibitor containing a saccharide containing the same so that the component and other components can be in direct contact with each other. Depending on the purpose of use, an appropriate process from the raw material stage to the product stage, or an existing product, for example, mixing, kneading, dissolving, melting, dispersing, suspending, emulsifying, immersing , Impregnation, spraying, coating, coating, spraying, pouring, crystallization, solidification, reverse micelle formation, etc. means that one or two or more methods are appropriately combined and brought into contact under normal pressure conditions. Under the high pressure condition, the reduced pressure condition, and the supercritical fluid is optionally used under the supercritical condition. Moreover, there is no restriction | limiting in particular in the form of the carbohydrate derivative of (alpha), (alpha) -trehalose used by this invention, or the carbohydrate containing this, For example, a syrup, a mass kit, a paste, a solid substance, a powder, a crystal | crystallization, a granule Any of tablet, tablet, etc. may be used as it is, or mixed with a bulking agent, excipient, binder, etc. as necessary to form various shapes such as granules, spheres, short bars, plates, cubes, tablets, etc. It is also optional to use it after molding.
組成物に、α,α−トレハロースの糖質誘導体、又は、これを含有する糖質を含有させる量は、その組成物に含まれる不飽和化合物のラジカル生成抑制効果を発揮できる量であればよく、特に制限はないが、通常、不飽和化合物を含有する組成物に対して、α,α−トレハロースの糖質誘導体、又は、これを含有する糖質を無水物としての換算で約0.01%以上約99.9%未満、さらに好ましくは、約1.0%以上約90%未満をできるだけ均一に含有せしめるのが好適である。通常0.01%未満では、不飽和化合物のラジカル生成を効果的に抑制するには不充分である。 The amount of the saccharide derivative of α, α-trehalose or the saccharide containing it in the composition may be an amount that can exhibit the radical generation inhibitory effect of the unsaturated compound contained in the composition. Although there is no particular limitation, normally, a composition containing an unsaturated compound, α, α-trehalose saccharide derivative, or saccharide containing this is about 0.01 in terms of an anhydride. % Or more and less than about 99.9%, and more preferably, about 1.0% or more and less than about 90% is contained as uniformly as possible. Usually, if it is less than 0.01%, it is insufficient for effectively suppressing radical generation of unsaturated compounds.
本発明でいう不飽和化合物とは、炭素鎖に、炭素−炭素間の不飽和結合(以下、単に「不飽和結合」という。)すなわち、二重結合又は三重結合を有する炭化水素、ならびに斯かる炭化水素における水素原子を他の元素や基などで置換した誘導体を意味し、脂肪酸類、アルコール類、単純脂質類、複合脂質類、テルペン類、合成高分子類、ビニル類などに属する化合物を挙げることができる。また、紫外線を含む光、熱、放射線、圧力などの物理的な要因により、変成、分解してラジカル生成の原因となる不飽和結合を生成する物質を含む。 The unsaturated compound referred to in the present invention is a carbon-carbon unsaturated bond (hereinafter simply referred to as “unsaturated bond”), that is, a hydrocarbon having a double bond or a triple bond, as well as such a compound. Derivatives in which hydrogen atoms in hydrocarbons are substituted with other elements or groups, including compounds belonging to fatty acids, alcohols, simple lipids, complex lipids, terpenes, synthetic polymers, vinyls, etc. be able to. In addition, it includes substances that generate unsaturated bonds that cause radical generation by modification and decomposition due to physical factors such as light including ultraviolet rays, heat, radiation, and pressure.
本発明でいう脂肪酸類とは、カルボキシル基を1個又は2個有し、分岐構造、環状構造及び/又はヒドロキシル基を有することもある鎖式化合物ならびにその塩を意味する。具体例としては、オレイン酸、パルミトレイン酸、ネルボン酸、ツズ酸、トウハク酸、バクセン酸などのモノエン型脂肪酸(二重結合を1個有する)、リノール酸、リノレン酸、アラキドン酸、エイコサペンタエン酸、ドコサペンタエン酸、ドコサヘキサエン酸、プロスタグランジン、トロンボキサン、ロイコトリエンなどのポリエン型脂肪酸(二重結合を2個以上有する)、リリン酸、キシメニン酸、エリトロゲン酸、クレペニン酸、マイコマイシンなどのアセチレン型脂肪酸(三重結合を1個以上有する)、ムコン酸などのポリエンジカルボン酸型脂肪酸(2個以上の二重結合と2個のカルボキシル基を有する)などが挙げられる。 The fatty acids referred to in the present invention means a chain compound having one or two carboxyl groups and having a branched structure, a cyclic structure and / or a hydroxyl group, and salts thereof. Specific examples include monoene type fatty acids (having one double bond) such as oleic acid, palmitoleic acid, nervonic acid, tuzuic acid, tough acid, vaccenic acid, linoleic acid, linolenic acid, arachidonic acid, eicosapentaenoic acid. , Acetylenes such as polyene type fatty acids (having two or more double bonds) such as docosapentaenoic acid, docosahexaenoic acid, prostaglandin, thromboxane, leukotriene, lilylic acid, xymenic acid, erythrogenic acid, crepenic acid, mycomycin Type fatty acids (having one or more triple bonds), polyene dicarboxylic acid type fatty acids such as muconic acid (having two or more double bonds and two carboxyl groups), and the like.
アルコール類とは、鎖式炭化水素の水素原子を水酸基で置換した化合物を意味し、水酸基を1個有する1価アルコールと、水酸基を2個以上有する多価アルコールとを含む。具体例としては、オレイルアルコールが挙げられる。 The alcohol means a compound in which a hydrogen atom of a chain hydrocarbon is substituted with a hydroxyl group, and includes a monohydric alcohol having one hydroxyl group and a polyhydric alcohol having two or more hydroxyl groups. A specific example is oleyl alcohol.
単純脂質類とは、構成原子が炭素原子、水素原子及び酸素原子からなり、分子中に脂肪酸類化合物に相当する炭化水素鎖を有する有機化合物を意味し、代表的なものとしては、脂肪酸類化合物とアルコール類化合物との脱水縮合物(エステル)ならびにその相当物が挙げられる。具体的としては、アルコール部分が1価アルコールであるオレイン酸デシル及びオレイン酸オクチルドデシル、アルコール部分がプロピレングリコールであるジオレイン酸プロピレングリコール、アルコール部分がグリセロールであり、脂肪酸部分が上記に例示したような不飽和脂肪酸であって、1分子中に1個、2個又は3個の脂肪酸部分を含むモノアシルグリセロール、ジアシルグリセロールならびにトリアシルグリセロール(以上3種をまとめて「中性脂肪」という場合がある)、アルコール部分がグリセリン重合体であり、脂肪酸部分が上記に例示したような不飽和脂肪酸であるポリグリセリン脂肪酸エステル、アルコール部分がショ糖である(ショ糖脂肪酸エステル)、ショ糖モノオレアート、ショ糖モノリノラート及びショ糖ジオレアートなどが挙げられる。なお、通常「油脂」と呼ばれるものはトリアシルグリセロールを主体とする油溶性物質を含む組成物であり、また、油脂はさらに、常温で液体の「脂肪油」と常温で個体の「脂肪」とに分類されており、これらは通常不飽和化合物を含んでいるので、当然ながら本発明の対象となり得る。 Simple lipids mean organic compounds whose constituent atoms consist of carbon atoms, hydrogen atoms, and oxygen atoms, and that have a hydrocarbon chain corresponding to a fatty acid compound in the molecule. Typical examples include fatty acid compounds. And dehydration condensates (esters) of alcohol compounds and their equivalents. Specifically, decyl oleate and octyldodecyl oleate in which the alcohol part is a monohydric alcohol, propylene glycol dioleate in which the alcohol part is propylene glycol, the alcohol part is glycerol, and the fatty acid part is as exemplified above Unsaturated fatty acids, monoacylglycerol, diacylglycerol and triacylglycerol containing one, two or three fatty acid moieties in one molecule (sometimes these three are collectively referred to as “neutral fat”) ), A polyglycerin fatty acid ester in which the alcohol part is a glycerin polymer, and the fatty acid part is an unsaturated fatty acid as exemplified above, the alcohol part is sucrose (sucrose fatty acid ester), sucrose monooleate, Sucrose monolinoleate and sucrose di Reato and the like. In addition, what is usually called “oil and fat” is a composition containing an oil-soluble substance mainly composed of triacylglycerol, and the fat and oil further includes “fatty oil” that is liquid at room temperature and “fat” of an individual at room temperature. Since these normally contain unsaturated compounds, they can of course be the subject of the present invention.
複合脂質類とは、上記で定義した単純脂質類と同じく分子中に脂肪酸類化合物に相当する炭化水素鎖を有する一方、構成原子として炭素原子、水素原子及び酸素原子に加えて、リン原子や窒素原子などを含む有機化合物を意味する。複合糖脂質類は一般に、グリセロリン脂質、グリセロ糖脂質、スフィンゴリン脂質、スフィンゴ糖脂質の4種に大別され、さらに本発明においてはこれらの誘導体や部分分解物、例えば、セラミドなども複合脂質類に含まれるものである。具体例としては、グリセロリン脂質としては、レシチン(ホスファチジルコリン)、ホスファチジルエタノールアミン、ホスファチジルイノシトールなどが、グリセロ糖脂質としては、分子内に1個又は2個以上のグルコシル基やガラクトシル基などの糖残基を有するジアシルグリセロールなどが、スフィンゴリン脂質としては、スフィンゴミエリンなどが、スフィンゴ糖脂質としては、セレブロシド、セラミドなどがそれぞれ挙げられる。 Complex lipids have a hydrocarbon chain corresponding to a fatty acid compound in the same molecule as the simple lipids defined above, but in addition to carbon atoms, hydrogen atoms and oxygen atoms as constituent atoms, phosphorus atoms and nitrogen An organic compound containing atoms and the like is meant. In general, complex glycolipids are roughly classified into four types of glycerophospholipids, glyceroglycolipids, sphingophospholipids, and glycosphingolipids. Further, in the present invention, these derivatives and partial degradation products such as ceramide are also complex lipids. Is included. As specific examples, glycerophospholipids include lecithin (phosphatidylcholine), phosphatidylethanolamine, phosphatidylinositol, and glyceroglycolipids include sugar residues such as one or more glucosyl groups and galactosyl groups in the molecule. As the sphingophospholipid, sphingomyelin and the like, and as the sphingoglycolipid, cerebroside, ceramide and the like can be mentioned.
テルペン類とは、化学式CH2=C(CH3)CH=CH2で表されるイソプレンを構成単位とする有機化合物を意味し、鎖状構造を有するものと環状構造を有するものがある。また、本発明においては、イソプレン構造を部分的に含む複合テルペンもテルペン類に含まれるものとする。具体例としては、モノテルペン、ジテルペン、トリテルペン、スクアレン、テトラテルペン、カロテノイドなどのほか、α−カロテン、β−カロテン、アスタキサンチン、カンタキサンチン、アブシジン酸、ビタミンA、ビタミンEなどの複合テルペンが挙げられる。 Terpenes mean organic compounds having isoprene represented by the chemical formula CH 2 ═C (CH 3 ) CH═CH 2 as structural units, and those having a chain structure and those having a cyclic structure. In the present invention, a complex terpene partially containing an isoprene structure is also included in the terpenes. Specific examples include monoterpenes, diterpenes, triterpenes, squalene, tetraterpenes, carotenoids, and other complex terpenes such as α-carotene, β-carotene, astaxanthin, canthaxanthin, abscisic acid, vitamin A, and vitamin E. .
合成高分子類とは、有機化学的に合成された高分子物質を意味し、合成ゴム、熱硬化性樹脂、熱可塑性樹脂に大別される。合成ゴムの多くは不飽和結合を有しているので本発明の有効な対象であり、具体例としては、イソプレンゴム、ブタジエンゴム、スチレン−ブタジエンゴム、ニトリルゴム、ニトリル−イソプレンゴムなどが挙げられる。また、熱硬化性樹脂の例としては、不飽和ポリエステル樹脂、ジアリルフタレート樹脂、エポキシ樹脂、フラン樹脂、メラミン樹脂、フェノール樹脂などが、熱可塑性樹脂としては、塩化ビニル樹脂、塩化ビニリデン樹脂、酢酸ビニル樹脂、ABS樹脂、ポリエチレン、ポリスチレン、ポリプロピレン、ナイロン、アセタール樹脂、アクリル樹脂、フッ素樹脂、酢酸セルロース、ポリカーボネイト、メチルペンテン樹脂、エチレン酢酸ビニル樹脂、ポリウレタン樹脂、ポリエステルエストラマーなどが挙げられる。 Synthetic polymers mean high-molecular substances synthesized organically, and are roughly classified into synthetic rubbers, thermosetting resins, and thermoplastic resins. Since many synthetic rubbers have unsaturated bonds, they are effective targets of the present invention. Specific examples include isoprene rubber, butadiene rubber, styrene-butadiene rubber, nitrile rubber, and nitrile-isoprene rubber. . Examples of thermosetting resins include unsaturated polyester resins, diallyl phthalate resins, epoxy resins, furan resins, melamine resins, phenol resins, etc., and thermoplastic resins include vinyl chloride resins, vinylidene chloride resins, vinyl acetate. Examples thereof include resins, ABS resins, polyethylene, polystyrene, polypropylene, nylon, acetal resins, acrylic resins, fluororesins, cellulose acetates, polycarbonates, methylpentene resins, ethylene vinyl acetate resins, polyurethane resins, and polyester elastomers.
ビニル類とは、化学式CH2=CH−で表されるビニル基、化学式CH2=C=で表されるビニリデン基若しくは化学式−CH=CH−で表されるビニレン基を有する有機化合物を意味する。具体例としては、エチレン、プロピレン、ブチレン、イソブチレンなどのオレフィン炭化水素、ブタジエン、イソプレンなどのポリエン炭化水素、酢酸ビニル、ラウリン酸ビニルなどの酸ビニルエステル、アクリル酸メチル、アクリル酸エチルなどのアクリル酸エステル、メタクリル酸メチル、メタクリル酸エチルなどのメタクリル酸エステル、ラウリルビニルエーテルなどのビニルエーテルのほか、塩化ビニル、塩化ビニリデン、スチレン、アクリロニトリル、アクリルアミド、マレイン酸、ビタミンD、ビタミンK、さらには、同じ特許出願人による特許第3232512号公報に開示されたスチリル色素、同じ特許出願人による国際公開WO 01/040382号明細書に開示されたインドレニン系ペンタメチンシアニン色素、同じ特許出願人による特開2002−212454号公報に開示されたトリメチンシアニン色素、同じ特許出願人による国際公開WO 01/062853号明細書に開示されたトリメチンシアニン色素、同じ特許出願人による国際公開WO 01/019923号明細書に開示されたジメチン系スチリル色素、同じ特許出願人による特開2001−32179号公報に開示されたスチリル色素、同じ特許出願人による特開2001−323179号公報に開示された非対称型インドレニン系ペンタメチンシアニン色素、同じ特許出願人による国際公開WO 00/061687号明細書に開示された非対称型トリメチン系シアニン色素、化粧品原料基準(日本公定書協会編、『化粧品原料基準 第二版注解 I』、1984年、薬事日報社発行)に収載されている感光素101号(別名プラトニン)、感光素201号(別名ピオニン)、感光素301号(別名タカナール)、感光素401号(別名ルミネキス)などが挙げられる。 Vinyl means an organic compound having a vinyl group represented by the chemical formula CH 2 ═CH—, a vinylidene group represented by the chemical formula CH 2 ═C═ or a vinylene group represented by the chemical formula —CH═CH—. . Specific examples include olefin hydrocarbons such as ethylene, propylene, butylene and isobutylene, polyene hydrocarbons such as butadiene and isoprene, acid vinyl esters such as vinyl acetate and vinyl laurate, acrylic acid such as methyl acrylate and ethyl acrylate. Esters, methacrylates such as methyl methacrylate and ethyl methacrylate, vinyl ethers such as lauryl vinyl ether, vinyl chloride, vinylidene chloride, styrene, acrylonitrile, acrylamide, maleic acid, vitamin D, vitamin K, and the same patent application The styryl dye disclosed in Japanese Patent No. 3232512, the indolenine-based pentamethine cyanine dye disclosed in International Publication WO 01/040382 by the same patent applicant, Trimethine cyanine dye disclosed in Japanese Patent Application Laid-Open No. 2002-212454 by the applicant, International publication WO 01/062853 by the same patent applicant, International publication by the same patent applicant The dimethine styryl dye disclosed in WO 01/019923, the styryl dye disclosed in JP 2001-32179 A by the same patent applicant, and the JP 2001-323179 A by the same patent applicant. Asymmetric indolenine pentamethine cyanine dye, asymmetric trimethine cyanine dye disclosed in the international patent application WO 00/061687 by the same patent applicant, cosmetic raw material standards 2nd edition commentary I ”(published by Yakuji Nippo Inc. in 1984) It is to have photosensitizer No. 101 (aka Puratonin), No. photosensitizer 201 (aka Pionin), No. photosensitizer 301 (aka Takanaru), and the like photosensitizer No. 401 (aka Ruminekisu).
本発明でいうラジカル生成は特定の原因に限定されるものではない。例えば、不飽和化合物は一般に、無触媒下で光照射や加温などにより、また、金属触媒などの適宜の触媒の作用により、さらに、活性酸素などの他のラジカルの作用によりラジカル化することが知られている。 The radical generation referred to in the present invention is not limited to a specific cause. For example, unsaturated compounds can generally be radicalized by light irradiation or heating in the absence of a catalyst, by the action of an appropriate catalyst such as a metal catalyst, and by the action of other radicals such as active oxygen. Are known.
本発明のラジカル生成抑制剤は、不飽和化合物又は不飽和化合物を含む組成物を原材料、添加物、製品などとして扱う分野であって、且つ、不飽和化合物の化学的変化の回避が求められる諸種の分野、例えば、飲食品分野、農林水産分野(飼料、餌料、ペットフードなどの家畜、家禽、ペット、養殖魚、養殖甲殻類などの餌を含む)、化粧品分野、医薬部外品分野、医薬品分野、日用品分野、化学工業分野、染料分野、塗料分野、コーティング剤分野、建材分野、香料分野、化学薬品分野、合成繊維分野、色素分野、感光色素分野、光記録媒体分野ならびに、これらの分野で利用される原材料、又は添加物の製造分野などの極めて広範な分野において有用である。 The radical generation inhibitor of the present invention is a field in which an unsaturated compound or a composition containing an unsaturated compound is used as a raw material, additive, product, etc., and various chemical substances that are required to avoid chemical changes in the unsaturated compound. Fields such as food and drink, agriculture, forestry and fisheries (including feed such as feed, feed and pet food, poultry, pets, farmed fish, cultured shellfish, etc.), cosmetics, quasi-drugs, pharmaceuticals Fields, daily necessities, chemical industry, dyes, paints, coatings, building materials, fragrances, chemicals, synthetic fibers, dyes, photosensitive dyes, optical recording media, and these fields It is useful in a very wide range of fields such as the raw materials used or the manufacturing field of additives.
本発明のラジカル生成抑制剤は、組成物に配合することにより当該組成物中でラジカル生成を抑制することから、発生する、過酸化脂質、ジオンやアルデヒドの生成抑制、メチオニン、システイン、チオタウリンなどの含硫アミノ酸の分解に起因する硫化物の生成、アミノ酸やペプチドと反応するメーラード反応による褐変などを抑制し、これらの反応に由来する、不快味、不快臭の発生の抑制や、着色・褐変の抑制、更には、香料や色素の劣化を抑制するなどにより、組成物の品質を長期間安定に保持することができる。また、野菜、切り花などの鮮度保持や、酸性度或いはアルカリ性度の強い飲食品を冷凍、冷蔵、チルド、常温、或いは加温して保存する際にも、これら飲食品の品質を長期間安定に保持することができる。 The radical production inhibitor of the present invention suppresses radical production in the composition by blending it into the composition, and thus is generated, such as lipid peroxide, dione and aldehyde production inhibition, methionine, cysteine, thiotaurine, etc. Suppresses the generation of sulfides caused by the decomposition of sulfur-containing amino acids, browning due to the Maillard reaction that reacts with amino acids and peptides, etc., suppresses the occurrence of unpleasant taste and unpleasant odor derived from these reactions, coloring and browning The quality of the composition can be stably maintained for a long period of time by suppressing the deterioration of the fragrance and the pigment. In addition, maintaining the freshness of vegetables, cut flowers, etc., and maintaining the quality of these foods and drinks for a long period of time when they are stored frozen or chilled, chilled, at room temperature, or warmed. Can be held.
従って、本発明のラジカル生成抑制剤は、飲食品分野にあっては、不飽和化合物である脂質と共にタンパク質を含有する組成物が大部分を占めることから、脂質からのラジカル生成を抑制し、その結果、ラジカル生成に起因する脂質過酸化物がタンパク質、着色料、香料などを修飾、変性させる過程を抑制することができるので、タンパク変性抑制剤、着色料や香料の安定化剤などとして飲食品の風味(品質)保持に極めて有利に利用できる。また、過酸化物を含有する飲食品を摂取した場合であっても、過酸化物によって組織や組織に存在する酵素、核酸関連物質、脂質などの機能性分子が修飾、変性することを効果的に抑制することができる。 Therefore, in the field of food and drink, the radical production inhibitor of the present invention occupies most of the composition containing a protein together with a lipid that is an unsaturated compound, and therefore suppresses radical production from the lipid. As a result, lipid peroxide resulting from radical generation can suppress the process of modifying and denaturing proteins, colorants, fragrances, etc., so food and drink as protein denaturation inhibitors, colorants and fragrance stabilizers, etc. It can be used very advantageously for maintaining the flavor (quality) of the food. In addition, it is effective to modify or denature functional molecules such as enzymes, nucleic acid-related substances, and lipids present in tissues and tissues by peroxides even when eating foods and drinks containing peroxides. Can be suppressed.
また、本発明のラジカル生成抑制剤は、化粧品などの皮膚外剤に配合して、頭皮や肌に適用した場合には、当該部位で、光などにより誘発される脂肪酸からのラジカル生成を抑制することにより、皮膚の老化、皺・小皺の発生、シミ・ソバカス発生などの防止、体臭の生成の抑制、過酸化脂質により誘発される炎症、ニキビの発生や増悪の抑制、化粧品などの皮膚外用剤の使用時の刺激性や炎症、それらに起因するかゆみの抑制などに効果を発揮することができる。本発明のラジカル生成抑制剤を、上記の皮膚の老化防止、抗皺・小皺、抗シミ・ソバカス、体臭抑制、抗ニキビ、抗炎症、抗老化などの目的で使用する場合、化粧品などの皮膚外用剤の原材料の総質量の0.01〜30%程度となるように配合するのが望ましい。また、特に、前記ラジカルスカベンジャー、トリクロサン、トリクロロカルバニリド、塩化ベンザルコニウム、塩化ベンゼトニウム、塩酸クロルヘキシジン、グルコン酸クロルヘキシジン、ハロカルバン、イソプロピルメチルフェノール、感光素などの抗菌剤、グリチルリチン酸およびその誘導体、アラントイン、ε−アミノカプロン酸などの抗炎症剤、イオウ、サリチル酸などの角質溶解剤、アルミニウムヒドロキシクロライド、塩化アルミニウム、硫酸アルミニウムカリウム、硫酸アルミニウム、酢酸アルミニウム、アラントインクロロヒドロアルミニウム、アルミニウムジルコニウムクロロハイドレート、p−フェノールスルホン酸亜鉛などの収斂剤、フラボノイド類含有植物抽出物、酸化亜鉛複合物、ハイドロキシアパタイトなどの消臭成分、香料などのマスキング剤、アミノトリメチルホスホン酸、β−アラニン二酢酸、フィチン酸、クエン酸をはじめとするオキシカルボン酸酸やその塩、シクロデキストリン、シクロヘキサンジアミン四酢酸、ジエチレントリアミンペンタメチレンホスホン酸、ジエタノールアミンN−酢酸、エチレンジアミン四酢酸そのナトリウ塩、カルシウム二ナトリウム塩やジアンモニウム塩とそのトリエタノールアミンとの塩類、エチドロン酸、ガラクタン酸、ヒドロキシエチル−エチレンジアミン四酢酸とその三ナトリウム塩、コハク酸、グルコン酸、グルクロン酸、ニトリロ三酢酸とその三ナトリウム塩、ペンテト酸、フィチン酸、リボン酸、クエン酸ジアンモニウム、アザシクロヘプタン二ホスホン酸二ナトリウム、ピロリン酸二ナトリウム、ヒドロキシプロピルシクロデキストリン、メチルシクロデキストリン、三リン酸五カリウム、アミノトリメチレンホスホン酸五ナトリウム、エチレンジアミンテトラメチレンホスホン酸五ナトリウム、ペンテト酸五ナトリウム、三リン酸五ナトリウム、クエン酸カリウム、キトサンメチレンホスホン酸ナトリウム、ヘキサメタリン酸ナトリウム、メタリン酸ナトリウム、ポリリン酸カリウム、ポリリン酸ナトリウム、トリメタリン酸ナトリウム、ジヒドロキシエチルグリシン、ジヒドロキシエチルグリシン酸ナトリウム、グルコン酸カリウム、グルコン酸ナトリウム、グルコペプチン酸ナトリウム(sodium glucopeptate)、グリセレス−1−ポリリン酸ナトリウム(sodium glycereth−1 polyphosphate)、ピロリン酸四カリウム、ポリリン酸トリエタノールアミン、ピロリン酸四ナトリウム、リン酸三ナトリウム、カリウムトリホスホノメチルアミンオキシド、メタケイ酸ナトリウム、フィチン酸ナトリウム、ポリジメチルグリシノフェノールスルホン酸ナトリウム、テトラヒドロキシエチルエチレンジアミン、テトラヒドロキシプロピルエチレンジアミン、エチドロン酸四カリウム、エチドロン酸四ナトリウム、イミノ二コハク酸四ナトリウム、エチレンジアミン二コハク酸三ナトリウム、エタノールアミンN,N−二酢酸、酢酸二ナトリウム、ジメルカプロール、デフェロキサミン、ジロックス(Zylox)、アスコルビン酸2−グルコシドなどのキレート剤及びフラボノイド類から選ばれる何れか1種又は2種以上を適宜組み合わせて併用することにより、本発明のラジカル生成抑制剤による、皮膚の老化防止、抗皺・小皺、抗シミ・ソバカス、体臭抑制、抗ニキビ、抗炎症などの作用を増強することも有利に実施できる。 Further, the radical production inhibitor of the present invention suppresses radical production from fatty acids induced by light or the like at the site when it is blended in a skin external preparation such as cosmetics and applied to the scalp or skin. Skin aging, generation of wrinkles and small wrinkles, spots and freckles, body odor generation, lipid peroxide-induced inflammation, acne generation and exacerbation, cosmetics and other external preparations for skin It is effective in suppressing irritation and inflammation during use, and itching caused by them. When the radical production inhibitor of the present invention is used for the purpose of preventing skin aging, anti-wrinkle / small wrinkles, anti-spots / sobacus, body odor control, anti-acne, anti-inflammatory, anti-aging, etc. It is desirable to blend so as to be about 0.01 to 30% of the total mass of the raw materials. In particular, the radical scavenger, triclosan, trichlorocarbanilide, benzalkonium chloride, benzethonium chloride, chlorhexidine hydrochloride, chlorhexidine gluconate, halocarban, isopropylmethylphenol, photosensitizers, glycyrrhizic acid and its derivatives, Anti-inflammatory agents such as allantoin and ε-aminocaproic acid, keratolytic agents such as sulfur and salicylic acid, aluminum hydroxychloride, aluminum chloride, potassium aluminum sulfate, aluminum sulfate, aluminum acetate, allantoin chlorohydroaluminum, aluminum zirconium chlorohydrate, p -Astringents such as zinc phenolsulfonate, plant extracts containing flavonoids, zinc oxide composites, hydroxyapatite, etc. Odor components, masking agents such as fragrances, aminotrimethylphosphonic acid, β-alanine diacetic acid, phytic acid, citric acid and other oxycarboxylic acids and their salts, cyclodextrin, cyclohexanediaminetetraacetic acid, diethylenetriaminepentamethylenephosphonic acid , Diethanolamine N-acetic acid, ethylenediaminetetraacetic acid sodium salt, calcium disodium salt or diammonium salt and triethanolamine salt, etidronic acid, galactanic acid, hydroxyethyl-ethylenediaminetetraacetic acid and trisodium salt, succinic acid , Gluconic acid, glucuronic acid, nitrilotriacetic acid and its trisodium salt, pentetate, phytic acid, ribbon acid, diammonium citrate, disodium azacycloheptane diphosphonate, dinaturo pyrophosphate , Hydroxypropylcyclodextrin, methylcyclodextrin, pentapotassium triphosphate, pentasodium aminotrimethylenephosphonate, pentasodium ethylenediaminetetramethylenephosphonate, pentasodium pentateate, pentasodium triphosphate, potassium citrate, chitosan methylenephosphone Sodium phosphate, sodium hexametaphosphate, sodium metaphosphate, potassium polyphosphate, sodium polyphosphate, sodium trimetaphosphate, dihydroxyethyl glycine, sodium dihydroxyethyl glycinate, potassium gluconate, sodium gluconate, sodium glucopeptate, glyceres -1-Sodium glycereth-1 poly phosphate), tetrapotassium pyrophosphate, triethanolamine polyphosphate, tetrasodium pyrophosphate, trisodium phosphate, potassium triphosphonomethylamine oxide, sodium metasilicate, sodium phytate, sodium polydimethylglycinophenolsulfonate, tetrahydroxy Ethylethylenediamine, tetrahydroxypropylethylenediamine, etidronate tetrapotassium, etidronate tetrasodium, imino disuccinate tetrasodium, ethylenediamine disuccinate trisodium, ethanolamine N, N-diacetic acid, disodium acetate, dimercaprol, deferoxamine , Zirox, ascorbic acid 2-glucoside and other chelating agents and any one or more selected from flavonoids It is also advantageous to enhance the action of the radical generation inhibitor of the present invention, such as anti-aging of skin, anti-wrinkle / small wrinkle, anti-spot / freckle, body odor control, anti-acne, anti-inflammation, etc. Can be implemented.
なお、上記成分以外にも、本発明のラジカル生成抑制剤は、その効果を妨げられない限り、例えば、同じ出願人が、特許文献7などおいて開示した血行促進作用を有する物質、抗炎症作用を有する物質、抗菌作用を有する物質、抗ニキビ作用を有する物質、保湿作用を有する物質、抗肌荒れ作用を有する物質、美白作用を有する物質、紫外線吸収作用を有する物質、紫外線散乱作用を有する物質、収斂作用を有する物質、清涼作用を有する物質、抗シワ作用を有する物質、抗酸化作用を有する物質、細胞賦活作用を有する物質、抗老化活性を有する物質、抗シワ活性を有する物質、腋臭抑制作用を有する物質、育毛活性を有する物質、発毛活性を有する物質、抗ふけ作用を有する物質、経皮吸収促進作用を有する物質やこれら以外の皮膚外用剤に使用される公知の物質やその他の皮膚外用剤に使用しうる物質から選ばれる何れか1種又は2種以上と組み合わせて、化粧品や皮膚外用剤として利用することも随意である。また、その剤型も、従来知られているいずれの形態であっても良く、例えば、化粧石けん、透明石けん、洗顔料、シャンプー、リンス等の清浄用化粧品、クリーム、乳液、化粧水、化粧油、パック等の基礎化粧品、ファンデーション、口紅、おしろい、アイシャドー、アイライナー、マスカラ、ほほ紅、眉墨等のメークアップ化粧品、日焼け・日焼け止め化粧品、パーマネント液、毛髪のセット剤などの毛髪化粧品、生理用品などの皮膚外用剤やトイレタリー製品、台所用洗剤、消臭剤などの雑貨、靴下、ストッキング、下着類、シーツ、タオル、布巾、タオル、手ぬぐい、おしぼり、不織布などの繊維製品、ティッシュペーパー、ウエットティッシュ、トイレットペーパー、紙おむつ、化学雑巾、集塵袋、ペットの床敷などとして利用できる。また、当該化粧品は、塊状、ペンシル状、スティック状、乳液状、クリーム状、溶液状、粉状、ゲル状、ムース状、スプレー、エアゾール、ロールオンなどの様々な形態で使用することができる。 In addition to the above components, the radical generation inhibitor of the present invention is, for example, a substance having a blood circulation promoting action disclosed in Patent Document 7 or the like by the same applicant, as long as the effect thereof is not hindered, an anti-inflammatory action A substance having an antibacterial action, a substance having an anti-acne action, a substance having a moisturizing action, a substance having an anti-skin roughening action, a substance having a whitening action, a substance having an ultraviolet absorbing action, a substance having an ultraviolet scattering action, Substance with astringent action, substance with refreshing action, substance with anti-wrinkle action, substance with anti-oxidation action, substance with cell activation action, substance with anti-aging activity, substance with anti-wrinkle action, odor control action Substances with hair growth, substances with hair-growth activity, substances with hair growth activity, substances with anti-dandruff action, substances with an action of promoting percutaneous absorption, and other skin external applications In conjunction with any one or more selected from materials which can be used in known substances and other skin external preparation used in it can be arbitrarily used as a cosmetic and external preparation for skin. The dosage form may be any conventionally known form, for example, cosmetics for cleaning such as cosmetic soap, transparent soap, facial cleanser, shampoo, rinse, cream, milky lotion, lotion, cosmetic oil. , Basic cosmetics such as packs, foundations, lipsticks, funny, eye shadows, eyeliners, mascara, cheeks, eyebrow make-up cosmetics, tanning / sunscreen cosmetics, permanent liquids, hair cosmetics such as hair set, menstruation Skin care products such as products and toiletries, kitchen detergents, deodorants, and other goods, socks, stockings, underwear, sheets, towels, towels, towels, towels, towels, non-woven fabrics, tissue paper, wet Can be used as tissue, toilet paper, disposable diapers, chemical cloths, dust bags, pet bedding, etc. . The cosmetic can be used in various forms such as a lump, pencil, stick, emulsion, cream, solution, powder, gel, mousse, spray, aerosol, and roll-on.
さらに、本発明のラジカル生成抑制剤は、活性などを失い易い各種生理活性物質又はこれを含む健康食品、化粧品、医薬部外品、医薬品などの安定化剤として有利に適用できる。例えば、インターフェロン−α、インターフェロン−β、インターフェロン−γ、ツモア・ネクロシス・ファクター−α、ツモア・ネクロシス・ファクター−β、マクロファージ遊走阻止因子、コロニー刺激因子、トランスファーファクター、インターロイキン類などのリンホカイン含有液やインターロイキン含有液、インシュリン、成長ホルモン、プロラクチン、エリトロポエチン、卵細胞刺激ホルモン、胎盤ホルモンなどのホルモン含有液、BCGワクチン、日本脳炎ワクチン、はしかワクチン、ポリオ生ワクチン、痘苗、破傷風トキソイド、ハブ抗毒素、ヒト免疫グロブリンなどの生物製剤含有液、フィコシアニン、フィコエリトリンをはじめとする色素タンパク質、リパーゼ、エラスターゼ、ウロキナーゼ、プロテアーゼ、β−アミラーゼ、イソアミラーゼ、グルカナーゼ、ラクターゼ、抗体類、補体系などの酵素や血液成分などのペプチド或いはタンパク質の変性を抑制し、それらの生理活性を安定に保持することができる。また、本発明のラジカル生成抑制剤は、高品質の健康食品、化粧品、医薬部外品、医薬品或いは試薬などの製造にも有利に利用できる。 Furthermore, the radical production inhibitor of the present invention can be advantageously applied as a stabilizer for various physiologically active substances that easily lose their activity or the like, or health foods, cosmetics, quasi drugs, and pharmaceuticals containing the same. For example, interferon-α, interferon-β, interferon-γ, tsumore necrosis factor-α, tsumoa necrosis factor-β, macrophage migration inhibitory factor, colony-stimulating factor, transfer factor, interleukin-containing liquids And interleukin-containing liquid, insulin, growth hormone, prolactin, erythropoietin, egg cell stimulating hormone, placental hormone-containing liquid, BCG vaccine, Japanese encephalitis vaccine, measles vaccine, polio vaccine, seedling, tetanus toxoid, hub antitoxin, Liquid containing biological products such as human immunoglobulin, phycocyanin, chromoprotein including phycoerythrin, lipase, elastase, urokinase, protease, β-amyl , Isoamylase, glucanase, lactase, antibodies, and inhibit the denaturation of peptides or proteins such as enzymes and blood components such as the complement system, their physiological activity can be stably maintained. The radical production inhibitor of the present invention can also be advantageously used for the production of high-quality health foods, cosmetics, quasi drugs, pharmaceuticals, reagents, and the like.
また、本発明のラジカル生成抑制剤は、特に、組織や細胞レベルのラジカル生成をも抑制することから、生体内で発生するラジカル生成を伴う炎症反応の抑制剤や炎症性分子の発現抑制剤として、アトピー、アレルギーをはじめとする皮膚炎、湿疹、蕁麻疹、虫刺され、火傷、日焼け、擦傷や切傷などの各種の炎症性疾患、口内炎、歯周病などによる歯肉炎、結膜炎、肺炎、慢性閉塞性呼吸器疾患、胃炎、大腸炎、潰瘍性大腸炎、クローン病などの臓器の炎症性疾患、手術後の患部の炎症、放射線障害、大気汚染、タバコなどにより発生するラジカルによる皮膚、口腔、鼻腔、肺などの細胞に発生する障害などの改善や発生防止にも有利に利用でき、さらには、生成したラジカルによる核酸や蛋白質の変成や細胞膜の破壊などに起因して発生する白血病や、消化器系・循環器系をはじめとする各種臓器に発生する悪性新生物、虚血再循環時のラジカル発生に起因する各種臓器や組織の不全、心臓・循環器系疾患や脳疾患、アルツハイマー病、パーキンソン氏病、シェーグレン症候群、リューマチなどの免疫性疾患の予防・治療、ドライアイや白内障をはじめとする眼性疾患の予防・治療、各種臓器や角膜などの移植臓器の劣化防止用の保存液、手術時の洗浄液、手術後などにおける臓器の癒着防止液、灌流液、透析液(腹膜透析液を含む)などに利用することも随意である。なお、医薬品(動物薬を含む)或いは医薬部外品として使用される本発明のラジカル生成抑制剤は、そのままで、或いは、製剤学的に許容される製剤用添加剤の1種又は2種以上と組み合わせた製剤として利用することができる。また、これら製剤は、液状、粉末、顆粒、シラップなどの何れの形態であってもよく、経口剤、注射剤(点滴や灌流を含む)、外用剤、点眼剤、点鼻剤、ハップ剤、坐剤などとして利用することができる。さらには、本発明のラジカル生成抑制剤、或いは、このラジカル生成抑制剤とラジカルスカベンジャーや他の製剤用添加剤を含有する液状製剤、微分製剤や微小カプセル製剤などを、ネブライザー、超音波加湿器、吸引器などを利用して飛散させて、生体に経鼻、経肺や経皮的にこれらの製剤を吸引させて、組織、器官、臓器などでのラジカル生成を抑制したり、さらには、室内で発生するラジカル生成を抑制することもできる。 In addition, the radical production inhibitor of the present invention particularly suppresses radical generation at the tissue and cell levels, and therefore, as an inhibitor of an inflammatory reaction accompanied by radical production generated in the living body or an expression inhibitor of inflammatory molecules. Dermatitis such as atopy, allergy, eczema, urticaria, insect bites, burns, sunburn, abrasions and cuts, gingivitis due to stomatitis, periodontal disease, conjunctivitis, pneumonia, chronic obstruction Respiratory organ disease, gastritis, colitis, ulcerative colitis, inflammatory diseases of organs such as Crohn's disease, inflammation of affected areas after surgery, radiation damage, air pollution, skin caused by radicals caused by tobacco, oral cavity, nasal cavity It can be advantageously used to improve and prevent damages that occur in cells such as the lungs, and it can also occur due to nucleic acid and protein modification and cell membrane destruction by the generated radicals. Leukemia, malignant neoplasms that develop in various organs including the digestive and circulatory systems, organ and tissue failure caused by radical generation during ischemic recirculation, heart and circulatory diseases and brain Prevention, treatment of immune diseases such as diseases, Alzheimer's disease, Parkinson's disease, Sjogren's syndrome, rheumatism, prevention and treatment of ophthalmic diseases such as dry eye and cataracts, prevention of deterioration of transplanted organs such as various organs and cornea It is also optional to use it as a preservative solution, a washing solution at the time of surgery, an anti-adhesion solution for organs after surgery, a perfusion solution, a dialysis solution (including peritoneal dialysis solution), and the like. In addition, the radical production inhibitor of the present invention used as a pharmaceutical (including veterinary drugs) or a quasi-drug is used as it is or one or more pharmaceutical additives that are pharmaceutically acceptable. And can be used as a preparation in combination. These preparations may be in any form such as liquid, powder, granule, syrup, etc., oral preparations, injections (including infusion and perfusion), external preparations, eye drops, nasal drops, haptics, It can be used as a suppository. Furthermore, the radical production inhibitor of the present invention, or a liquid preparation containing this radical production inhibitor and a radical scavenger or other preparation additive, a differential preparation, a microcapsule preparation, etc., are used as a nebulizer, an ultrasonic humidifier, Spatter using an aspirator, etc. to cause the living body to inhale these preparations nasally, pulmonarily or transcutaneously to suppress radical generation in tissues, organs, organs, etc. It is also possible to suppress the generation of radicals generated by.
また、上記のように、本発明のラジカル生成抑制剤は、これと併用するラジカルスカベンジャーの持つ独特の、苦味、渋味、生臭味などの不快味や不快臭を効果的にマスクし、さらには、ラジカルスカベンジャー自身の酸化やメーラード反応などに起因する褐変や変色を抑制することから、ラジカルスカベンジャー自身やその酸化、分解などにより生じる不快味及び/又は不快臭や、褐変及び/又は変色の抑制剤として利用することができる。さらに、本発明のラジカル生成抑制剤は、ラジカル生成により発生する体臭や汗などの付着した衣類やシーツからの異臭の発生、ラジカル生成により進行する生体の炎症を抑制することから、皮膚の老化防止剤、抗皺・小皺剤、抗シミ・ソバカス剤、体臭抑制剤、抗炎症剤、抗ニキビ剤などとして利用することも随意である。さらに、体臭を抑制する場合には、当該ラジカル生成抑制剤と共に、乳化剤及びポリフェノール類を併用することにより、その抑制効果を増強することができる。 In addition, as described above, the radical generation inhibitor of the present invention effectively masks unpleasant tastes and unpleasant odors, such as bitterness, astringency, and raw odor, unique to the radical scavenger used in combination therewith, Suppresses browning and discoloration caused by oxidation and Maillard reaction of radical scavengers themselves, and therefore suppresses unpleasant taste and / or unpleasant odor, browning and / or discoloration caused by radical scavengers themselves and their oxidation and decomposition It can be used as an agent. Furthermore, the radical generation inhibitor of the present invention prevents skin aging because it suppresses the generation of off-flavours from clothing and sheets with body odor and sweat generated by radical generation, and inflammation of the living body that proceeds by radical generation. It is also optional to use it as an agent, anti-wrinkle / pox, anti-spot / bucky agent, body odor inhibitor, anti-inflammatory agent, anti-acne agent and the like. Furthermore, when suppressing body odor, the inhibitory effect can be strengthened by using an emulsifier and polyphenol together with the radical production inhibitor.
また、本発明のラジカル生成抑制剤は、上記合成高分子樹脂に配合することにより、紫外線をはじめとする光、熱、放射線、圧力などにより誘発されるラジカル生成抑制効果にすぐれ、樹脂の劣化を防止することり利用できるだけでなく、塗料、インク、接着剤、コーティング剤などのように、その成分として上記合成高分子樹脂を含む組成物の増量や劣化(色、可塑性、剛性、接着性などの劣化を含む)抑制の目的で配合することも随意である。中でも、本発明のラジカル生成抑制剤、とりわけ、α−マルトシルα,α−トレハロース及び/又はα−マルトトリオシルα,α−トレハロースは、上記作用に加えて、塗料、インク(インクジェットプリンター用インクを含む)、或いは、コーティング剤(車や電化製品用の塗装面の保護、つや出しなどの目的で使用されるものはもとより、紙や上記以外の塗装面の保護やつや出し、印刷用の用紙のインクのにじみ防止などの目的で使用されるものを含む)の付着性、塗布性の改善効果が顕著なことから、塗料の付着性及び/又は塗布性改善剤として使用することも随意である。この場合の、α,α−トレハロースの糖質誘導体のこれら組成物への配合量は、当該組成物の目的から逸脱しない限り特に制限はなく、通常、該組成物の総質量の0.01〜30%程度であればよく、0.1〜10%がより望ましい。 In addition, the radical production inhibitor of the present invention is excellent in the radical production inhibition effect induced by light, heat, radiation, pressure, etc. including ultraviolet rays, and can deteriorate the resin by blending with the above synthetic polymer resin. Not only can it be used to prevent, but also increase or deteriorate the composition containing the above synthetic polymer resin as its component, such as paint, ink, adhesive, coating agent, etc. (deterioration such as color, plasticity, rigidity, adhesiveness It is also optional to mix for the purpose of suppression. Among them, the radical production inhibitor of the present invention, in particular, α-maltosyl α, α-trehalose and / or α-maltotriosyl α, α-trehalose, in addition to the above-mentioned action, is a paint, ink (ink jet printer ink). Or coating agents (not only those used for the purpose of protecting and glossing painted surfaces for cars and electrical appliances, but also for protecting and glossing paper and other painted surfaces, and for printing paper inks for printing) It is also optional to use it as a paint adhesion and / or coating property improving agent since the effect of improving the adhesion property and coating property (including those used for the purpose of preventing bleeding) is remarkable. In this case, the amount of α, α-trehalose carbohydrate derivative added to these compositions is not particularly limited as long as it does not depart from the purpose of the composition, and is usually 0.01 to the total mass of the composition. It may be about 30%, and 0.1 to 10% is more desirable.
以下、実験例に基づいてα,α−トレハロースの糖質誘導体、又は、これを含有する糖質による、不飽和化合物のラジカル生成抑制についてより詳細に説明する。 Hereinafter, suppression of radical formation of unsaturated compounds by a saccharide derivative of α, α-trehalose or a saccharide containing the same will be described in more detail based on experimental examples.
<実験1>
<α,α−トレハロースの糖質誘導体を含有する糖質及びα−マルトシルα,α−トレハロースの調製>
以下の実験で使用したα,α−トレハロースの糖質誘導体及びα−マルトシルα,α−トレハロースは、以下の方法で調製した。
<α−グルコシルα,α−トレハロース>
特許文献2の実験4に記載の方法により調製し、その純度は98.1%であった。
<α−マルトシルα,α−トレハロース>
後述の実施例5に記載の方法により調製し、その純度は97.8%であった。
<α,α−トレハロースの糖質誘導体含有糖質(還元性糖質を含有)>
後述の実施例1の方法により調製した。本品は、濃度75%、DE13.7のシラップであり、無水物換算で、α,α−トレハロースの糖質誘導体として、α−マルトシルα,α−トレハロース52.5%を含有しており、他に、α−グルコシルα,α−トレハロース4.1%、α−マルトトリオシルα,α−トレハロース1.1%、それ以外のα−グリコシルα,α−トレハロース0.4%を含有していた。また、本品は、無水物換算で、還元性の糖質として、グルコースなどの単糖類を2.1%、マルトースなどの2糖類を8.9%、α−グルコシルα,α−トレハロース以外の3糖類を6.7%、α−マルトシルα,α−トレハロース以外の4糖類を17.6%、α−グリコシルα,α−トレハロース以外の5糖類以上の糖質を6.6%含有していた。
<α,α−トレハロースの糖質誘導体含有糖質(還元性糖質を糖アルコールに変換)>
上記シラップ状のα,α−トレハロースの糖質誘導体含有糖質(還元性糖を含有)に水を加えて、濃度約60%に調製して、オートクレーブに入れ、触媒としてラネーニッケルを約8.5%添加し、攪拌しながら温度を128℃に上げ、水素圧を80kg/cm2に上げて水素添加して、α,α−トレハロースの糖質誘導体と共存するグルコース、マルトースなどの還元性糖質を、それらの糖アルコールに変換した後、ラネーニッケルを除去し、次いで、脱色、脱塩して精製し、濃縮して、濃度75%のシラップ状のα,α−トレハロースの糖質誘導体含有糖質を調製した。本品は、無水物換算で、α−マルトシルα,α−トレハロースを約53%、及び、これ以外のα,α−トレハロースの糖質誘導体を、無水物換算で、約10%含有し、ソルビトール、マルチトールをはじめとする糖アルコールを約37%含有していた。
<Experiment 1>
<Preparation of a saccharide containing a saccharide derivative of α, α-trehalose and α-maltosyl α, α-trehalose>
The carbohydrate derivatives of α, α-trehalose and α-maltosyl α, α-trehalose used in the following experiments were prepared by the following method.
<Α-Glucosyl α, α-trehalose>
It was prepared by the method described in Experiment 4 of Patent Document 2, and its purity was 98.1%.
<Α-maltosyl α, α-trehalose>
Prepared by the method described in Example 5 below, the purity was 97.8%.
<Carbohydrates containing carbohydrate derivatives of α, α-trehalose (including reducing carbohydrates)>
Prepared by the method of Example 1 described below. This product is syrup with a concentration of 75% and DE 13.7, and contains α-maltosyl α, α-trehalose 52.5% as a carbohydrate derivative of α, α-trehalose in terms of anhydride, In addition, α-glucosyl α, α-trehalose 4.1%, α-maltotriosyl α, α-trehalose 1.1%, and other α-glycosyl α, α-trehalose 0.4%. It was. In addition, this product, in terms of anhydride, is a reducing saccharide such as 2.1% monosaccharides such as glucose, 8.9% disaccharides such as maltose, and other than α-glucosyl α, α-trehalose. It contains 6.7% trisaccharide, 17.6% tetrasaccharide other than α-maltosyl α, α-trehalose, and 6.6% saccharide more than 5 saccharides other than α-glycosyl α, α-trehalose. It was.
<Carbohydrates containing carbohydrate derivatives of α, α-trehalose (converting reducing carbohydrates into sugar alcohols)>
The syrup-like α, α-trehalose sugar derivative-containing carbohydrate (containing reducing sugar) is added with water to prepare a concentration of about 60%, put in an autoclave, and Raney nickel as a catalyst is about 8.5. Reducing saccharides such as glucose and maltose coexisting with a saccharide derivative of α, α-trehalose by raising the temperature to 128 ° C. while stirring, raising the hydrogen pressure to 80 kg / cm 2 , and adding hydrogen. Are converted to their sugar alcohols, and then Raney nickel is removed, followed by decolorization, desalting, purification, and concentration, and a carbohydrate containing a saccharide derivative of α, α-trehalose in a concentration of 75% syrup. Was prepared. This product contains about 53% of α-maltosyl α, α-trehalose in terms of anhydride, and about 10% of other carbohydrate derivatives of α, α-trehalose in terms of anhydride, sorbitol About 37% of sugar alcohols including maltitol were contained.
<実験2>
<ラジカル生成抑制に及ぼす各種糖質の影響1>
ラジカル生成抑制に及ぼす各種糖質の影響を調べるための実験は次のようにして行った。
<試験用糖質溶液の調製>
マンニット(試薬特級)、試薬級含水結晶α,α−トレハロース(株式会社林原生物化学研究所販売)、実験1で調製したα−グルコシルα,α−トレハロース、α−マルトシルα,α−トレハロース、又は、シラップ状のα,α−トレハロースの糖質誘導体含有糖質(還元性糖質を糖アルコールに変換)のいずれかの糖質を、精製水で、各々9.375mM、18.75mM、37.5mM或いは75mMとなるように希釈して、試験用糖質溶液を調製した。なお、α,α−トレハロースの糖質誘導体を含有するシラップは、その主成分のα−マルトシルα,α−トレハロースが、上記モル濃度となるように調製した。
<ヒドロキシラジカルの生成量の測定>
1mM過酸化水素(H2O2)溶液50μlの入った容器に、89mM5,5−ジメチル−1−ピロリン−オキシド(DMPO、和光純薬株式会社販売)溶液50μlを加えて攪拌し、これに上記試験用糖質溶液の何れか1種、50μlを加えて攪拌した。これらの溶液の各々に、1mMの硫酸鉄と1mMのジエチレントリアミン−N,N,N,N’’,N’’−5酢酸(DTPA、和光純薬株式会社販売)を含む溶液50μlを添加混合して反応を開始させ、電子スピン共鳴スペクトル(ESR)測定用セルに入れて、測定装置にセットして、反応開始40秒後のヒドロキシラジカルの生成量を測定した。対照として、試験用糖質溶液に代えて、精製水50μlを加えて、同様の測定を行った。なお、ESRの測定には(株)日本電子製「Free Radical Monitor JES−FR30」を用い、ヒドロキシラジカルの生成量は、スピントラップ剤として使用した5,5−ジメチル−1−ピロリン−オキシド−OH(ヒドロキシラジカル)に特有の4つのシグナルピークのうち、走査開始後最初に観察されるピークと、JES−FR30装置に装着されている外部標準のMn2+のピークの高さとの比を求めて、対照を100とした相対値として、表1に示す。
<Experiment 2>
<Effects of various carbohydrates on radical generation inhibition 1>
Experiments to investigate the effects of various carbohydrates on radical production inhibition were performed as follows.
<Preparation of test carbohydrate solution>
Mannit (special grade reagent), reagent-grade water-containing crystal α, α-trehalose (available from Hayashibara Biochemical Laboratories Co., Ltd.), α-glucosyl α, α-trehalose, α-maltosyl α, α-trehalose prepared in Experiment 1 Alternatively, any saccharide of a syrup-like α, α-trehalose saccharide derivative-containing saccharide (reducing saccharide is converted into a sugar alcohol) with purified water, 9.375 mM, 18.75 mM, 37 A carbohydrate solution for test was prepared by diluting to 5 mM or 75 mM. The syrup containing a saccharide derivative of α, α-trehalose was prepared so that the main component α-maltosyl α, α-trehalose was in the above molar concentration.
<Measurement of hydroxy radical production>
In a container containing 50 μl of 1 mM hydrogen peroxide (H 2 O 2 ) solution, 50 μl of 89 mM 5,5-dimethyl-1-pyrroline-oxide (DMPO, sold by Wako Pure Chemical Industries, Ltd.) solution was added and stirred. 50 μl of any one of the carbohydrate solutions for testing was added and stirred. To each of these solutions, 50 μl of a solution containing 1 mM iron sulfate and 1 mM diethylenetriamine-N, N, N, N ″, N ″ -5acetic acid (DTPA, sold by Wako Pure Chemical Industries, Ltd.) was added and mixed. Then, the reaction was started, placed in an electron spin resonance spectrum (ESR) measurement cell, set in a measurement apparatus, and the amount of hydroxy radicals produced 40 seconds after the start of the reaction was measured. As a control, instead of the test carbohydrate solution, 50 μl of purified water was added and the same measurement was performed. For measurement of ESR, “Free Radical Monitor JES-FR30” manufactured by JEOL Ltd. was used, and the amount of hydroxy radical produced was 5,5-dimethyl-1-pyrroline-oxide-OH used as a spin trap agent. Among the four signal peaks peculiar to (hydroxy radical), the ratio of the peak first observed after the start of scanning and the height of the peak of the external standard Mn 2+ attached to the JES-FR30 apparatus is obtained. Table 1 shows the relative values with the control as 100.
<結果>
表1から明らかなように、ヒドロキシラジカルの生成は、いずれの糖質においても、その添加量の増加とともに減少した。その抑制の程度は、α,α−トレハロースの糖質誘導体含有糖質(還元性糖質を糖アルコールに変換)が最も強く、α−グルコシルα,α−トレハロース及びα−マルトシルα,α−トレハロースがこれに続いた。α,α−トレハロースは、これらのα,α−トレハロースの糖質誘導体やこの糖質含有糖質よりも、ヒドロキシラジカル生成抑制の程度が弱く、マンニットが最も弱かった。
<Result>
As is clear from Table 1, the generation of hydroxy radicals decreased with increasing amount of any sugar. The degree of inhibition is strongest in carbohydrates containing carbohydrate derivatives of α, α-trehalose (converting reducing sugars to sugar alcohols), and α-glucosyl α, α-trehalose and α-maltosyl α, α-trehalose. Followed. α, α-trehalose had a weaker degree of inhibition of hydroxy radical production and mannitol was the weakest than these saccharide derivatives of α, α-trehalose and this saccharide-containing saccharide.
<実験3>
<ラジカル生成抑制に及ぼす各種糖質の影響2>
<試験用糖質溶液の調製>
実験2と同様に、マンニット(試薬特級)、試薬級含水結晶α,α−トレハロース(株式会社林原生物化学研究所販)、実験1で調製したα−グルコシルα,α−トレハロース、α−マルトシルα,α−トレハロース、シラップ状のα,α−トレハロースの糖質誘導体含有糖質(還元性糖質を含有、又は、還元性糖質を糖アルコールに変換)のいずれかの糖質を、精製水で、各々9.375mM、18.75mM、37.5mM或いは75mMとなるように希釈して、試験用糖質溶液を調製した。なお、α,α−トレハロースの糖質誘導体を含有するシラップは、その主成分のα−マルトシルα,α−トレハロースが、上記モル濃度となるように調製した。
<ヒドロキシラジカルの生成量の測定>
0.1Mリン酸緩衝液(pH7.4)50μmlを入れた容器に、180mM5,5−ジメチル−1−ピロリン−オキシド(DMPO、和光純薬株式会社販売)溶液50μlを加えて攪拌し、これに上記試験用糖質溶液の何れか1種50μlを加えて攪拌した。これらの溶液の各々に、100mM 2,2’−アゾビス(2−アミジノプロパン)2塩酸塩(AAPH)溶液50μlを添加混合して反応を開始させ、電子スピン共鳴スペクトル(ESR)測定用セルに入れて、測定装置にセットして、反応開始3分30秒後のヒドロキシラジカルの生成量を測定した。対照として、試験用糖質溶液に代えて、精製水50μlを加えて、同様の測定を行った。なお、ESRの測定は、実験2と同様に行った。その結果を表2に示す。
<Experiment 3>
<Effects of various carbohydrates on radical production inhibition 2>
<Preparation of test carbohydrate solution>
As in Experiment 2, Mannit (special grade reagent), reagent-grade water-containing crystal α, α-trehalose (sales from Hayashibara Biochemicals Co., Ltd.), α-glucosyl α, α-trehalose, α-maltosyl prepared in Experiment 1 Purify any saccharide of α, α-trehalose or syrup-like α, α-trehalose saccharide derivative-containing saccharide (containing reducing saccharide or converting reducing saccharide to sugar alcohol) A carbohydrate solution for test was prepared by diluting with water to 9.375 mM, 18.75 mM, 37.5 mM, or 75 mM, respectively. The syrup containing a saccharide derivative of α, α-trehalose was prepared so that the main component α-maltosyl α, α-trehalose was in the above molar concentration.
<Measurement of hydroxy radical production>
In a container containing 50 μml of 0.1 M phosphate buffer (pH 7.4), 50 μl of 180 mM 5,5-dimethyl-1-pyrroline-oxide (DMPO, sold by Wako Pure Chemical Industries, Ltd.) solution was added and stirred. 50 μl of any one of the above carbohydrate solutions for test was added and stirred. To each of these solutions, 50 μl of a 100 mM 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH) solution was added and mixed to initiate the reaction, and placed in an electron spin resonance spectrum (ESR) measurement cell. Then, it was set in a measuring device, and the amount of hydroxy radicals produced 3 minutes and 30 seconds after the start of the reaction was measured. As a control, instead of the test carbohydrate solution, 50 μl of purified water was added and the same measurement was performed. The ESR measurement was performed in the same manner as in Experiment 2. The results are shown in Table 2.
表2から明らかなように、ヒドロキシラジカル生成は、いずれの糖質においても、その添加量の増加とともに減少した。その抑制の程度は、α,α−トレハロースの糖質誘導体含有糖質が最も強く、α−グルコシルα,α−トレハロース及びα−マルトシルα,α−トレハロースがこれに続いた。α,α−トレハロースは、これらのα,α−トレハロースの糖質誘導体やこの糖質含有糖質よりも、ヒドロキシラジカル生成抑制の程度が弱く、マンニットが最も弱かった。また、α,α−トレハロースの糖質誘導体含有糖質同士を比較すると、還元性の糖質を含むものよりも、その還元性の糖質を糖アルコールに変換したものの方が、ヒドロキシラジカル生成を強く抑制した。 As is apparent from Table 2, the generation of hydroxy radicals decreased with the increase in the amount of any carbohydrate. The degree of inhibition was strongest in carbohydrates containing a carbohydrate derivative of α, α-trehalose, followed by α-glucosyl α, α-trehalose and α-maltosyl α, α-trehalose. α, α-trehalose had a weaker degree of inhibition of hydroxy radical production and mannitol was the weakest than these saccharide derivatives of α, α-trehalose and this saccharide-containing saccharide. In addition, when carbohydrates containing carbohydrate derivatives of α, α-trehalose are compared with each other, those in which the reducing sugar is converted to a sugar alcohol are more likely to generate hydroxy radicals than those containing the reducing sugar. Strongly suppressed.
<実験4>
<皮膚の炎症に及ぼすα,α−トレハロースの糖質誘導体の影響>
ラジカルの発生は炎症にも深く関与しているといわれている。そこで、皮膚の炎症に及ぼすα,α−トレハロースの糖質誘導体の影響を調べる実験を以下のように行った。
<皮膚への塗布剤>
実験1で調製したシラップ状のα,α−トレハロースの糖質誘導体含有糖質(還元性糖質を糖アルコールに変換)16gに、精製水80mlを加えて攪拌し、0.22μmのフィルターで除菌して、試験液とした。陰性対照として、精製水を、また、陽性対照として、プレドニゾロン軟膏(帝国製薬株式会社販売、商品名「ビスオコリームA」)を使用した。
<マウスでのアトピー性皮膚炎の誘発>
塩化ピクリル(東京化成株式会社販売)を、エタノールを用いて再結晶し、その5%溶液(エタノール:アセトン=4:1の溶液に溶解)及び1%溶液(オリーブ油に溶解)を調製した。この塩化ピクリルの5%溶液150μlを、5週令の雌性のNC/Ngaマウス(日本エスエルシー株式会社販売)の足蹠、バリカンで毛刈りした胸部及び腹部に塗布して、初回感作を行った。初回感作時に、背部をバリカンで毛刈りしておき、当該部位に、初回感作から、7日、14日、21日、28日、35日及び42日に、前記1%塩化ピクリル溶液150μlを塗布して、アトピー性皮膚炎の誘発を行った。
<アトピー性皮膚炎に及ぼすα,α−トレハロースの糖質誘導体含有糖質の影響>
前記マウスの塩化ピクリルによるアトピー性皮膚炎誘発部位(バリカンで毛刈した背部)に、塩化ピクリルの初回感作日から、試験液150μlを、1日2回、5日間連続して塗布し、2日間休止するサイクルを、7回繰り返し、初回感作日から28日(皮膚炎の症状が最初に観察された日)、35日、42日及び49日目に背部の肉眼観察と体重測定を行った。肉眼観察は、発赤・出血、擦傷・組織欠損、痂皮形成・乾燥の範囲、擦傷の強度の4項目について、4段階の評点化を行い(0;無症状、1;軽度、2;中等度、3;重度)、その合計を求めて、皮膚炎症状のスコアとした。陰性対照は、その150μlを、試験液と同じスケジュールで投与した。また、陽性対照は、その0.1gを、皮膚炎症状が確認された後の、初回感作から29日、32日、34日、36日、39日、42日、46日に、背部の炎症誘発部位に塗布した。なお、試験は、いずれの群も10匹のマウスを使用した。10匹のマウスの、皮膚炎症状のスコアの平均の推移を表3に、平均体重の推移を表4に示す。
<Experiment 4>
<Effects of carbohydrate derivatives of α, α-trehalose on skin inflammation>
The generation of radicals is said to be deeply involved in inflammation. Therefore, an experiment for examining the effect of a carbohydrate derivative of α, α-trehalose on skin inflammation was performed as follows.
<Skin application>
To 16 g of syrup-like α, α-trehalose-containing saccharides (reducing saccharides are converted to sugar alcohols) prepared in Experiment 1, 80 ml of purified water is added and stirred, and then removed with a 0.22 μm filter. Bacteria were used as test solutions. Purified water was used as a negative control, and prednisolone ointment (available from Teikoku Pharmaceutical Co., Ltd., trade name “Bisco Collime A”) was used as a positive control.
<Induction of atopic dermatitis in mice>
Picryl chloride (sold by Tokyo Chemical Industry Co., Ltd.) was recrystallized using ethanol to prepare a 5% solution (dissolved in a solution of ethanol: acetone = 4: 1) and a 1% solution (dissolved in olive oil). The first sensitization is performed by applying 150 μl of this 5% solution of picryl chloride to the footpad, chest and abdomen of a 5-week-old female NC / Nga mouse (sold by Nippon SLC Co., Ltd.), shaved with clippers. It was. At the time of the first sensitization, the back portion was shaved with a clipper, and 150 μl of the 1% picryl chloride solution was applied to the site on the 7th, 14th, 21st, 28th, 35th and 42nd days after the first sensitization. Was applied to induce atopic dermatitis.
<Effects of carbohydrates containing carbohydrate derivatives of α, α-trehalose on atopic dermatitis>
From the day of first sensitization with picric chloride, 150 μl of the test solution was applied twice a day for 5 consecutive days to the atopic dermatitis induction site (back of hair clipped with clippers) of the mouse. A cycle of resting for 7 days was repeated, and macroscopic observation of the back and weight measurement were performed on the 28th day (the day on which dermatitis symptoms were first observed), 35th day, 42nd day and 49th day from the first sensitization day. It was. Macroscopically, the four items of redness / bleeding, scratches / tissue defects, scab formation / drying range, and scratch strength were scored in four levels (0; asymptomatic, 1; mild, 2; moderate). 3; severe) and the sum thereof was determined to give a score of skin inflammation. The negative control, 150 μl, was administered on the same schedule as the test solution. In addition, 0.1 g of the positive control was applied on the back of the first sensitization after confirmation of skin inflammation on the 29th, 32nd, 34th, 36th, 39th, 42th, and 46th days after the first sensitization. It was applied to the pro-inflammatory site. In the test, 10 mice were used in each group. Table 3 shows the transition of the average score of skin inflammation of 10 mice, and Table 4 shows the transition of the average body weight.
表3から明らかなように、α,α−トレハロースの糖質誘導体を含有する試験液を塗布した場合は、陽性対照として使用した抗炎症剤として常用されているプレドニゾンを塗布した場合よりは劣るものの、塩化ピクリルにより誘発されたアトピー性皮膚炎の症状を、陰性対照を塗布した場合に比べて、抑制することが確認された。また、表4から明らかなように、試験液を塗布したマウスの体重は、陰性対照と同様に、経時的に増加しているのに対して、陽性対照を塗布したマウスでは、体重の増加が、塩化ピクリルの初回感作から42日目以降減少しており、ステロイド剤投与の副作用が認められた。この実験の結果は、α,α−トレハロースの糖質誘導体含有糖質が、皮膚の炎症の予防、或いは、治療に有効で、かつ、副作用のない安全な糖質であることを物語っている。 As is clear from Table 3, when a test solution containing a carbohydrate derivative of α, α-trehalose was applied, it was inferior to the case where prednisone commonly used as an anti-inflammatory agent used as a positive control was applied. It was confirmed that the symptoms of atopic dermatitis induced by picryl chloride were suppressed as compared with the case where a negative control was applied. Further, as is clear from Table 4, the weight of the mouse to which the test solution was applied increased with time as in the negative control, whereas the weight of the mouse to which the positive control was applied increased. From the first sensitization of picryl chloride, it decreased after the 42nd day, and a side effect of steroid administration was observed. The results of this experiment indicate that the carbohydrate derivative-containing carbohydrate of α, α-trehalose is a safe carbohydrate that is effective in preventing or treating skin inflammation and has no side effects.
<実験5>
<アスコルビン酸の褐変に及ぼすα,α−トレハロースの糖質誘導体の影響>
アスコルビン酸は、ラジカルスカベンジャーとして利用されているものの、溶液状態や水分を含んだ状態では、容易に酸化されて褐変を生じることから、組成物に配合すると、当該組成物の品質低下の原因となる場合がある。そこで、アスコルビン酸の褐変に及ぼすα,α−トレハロースの糖質誘導体の影響を調べる実験を以下のようにして行った。即ち、糖質として、実験1で調製したα−マルトシルα,α−トレハロース、α,α−トレハロースの糖質誘導体含有糖質(還元性糖質を含有)、α,α−マルトシルα,α−トレハロース含有糖質(還元性糖質を糖アルコールに還元)、含水結晶α,α−トレハロース、スクロース(和光純薬工業株式会社販売)及びグルコース(和光純薬工業株式会社販売)を用いた。各々の糖質をそれぞれ無水物換算で5gメスフラスコに秤量し、適量の精製水を加えて溶解した。これらの糖質溶液のそれぞれにL−アスコルビン酸(和光純薬工業株式会社販売)を無水物換算で0.5g加え、それぞれを1%クエン酸ナトリウム水溶液でpHを3.0に調整した後、精製水を加えて全量を50mlに調整した。また、対照として糖質無添加のL−アスコルビン酸水溶液を同様に調製した。それぞれの水溶液20mlを30ml容の試験管に入れスクリューキャップで密栓した後、50℃で14日間保存した。保存開始時、保存7日目、及び、保存14日目の水溶液について、光路1cmのセルを用いて、420nmの吸光度を測定し、着色度として表5にまとめた。また、各糖質を添加した溶液の着色度を対照の着色度で除し、100倍し、100から減じて、着色の抑制率(%)として、表5にまとめた。
<Experiment 5>
<Influence of carbohydrate derivatives of α, α-trehalose on browning of ascorbic acid>
Ascorbic acid is used as a radical scavenger, but it easily oxidizes and browns when it is in a solution or in a water-containing state. There is a case. Then, the experiment which investigates the influence of the carbohydrate derivative of (alpha) and (alpha) -trehalose which has on the browning of ascorbic acid was conducted as follows. That is, as a saccharide, α-maltosyl α, α-trehalose prepared in Experiment 1, a saccharide derivative-containing saccharide of α, α-trehalose (including a reducing saccharide), α, α-maltosyl α, α- Trehalose-containing sugar (reducing reducing sugar to sugar alcohol), hydrous crystal α, α-trehalose, sucrose (Wako Pure Chemical Industries, Ltd.) and glucose (Wako Pure Chemical Industries, Ltd.) were used. Each saccharide was weighed into a 5 g volumetric flask in terms of anhydride, and dissolved by adding an appropriate amount of purified water. After adding 0.5 g of L-ascorbic acid (Wako Pure Chemical Industries, Ltd.) in terms of anhydride to each of these carbohydrate solutions and adjusting the pH to 3.0 with a 1% aqueous sodium citrate solution, Purified water was added to adjust the total volume to 50 ml. Further, as a control, an L-ascorbic acid aqueous solution containing no sugar was similarly prepared. 20 ml of each aqueous solution was placed in a 30 ml test tube and sealed with a screw cap, and then stored at 50 ° C. for 14 days. The absorbance at 420 nm was measured for the aqueous solutions at the start of storage, on the 7th day of storage, and on the 14th day of storage using a cell with a 1 cm optical path, and the degree of coloration is summarized in Table 5. Further, the coloring degree of the solution to which each saccharide was added was divided by the coloring degree of the control, multiplied by 100, and subtracted from 100, and the coloring inhibition rate (%) is summarized in Table 5.
表5から明らかなように、糖質無添加の対照に比べ、いずれの糖質を添加した溶液においても、L−アスコルビン酸の着色は抑制された。実験に使用した糖質のうち、α−マルトシルα,α−トレハロース、α,α−トレハロースの糖質誘導体含有糖質(還元性糖質を含有)及びα,α−マルトシルα,α−トレハロース含有糖質(還元性糖質を糖アルコールに還元)を添加した場合には、保存開始7及び14日目でともに、着色の抑制率が50%以上となったのに対して、その他の3種類の糖質を添加した場合は、着色度の抑制率が50%未満となり、α,α−トレハロースの糖質誘導体及びこれを含有する糖質は、アスコルビン酸の着色を抑制する効果に優れていることが確認された。また、実験に使用した、α,α−トレハロースの糖質誘導体或いはこれを含有する糖質の中では、α,α−トレハロースの糖質誘導体含有糖質(還元性糖質を含有)が、他の2種類の糖質よりもアスコルビン酸の着色を強く抑制することが判明した。 As is clear from Table 5, the coloring of L-ascorbic acid was suppressed in the solution to which any saccharide was added, compared to the control to which no saccharide was added. Of the carbohydrates used in the experiment, α-maltosyl α, α-trehalose, α, α-trehalose-containing carbohydrate derivative-containing carbohydrates (including reducing carbohydrates) and α, α-maltosyl α, α-trehalose included When sugar (reducing reducing sugar to sugar alcohol) was added, the coloration inhibition rate was 50% or more on the 7th and 14th days from the start of storage, whereas the other three types When the saccharide is added, the degree of inhibition of the coloring degree is less than 50%, and the saccharide derivative of α, α-trehalose and the saccharide containing the same are excellent in the effect of suppressing the coloration of ascorbic acid. It was confirmed. Among the saccharide derivatives of α, α-trehalose used in the experiments or saccharides containing them, saccharide derivatives containing saccharide derivatives of α, α-trehalose (including reducing saccharides) It was found that coloring of ascorbic acid was suppressed more strongly than the two types of carbohydrates.
<実験6>
<アスコルビン酸の褐変に及ぼすα,α−トレハロースの糖質誘導体及びpHの影響>
実験5において、最も強くL−アスコルビン酸の着色を抑制したα,α−トレハロースの糖質誘導体含有糖質(還元性糖質を含有)を用いて、アスコルビン酸の褐変に及ぼすα,α−トレハロースの糖質誘導体及びpHの影響を調べる実験を以下のようにして行った。即ち、実験1で調製したα,α−トレハロースの糖質誘導体含有糖質(還元性糖質を含有)を、無水物換算で5gずつメスフラスコ5本に秤量し、各々適量の精製水を加えて溶解した後、その各々にL−アスコルビン酸(和光純薬工業株式会社販売)を無水物換算で0.5g加えた。これらのL−アスコルビン酸水溶液に、それぞれ1%クエン酸ナトリウム水溶液を加えて、pHを3.0、4.0又は5.0に、4%水酸化ナトリウムを加えてpHを6.0又は7.0のいずれかに調整した後、精製水を加えて全量を50mlに調整し試験液とした。また、対照として、試験液で使用したトレハロース5gに代えて、スクロース(和光純薬工業株式会社販売)を無水物換算で5g使用する以外は試験液と同じ条件のL−アスコルビン酸の水溶液、及び、糖質を使用しないこと以外は試験液と同じ条件のL−アスコルビン酸水溶液を調製した。これらのL−アスコルビン酸の水溶液20mlを、各々30ml容の試験管に入れスクリューキャップで密栓した後、50℃で7日間保存した。保存開始時及び保存開始7日目の水溶液について、実験5と同様の方法により着色度(褐変)と着色の抑制率(%)を求め、表6にまとめた。
<Experiment 6>
<Effects of carbohydrate derivatives of α, α-trehalose and pH on browning of ascorbic acid>
In Experiment 5, α, α-trehalose exerted on browning of ascorbic acid using a carbohydrate derivative-containing carbohydrate (containing a reducing sugar) of α, α-trehalose that most strongly inhibited coloring of L-ascorbic acid An experiment for examining the effects of saccharide derivatives and pH was conducted as follows. That is, the saccharide derivative-containing saccharide (containing reducing saccharide) of α, α-trehalose prepared in Experiment 1 was weighed into 5 volumetric flasks each in 5 g in terms of anhydride, and an appropriate amount of purified water was added to each. After dissolution, 0.5 g of L-ascorbic acid (sold by Wako Pure Chemical Industries, Ltd.) was added to each of them in terms of anhydride. To each of these L-ascorbic acid aqueous solutions, a 1% sodium citrate aqueous solution is added to adjust the pH to 3.0, 4.0 or 5.0, and 4% sodium hydroxide is added to adjust the pH to 6.0 or 7 respectively. After adjusting to 0.0, purified water was added to adjust the total volume to 50 ml to obtain a test solution. In addition, as a control, instead of 5 g of trehalose used in the test solution, an aqueous solution of L-ascorbic acid under the same conditions as the test solution, except that 5 g of sucrose (Wako Pure Chemical Industries, Ltd.) was used in terms of anhydride, and An L-ascorbic acid aqueous solution was prepared under the same conditions as the test solution except that no carbohydrate was used. 20 ml of each of these L-ascorbic acid aqueous solutions was placed in a 30 ml test tube, sealed with a screw cap, and stored at 50 ° C. for 7 days. With respect to the aqueous solution at the start of storage and on the seventh day after the start of storage, the degree of coloring (browning) and the coloration inhibition rate (%) were determined in the same manner as in Experiment 5, and are summarized in Table 6.
表6から明らかなように、α,α−トレハロースの糖質誘導体含有糖質(還元性糖質を含む)は、糖質無添加及びスクロース添加の場合と比較して、弱酸性条件(pH3.0及び4.0)において、L−アスコルビン酸水溶液の着色を、強く抑制することが判明した。また、中性付近(pH5.0乃至7.0)では、糖質無添加或いはスクロース添加の場合に比して、L−アスコルビン酸の着色を抑制はしたものの、その程度は弱く、特に、pH7.0の条件では、スクロース添加の場合と、その抑制の程度にはほとんど差が認められなかった。これらの結果から、α,α−トレハロースの糖質誘導体又はα,α−トレハロースの糖質誘導体含有糖質が、L−アスコルビン酸の着色を、酸性域で特に効果的に抑制できることが判明した。 As is apparent from Table 6, the carbohydrate derivative-containing carbohydrates (including reducing carbohydrates) of α, α-trehalose are weakly acidic (pH 3) compared to the case of no carbohydrate addition and sucrose addition. 0 and 4.0), it was found that coloring of the L-ascorbic acid aqueous solution was strongly suppressed. Further, in the vicinity of neutrality (pH 5.0 to 7.0), although coloring of L-ascorbic acid was suppressed as compared with the case of no addition of saccharide or addition of sucrose, the degree thereof was weak, in particular, pH 7 Under the condition of 0.0, almost no difference was observed between the case of sucrose addition and the degree of inhibition. From these results, it was found that a carbohydrate derivative of α, α-trehalose or a carbohydrate derivative-containing carbohydrate of α, α-trehalose can particularly effectively suppress coloring of L-ascorbic acid in the acidic region.
以上の実験結果は、本発明を応用し、α,α−トレハロースの糖質誘導体、又は、α,α−トレハロースの糖質誘導体含有糖質を、ラジカル生成により、保存中に異臭の発生、硬化、分解、変性、着色(褐変)、変色、退色などの品質劣化や、更には、機能低下が生じる恐れのある不飽和化合物を含む組成物に含有させることにより、ラジカル生成を抑制できることを物語っている。また、このα,α−トレハロースの糖質誘導体含有糖質を皮膚などの炎症部位に適用することにより、当該部位でのラジカル生成を抑制し、その炎症を抑制することができることを物語っている。更に、α,α−トレハロースの糖質誘導体、又は、α,α−トレハロースの糖質誘導体含有糖質は、ラジカルスカベンジャーと併用した場合に、ラジカルスカベンジャーに起因する褐変(着色や退色も含む)も抑制できることを物語っている。 The above experimental results show that by applying the present invention, a saccharide derivative of α, α-trehalose or a saccharide derivative-containing saccharide of α, α-trehalose is generated and cured during storage by radical generation. It tells us that radical generation can be suppressed by including it in a composition containing an unsaturated compound that may cause degradation of quality such as decomposition, modification, coloring (browning), discoloration, fading, etc. Yes. Further, it shows that by applying the carbohydrate derivative-containing carbohydrate of α, α-trehalose to an inflammatory site such as skin, radical generation at the site can be suppressed and the inflammation can be suppressed. Furthermore, α, α-trehalose saccharide derivatives or α, α-trehalose saccharide derivative-containing saccharides also undergo browning (including coloring and fading) due to radical scavengers when used in combination with radical scavengers. It tells you that it can be suppressed.
以下に、本発明のラジカル生成抑制剤及び該ラジカル生成抑制剤を含んでなる組成物の例を具体的に挙げて説明する。しかし、本発明はこれらの実施例によって限定されるものではない。 Hereinafter, specific examples of the radical production inhibitor of the present invention and the composition comprising the radical production inhibitor will be described. However, the present invention is not limited to these examples.
<ラジカル生成抑制剤>
濃度20%のとうもろこし澱粉乳に最終濃度0.1%となるように炭酸カルシウムを加えた後、pH6.5に調整し、これにα−アミラーゼ(ノボ社販売、商品名「ターマミール60L」)を澱粉グラム当たり0.2%になるよう加え、95℃で15分間反応させた。その反応液を、120℃で10分間オートクレーブした後、50℃に冷却し、pHを5.8に調整後、澱粉グラム当たり特開昭63−240784号公報に開示されたマルトテトラオース生成アミラーゼ(株式会社林原生物化学研究所製造)を5単位と、イソアミラーゼ(株式会社林原生物化学研究所製造)を500単位となるように加え、48時間反応させ、これにα−アミラーゼ(上田化学株式会社販売、商品名「α−アミラーゼ2A」)を澱粉グラム当たり30単位加え、更に、65℃で4時間反応させた。その反応液を、120℃で10分間オートクレーブし、次いで45℃に冷却し、特許文献2に開示されたアルスロバクター・スピーシーズQ36(FERM BP−4316)由来の非還元性糖質生成酵素を澱粉グラム当たり2単位の割合になるよう加え、48時間反応させた。その反応液を95℃で10分間保った後、冷却し、濾過して得られる濾液を、常法に従って活性炭で脱色し、H型及びOH型イオン交換樹脂により脱塩して精製した糖化液を、更に濃縮して濃度70%のシラップ状のラジカル生成抑制剤を、無水物換算で、収率約90%で得た。本品は、DE13.7で、無水物換算で、α,α−トレハロースの糖質誘導体として、α−マルトシルα,α−トレハロース52.5%を含有しており、他に、α−グルコシルα,α−トレハロース4.1%、α−マルトトリオシルα,α−トレハロース1.1%、それ以外のα−グリコシルα,α−トレハロース0.4%を含有していた。また、本品は、中華まんじゅうや蒸しパンなどにムチムチした食感を与える飲食品の品質改良剤として使用することもできる。
<Radical production inhibitor>
After adding calcium carbonate to corn starch milk having a concentration of 20% to a final concentration of 0.1%, the pH is adjusted to 6.5, and α-amylase (sold by Novo, trade name “Termameal 60L”) is added thereto. It was added to 0.2% per gram starch and reacted at 95 ° C. for 15 minutes. The reaction solution was autoclaved at 120 ° C. for 10 minutes, cooled to 50 ° C., adjusted to pH 5.8, and then maltotetraose-producing amylase disclosed in JP-A-63-240784 per gram of starch ( 5 units of Hayashibara Biochemical Laboratories Co., Ltd.) and 500 units of isoamylase (Manufactured by Hayashibara Biochemical Laboratories Co., Ltd.) are added and reacted for 48 hours. 30 units per gram starch were added and further reacted at 65 ° C. for 4 hours. The reaction solution was autoclaved at 120 ° C. for 10 minutes, then cooled to 45 ° C., and non-reducing saccharide-forming enzyme derived from Arthrobacter species Q36 (FERM BP-4316) disclosed in Patent Document 2 was starched. The mixture was added at a rate of 2 units per gram and allowed to react for 48 hours. The reaction solution is kept at 95 ° C. for 10 minutes, then cooled, filtered, and the filtrate obtained is decolorized with activated carbon according to a conventional method, and desalted with H-type and OH-type ion exchange resins to obtain a purified saccharified solution. Further concentration was performed to obtain a syrup-like radical production inhibitor having a concentration of 70% in a yield of about 90% in terms of anhydride. This product is DE 13.7, and contains α-maltosyl α, α-trehalose 52.5% as a carbohydrate derivative of α, α-trehalose in terms of anhydride, in addition, α-glucosyl α , Α-trehalose 4.1%, α-maltotriosyl α, α-trehalose 1.1%, and other α-glycosyl α, α-trehalose 0.4%. Moreover, this product can also be used as a quality improver for foods and drinks that gives a crisp texture to Chinese buns, steamed bread, and the like.
<ラジカル生成抑制剤>
実施例1の方法で得たシラップを常法により噴霧乾燥して非晶質粉末状のラジカル生成抑制剤を調製した。
<Radical production inhibitor>
The syrup obtained by the method of Example 1 was spray-dried by a conventional method to prepare an amorphous powdery radical production inhibitor.
<ラジカル生成抑制剤>
実施例1の方法で得た、H型及びOH型イオン交換樹脂により脱塩して精製した糖化液を、さらに、精製するために、塩型強酸性カチオン交換樹脂(ダウケミカル社販売、商品名「ダウエックス50W−X4」、Mg++型)を用いたカラム分画を行った。樹脂を内径5.4cmのジャケット付ステンレス製カラム4本に充填し、直列につなぎ樹脂層を全長20mとした。カラム内温度を55℃に維持しつつ、糖液を樹脂に対して5%(v/v)加え、これに55℃の温水をSV0.13で流して分画し、グルコース及びマルトース高含有画分を除去し、α,α−トレハロースの糖質誘導体高含有画分を集め、更に精製、濃縮後、噴霧乾燥して非晶質粉末状のラジカル生成抑制剤を調製した。本品は、無水物換算で、α,α−トレハロースの糖質誘導体としてα−マルトシルα,α−トレハロース70.2%を含有しており、他に、α−グルコシルα,α−トレハロース6.1%、α−マルトトリオシルα,α−トレハロース2.1%、それ以外のα−グリコシルα,α−トレハロース4.1%を含有していた。本品は、ラジカル生成抑制剤として有利に利用できる。また、本品は、ビタミンA、ビタミンD、ビタミンEなどの脂溶性ビタミンやアスコルビン酸、これらビタミンの誘導体をはじめとするラジカルスカベンジャーを配合した液状の製剤を、噴霧乾燥などにより粉末化するための粉末化基剤としても極めて有利に利用できる。
<Radical production inhibitor>
In order to further purify the saccharified solution obtained by desalting with the H-type and OH-type ion exchange resins obtained by the method of Example 1, a salt-type strongly acidic cation exchange resin (sold by Dow Chemical Co., Ltd., trade name) Column fractionation using “Dowex 50W-X4”, Mg ++ type) was performed. The resin was packed into four jacketed stainless steel columns with an inner diameter of 5.4 cm, and the resin layer was connected in series to a total length of 20 m. While maintaining the temperature in the column at 55 ° C., 5% (v / v) of the sugar solution is added to the resin, and this is fractionated by flowing warm water at 55 ° C. with SV 0.13 to obtain a high glucose and maltose content fraction. The fraction containing α, α-trehalose containing a high sugar derivative was collected, further purified, concentrated, and spray-dried to prepare an amorphous powdery radical production inhibitor. This product contains 70.2% α-maltosyl α, α-trehalose as a carbohydrate derivative of α, α-trehalose in terms of anhydride, and in addition, α-glucosyl α, α-trehalose. It contained 1%, α-maltotriosyl α, α-trehalose 2.1%, and other α-glycosyl α, α-trehalose 4.1%. This product can be advantageously used as a radical production inhibitor. In addition, this product is used to powderize liquid preparations containing fat-soluble vitamins such as vitamin A, vitamin D, and vitamin E, ascorbic acid, and radical scavengers including derivatives of these vitamins by spray drying. It can also be used very advantageously as a powdered base.
<ラジカル生成抑制剤>
馬鈴薯澱粉1質量部に水6質量部を加え、更に、澱粉当たり0.01%の割合になるようにα−アミラーゼ(ナガセ生化学工業株式会社製造、商品名「ネオスピターゼ」)を加えて撹拌混合し、pH6.0に調整後、この懸濁液を85乃至90℃に保ち、糊化と液化を同時に起こさせ、直ちに120℃に5分間加熱して、DE1.0未満にとどめ、これを55℃に急冷し、pH7.0に調整し、これにデンプン枝切り酵素(株式会社林原生物化学研究所製造、商品名「プルラナーゼ」(EC 3.2.1.41))及び特開昭63−240784号公報に開示されたマルトテトラオース生成アミラーゼを、それぞれ澱粉グラム当たり150単位及び8単位の割合で加え、pH7.0、50℃で36時間反応させた。この反応液を、120℃で10分間オートクレーブし、次いで、53℃まで冷却し、特許文献5に開示されたアルスロバクター・スピーシーズS34(FERM BP−6450)由来の非還元性糖質生成酵素を澱粉グラム当たり2単位の割合になるよう加え、64時間反応させた。この反応液を95℃で10分間保った後、冷却し、濾過して得られる濾液を、常法に従って、活性炭で脱色し、H型、OH型イオン交換樹脂により脱塩して精製し、更に濃縮して、噴霧乾燥して非晶質粉末状態のラジカル生成抑制剤を、無水物換算で、収率約90%で得た。本品は、DE 11.4で、無水物換算で、α−マルトシルα,α−トレハロース62.5%を含有しており、他に、α−グルコシルα,α−トレハロース2.1%、α−マルトトリオシルα,α−トレハロース0.8%、それ以外のα−グリコシルα,α−トレハロース0.5%を含有していた
<Radical production inhibitor>
Add 6 parts by weight of water to 1 part by weight of potato starch, and then add α-amylase (manufactured by Nagase Seikagaku Corporation, trade name “Neospirase”) so that the ratio is 0.01% per starch. After adjusting the pH to 6.0, the suspension is kept at 85 to 90 ° C. to cause gelatinization and liquefaction at the same time, and immediately heated to 120 ° C. for 5 minutes to stay below DE 1.0. Quenched to 0 ° C., adjusted to pH 7.0, starch debranching enzyme (manufactured by Hayashibara Biochemical Laboratories, Inc., trade name “Pullanase” (EC 3.2.1.41)) and JP-A 63- The maltotetraose-producing amylase disclosed in 240784 was added at a rate of 150 units and 8 units per gram of starch, respectively, and reacted at pH 7.0 and 50 ° C. for 36 hours. This reaction solution was autoclaved at 120 ° C. for 10 minutes, then cooled to 53 ° C., and a non-reducing carbohydrate-forming enzyme derived from Arthrobacter species S34 (FERM BP-6450) disclosed in Patent Document 5 was used. The mixture was added at a rate of 2 units per gram of starch and allowed to react for 64 hours. The reaction solution is kept at 95 ° C. for 10 minutes, then cooled and filtered, and the filtrate obtained is decolorized with activated carbon and purified by desalting with H-type and OH-type ion exchange resins according to a conventional method. It concentrated and spray-dried, and the radical production | generation inhibitor in the amorphous powder state was obtained with about 90% of yield in conversion of the anhydride. This product is DE 11.4 and contains α-maltosyl α, α-trehalose 62.5% in terms of anhydride, and α-glucosyl α, α-trehalose 2.1%, α -It contained 0.8% maltotriosyl α, α-trehalose and 0.5% other α-glycosyl α, α-trehalose
<ラジカル生成抑制剤>
試薬級のマルトテトラオース(株式会社林原生物化学研究所販売、純度97.0%以上)の20%溶液をpH7.0に調整後、特許文献2に開示された非還元性糖質生成酵素を、無水物換算で、糖質グラム当たり2単位となるように加えて、46℃で、48時間、糖化して、固形物あたり79.8%のα−マルトシルα,α−トレハロースを含有する溶液を得た。この溶液を、pH6.0に調整後、無水物換算で、糖質グラム当たり10単位となるようにβ−アミラーゼ(ナガセ生化学工業株式会社販売)を加えて、50℃で48時間反応させて、マルトテトラオースを分解した。この反応液を、120℃で10分間オートクレーブし、冷却した後、ろ過して得られる溶液を、アルカリ金属型強酸性カチオン交換樹脂(東京有機化学工業株式会社販売、「XT−1016」、Na+型、架橋度4%)を用いて分画し、α−マルトシルα−トレハロース高含有画分を集め、精製、濃縮後、噴霧乾燥して非晶質粉末状態のラジカル生成抑制剤を調製した。本品は、α−マルトシルα,α−トレハロースを98.1%含有しており、ソモジ ネルソン法による測定での還元力測定では、還元力は検出限界以下であった。
<Radical production inhibitor>
After adjusting 20% solution of reagent grade maltotetraose (Hayashibara Biochemical Laboratories Co., Ltd., purity 97.0% or more) to pH 7.0, the non-reducing carbohydrate-forming enzyme disclosed in Patent Document 2 A solution containing 79.8% α-maltosyl α, α-trehalose per solid after addition of 2 units per gram of carbohydrate in terms of anhydride and saccharification at 46 ° C. for 48 hours Got. After adjusting this solution to pH 6.0, β-amylase (manufactured by Nagase Seikagaku Co., Ltd.) was added so as to be 10 units per gram of carbohydrate in terms of anhydride, and reacted at 50 ° C. for 48 hours. , Decomposed maltotetraose. The reaction solution was autoclaved at 120 ° C. for 10 minutes, cooled, and then filtered to obtain an alkali metal strong acid cation exchange resin (available from Tokyo Organic Chemical Industry Co., Ltd., “XT-1016”, Na + Fractionation was performed using a mold and a crosslinking degree of 4%, and α-maltosyl α-trehalose-rich fractions were collected, purified, concentrated, and spray-dried to prepare a radical generation inhibitor in an amorphous powder state. This product contained 98.1% of α-maltosyl α, α-trehalose, and the reducing power was less than the detection limit in the measuring of reducing power measured by the somogene nelson method.
この標品を、再度水に溶解し、活性炭処理して、パイロジェンを除去し、噴霧乾燥して、非晶質粉末状のラジカル生成抑制剤を調製した。本品は、パイロジェンを除去しているので、特に医薬品などのようなパイロジェンを含まないことが要求される組成物や医薬品用のラジカル生成抑制剤として好適である。 This preparation was dissolved again in water, treated with activated carbon to remove pyrogen, and spray-dried to prepare an amorphous powdery radical production inhibitor. Since this product removes pyrogen, it is particularly suitable as a radical generation inhibitor for compositions and pharmaceuticals that are required to contain no pyrogen such as pharmaceuticals.
<ラジカル生成抑制剤>
実施例1の方法で得たα,α−トレハロースの糖質誘導体を含有するシラップに水を加えて、濃度約60%に調製して、オートクレーブに入れ、触媒としてラネーニッケルを約8.5%添加し、攪拌しながら温度を128℃に上げ、水素圧を80kg/cm2に上げて水素添加して、α,α−トレハロースの糖質誘導体と共存するグルコース、マルトースなどの還元性糖質を、それらの糖アルコールに変換した後、ラネーニッケルを除去し、次いで、脱色、脱塩して精製し、濃縮して濃度70%のシラップ状のラジカル生成抑制剤を調製した。
<Radical production inhibitor>
Water is added to the syrup containing the saccharide derivative of α, α-trehalose obtained by the method of Example 1 to prepare a concentration of about 60%, put in an autoclave, and about 8.5% of Raney nickel is added as a catalyst. Then, the temperature is increased to 128 ° C. while stirring, the hydrogen pressure is increased to 80 kg / cm 2 , hydrogenation is performed, and reducing sugars such as glucose and maltose coexisting with the sugar derivative of α, α-trehalose are added. After conversion to sugar alcohols, Raney nickel was removed, followed by decolorization, desalting and purification, and concentration to prepare a syrup-like radical production inhibitor having a concentration of 70%.
<ラジカル生成抑制剤>
実施例3の方法で得た非晶質状態のラジカル生成抑制剤を水に溶解し、濃度約60%水溶液にし、オートクレーブに入れ、触媒としてラネーニッケルを約9%添加し、攪拌しながら温度を130℃に上げ、水素圧を75kg/cm2に上げて水素添加して、α,α−トレハロースの糖質誘導体と共存するグルコース、マルトースなどの還元性糖質を、それらの糖アルコールに変換した後、ラネーニッケルを除去し、次いで、脱色、脱塩して精製し、濃縮してシラップ状のラジカル生成抑制剤を調製した。更にこのシラップを、常法により噴霧乾燥して、非晶質粉末状のラジカル生成抑制剤を調製した。
<Radical production inhibitor>
The amorphous radical production inhibitor obtained by the method of Example 3 is dissolved in water to make an aqueous solution having a concentration of about 60%, put into an autoclave, about 9% of Raney nickel is added as a catalyst, and the temperature is increased to 130 with stirring. After raising the hydrogen pressure to 75 kg / cm 2 and hydrogenating it to convert reducing sugars such as glucose and maltose coexisting with the sugar derivatives of α, α-trehalose into their sugar alcohols Then, Raney nickel was removed, then decolorized, desalted and purified, and concentrated to prepare a syrup-like radical production inhibitor. Furthermore, this syrup was spray-dried by a conventional method to prepare an amorphous powdery radical production inhibitor.
<ラジカル生成抑制剤>
濃度6%の馬鈴薯澱粉乳を加熱糊化後、pH4.5、温度50℃に調整し、これにイソアミラーゼ(株式会社林原生物化学研究所製造)を澱粉グラム当たり2500単位加えて20時間反応させた。その反応液をpH6.0に調整後、120℃で10分間オートクレーブした後、45℃に冷却し、これにα−アミラーゼ(ノボ社販売、商品名「ターマミール60L」)を澱粉グラム当たり150単位になるよう加え、24時間反応させた。その反応液を、120℃で20分間オートクレーブし、45℃に冷却後、特許文献2に開示されたアルスロバクター・スピーシーズQ36(FERM BP−4316)由来の非還元性糖質生成酵素を、澱粉グラム当たり2単位の割合で加え、64時間反応させた。この反応液を95℃で10分間保った後、冷却し、濾過して得られる濾液を、常法に従って、活性炭で脱色し、H型、OH型イオン交換樹脂により脱塩して精製し、更に、濃縮して、濃度65%のシラップ状のラジカル生成抑制剤を、無水物換算で、収率約89%で得た。本品は、無水物換算で、α−グルコシルα,α−トレハロース3.2%、α−マルトシルα,α−トレハロース6.5%、α−マルトトリオシルα,α−トレハロース28.5%及びグルコース重合度6以上のα−グリコシルα,α−トレハロース11.9%含有していた。
<Radical production inhibitor>
After heating gelatinization of potato starch milk with a concentration of 6%, the pH is adjusted to 4.5 and the temperature is adjusted to 50 ° C., and 2500 units of isoamylase (produced by Hayashibara Biochemical Laboratories Co., Ltd.) is added to the starch and reacted for 20 hours. It was. The reaction solution was adjusted to pH 6.0, autoclaved at 120 ° C. for 10 minutes, cooled to 45 ° C., and α-amylase (sold by Novo, trade name “Termameal 60L”) to 150 units per gram of starch. And reacted for 24 hours. The reaction solution was autoclaved at 120 ° C. for 20 minutes, cooled to 45 ° C., and the non-reducing saccharide-forming enzyme derived from Arthrobacter species Q36 (FERM BP-4316) disclosed in Patent Document 2 was added to starch. Two units per gram were added and allowed to react for 64 hours. The reaction solution is kept at 95 ° C. for 10 minutes, then cooled and filtered, and the filtrate obtained is decolorized with activated carbon and purified by desalting with H-type and OH-type ion exchange resins according to a conventional method. After concentration, a syrup-like radical production inhibitor having a concentration of 65% was obtained in a yield of about 89% in terms of anhydride. This product is α-glucosyl α, α-trehalose 3.2%, α-maltosyl α, α-trehalose 6.5%, α-maltotriosyl α, α-trehalose 28.5% in terms of anhydride. It contained 11.9% α-glycosyl α, α-trehalose having a glucose polymerization degree of 6 or more.
本品を、実施例7の方法に準じて、水素添加し、α,α−トレハロースの糖質誘導体と共存するグルコース、マルトースなどの還元性糖質を、その糖アルコールに変換した後、常法により精製して、シラップ状のラジカル生成抑制剤を調製した。さらに、このシラップを、常法により噴霧乾燥して、非晶質状態の粉末状のラジカル生成抑制剤を調製した。 This product was hydrogenated according to the method of Example 7 to convert reducing sugars such as glucose and maltose coexisting with the sugar derivative of α, α-trehalose into the sugar alcohol, followed by a conventional method. To prepare a syrup-like radical production inhibitor. Furthermore, this syrup was spray-dried by a conventional method to prepare an amorphous powdery radical production inhibitor.
<ラジカル生成抑制剤>
濃度33%のとうもろこし澱粉乳に最終濃度0.1%となるように炭酸カルシウムを加えた後、pH6.0に調整し、これにα−アミラーゼ(ノボ社販売、商品名「ターマミール60L」)を澱粉グラム当たり0.2%になるように加え、95℃で15分間反応させた。その反応液を、120℃で30分間オートクレーブした後、50℃に冷却し、これにイソアミラーゼ(株式会社林原生物化学研究所製造)を澱粉グラム当たり500単位及び特開平7−236478号に記載のマルトヘキサオース・マルトヘプタオース生成アミラーゼを澱粉グラム当たり1.8単位の割合になるように加え、40時間反応させた。本反応液を、120℃で10分間オートクレーブし、53℃まで冷却後、pH5.7に調整して、特許文献5に開示されたアルスロバクター・スピーシーズS34(FERM BP−6450)由来の非還元性糖質生成酵素を澱粉グラム当たり2単位の割合になるよう加え、64時間反応させた。この反応液を95℃で10分間保った後、冷却し、濾過して得られる濾液を、常法に従って、活性炭で脱色し、H型、OH型イオン交換樹脂により脱塩して精製し、更に濃縮して、噴霧乾燥して非晶質状態の粉末状のラジカル生成抑制剤を、無水物換算で、収率約87%で得た。本品は、無水物換算で、α−グルコシルα,α−トレハロース8.2%、α−マルトシルα,α−トレハロース6.5%、α−マルトトリオシルα,α−トレハロース5.6%、α−マルトテトラオシルα,α−トレハロース21.9%、α−マルトペンタオシルα,α−トレハロース9.3%、及びグルコース重合度8以上のα−グリコシルα,α−トレハロース14.1%含有していた。
<Radical production inhibitor>
After adding calcium carbonate to corn starch milk having a concentration of 33% to a final concentration of 0.1%, the pH is adjusted to 6.0, and α-amylase (sold by Novo, trade name “Termameal 60L”) is added thereto. It added so that it might become 0.2% per gram starch, and it was made to react at 95 degreeC for 15 minutes. The reaction solution was autoclaved at 120 ° C. for 30 minutes and then cooled to 50 ° C., and isoamylase (produced by Hayashibara Biochemical Laboratories Co., Ltd.) was added to 500 units per gram starch and described in JP-A-7-236478 Maltohexaose / maltoheptaose-producing amylase was added at a rate of 1.8 units per gram starch and allowed to react for 40 hours. This reaction solution was autoclaved at 120 ° C. for 10 minutes, cooled to 53 ° C., adjusted to pH 5.7, and non-reduced from Arthrobacter species S34 (FERM BP-6450) disclosed in Patent Document 5. Sex saccharide-forming enzyme was added at a rate of 2 units per gram of starch and allowed to react for 64 hours. The reaction solution is kept at 95 ° C. for 10 minutes, then cooled and filtered, and the filtrate obtained is decolorized with activated carbon and purified by desalting with H-type and OH-type ion exchange resins according to a conventional method. Concentrated and spray-dried to obtain an amorphous powdery radical production inhibitor in an yield of about 87% in terms of anhydride. This product is α-glucosyl α, α-trehalose 8.2%, α-maltosyl α, α-trehalose 6.5%, α-maltotriosyl α, α-trehalose 5.6% in terms of anhydride. α-maltotetraosyl α, α-trehalose 21.9%, α-maltopentaosyl α, α-trehalose 9.3%, and α-glycosyl α, α-trehalose 14.1 having a degree of glucose polymerization of 8 or more % Content.
本品を、実施例7の方法に準じて、水素添加し、α,α−トレハロースの糖質誘導体と共存するグルコース、マルトースなどの還元性糖質を、その糖アルコールに変換した後、常法により精製後、噴霧乾燥して、非晶質粉末状のラジカル生成抑制剤を調製した。 This product was hydrogenated according to the method of Example 7 to convert reducing sugars such as glucose and maltose coexisting with the sugar derivative of α, α-trehalose into the sugar alcohol, followed by a conventional method. After purification by spray drying, an amorphous powdery radical production inhibitor was prepared.
<ラジカル生成抑制剤>
実施例2で得たα,α−トレハロースの糖質誘導体含有粉末60質量部に対して、市販の無水結晶マルチトール(株式会社林原商事販売、商品名「マビット」)35質量部を混合し、粉末混合物を調製した。本品は、ラジカル生成抑制剤として有利に利用できる。
<Radical production inhibitor>
With respect to 60 parts by mass of the α, α-trehalose sugar derivative-containing powder obtained in Example 2, 35 parts by mass of commercially available anhydrous crystalline maltitol (Hayashibara Shoji Co., Ltd., trade name “Mabit”) was mixed. A powder mixture was prepared. This product can be advantageously used as a radical production inhibitor.
<ラジカル生成抑制剤>
実施例2で得た粉末状のラジカル生成抑制剤70質量部に対して、リンゴ酸2質量部、アスコルビン酸2−グルコシド(株式会社林原生物化学研究所販売、商品名「アスコフレッシュ」)10質量部、酵素処理ヘスペリジン2質量部(東洋精糖株式会社販売、商品名「αGヘスペリジン」)を混合して、粉末混合品を調製した。本品は、ラジカル生成抑制剤として有利に利用できる。
<Radical production inhibitor>
10 parts by mass of malic acid 2 parts by mass, ascorbic acid 2-glucoside (sales by Hayashibara Biochemical Laboratories, Inc., trade name “ASCO Fresh”) with respect to 70 parts by mass of the powdery radical production inhibitor obtained in Example 2 Part and 2 parts by mass of enzyme-treated hesperidin (sold by Toyo Seika Co., Ltd., trade name “αG Hesperidin”) were mixed to prepare a powder mixture. This product can be advantageously used as a radical production inhibitor.
<ラジカル生成抑制剤>
実施例2で得た粉末状のラジカル生成抑制剤70質量部に対して、アスコルビン酸2−グルコシド(株式会社林原生物化学研究所販売)10質量部を混合し、さらに酵素処理ルチン2質量部(東洋精糖株式会社販売、商品名「αGルチン」)を加えて、粉末混合品を調製した。本品は、加工飲食品、化粧品、医薬部外品、医薬品、飼料、餌料、化学工業品を始めとする、ラジカル生成により、保存中に異臭の発生、退色、硬化、分解、変性などの品質劣化や機能低下が生じ易い不飽和化合物を含有する組成物に含有させることにより、ラジカル生成を抑制し、安定に保つためのラジカル生成抑制剤として利用することができる。
<Radical production inhibitor>
To 70 parts by mass of the powdery radical production inhibitor obtained in Example 2, 10 parts by mass of ascorbic acid 2-glucoside (sales by Hayashibara Biochemical Laboratories, Inc.) is mixed, and further 2 parts by mass of enzyme-treated rutin ( Toyo Seika Co., Ltd., trade name “αG rutin”) was added to prepare a powder mixture. This product has quality such as generation of odor, fading, curing, decomposition, and modification during storage due to radical generation, including processed foods, cosmetics, quasi drugs, pharmaceuticals, feed, feed, chemical industrial products, etc. By containing it in a composition containing an unsaturated compound that easily deteriorates or lowers its function, it can be used as a radical generation inhibitor for suppressing radical generation and keeping it stable.
<ラジカル生成抑制剤>
実施例2で得たラジカル生成抑制剤50質量部に対して、市販の食品級含水結晶α,α−トレハロース(株式会社林原商事販売、商品名「トレハ」)50質量部を混合し、粉末混合物を得た。本品は、加工飲食品、化粧品、医薬部外品、医薬品、飼料、餌料、化学工業品を始めとする、ラジカル生成により、保存中に異臭の発生、退色、硬化、分解、変性などの品質劣化や機能低下が生じ易い不飽和化合物を含有する組成物に含有させることにより、ラジカル生成を抑制し、安定に保つためのラジカル生成抑制剤として利用することができる。また、本品は、直接、或いは、シュガーエステルなどを添加して、造粒、さらには、打錠して、顆粒、錠剤の形態での利用も容易である。
<Radical production inhibitor>
50 parts by mass of a commercially available food-grade water-containing crystal α, α-trehalose (Hayashibara Shoji Co., Ltd., trade name “Treha”) is mixed with 50 parts by mass of the radical production inhibitor obtained in Example 2, and a powder mixture Got. This product has quality such as generation of odor, fading, curing, decomposition, and modification during storage due to radical generation, including processed foods, cosmetics, quasi drugs, pharmaceuticals, feed, feed, chemical industrial products, etc. By containing it in a composition containing an unsaturated compound that easily deteriorates or lowers its function, it can be used as a radical generation inhibitor for suppressing radical generation and keeping it stable. In addition, the product can be easily used in the form of granules or tablets by granulation or tableting directly or by adding a sugar ester or the like.
<ラジカル生成抑制剤>
市販の食品級含水結晶α,α−トレハロース(株式会社林原商事販売、商品名「トレハ」)を、水に溶解し、60℃に加熱しながら、減圧濃縮して、トレハロースの濃度が75%の溶液を調製し、室温に放置して結晶を析出させ、該結晶を水で洗浄する操作を2回くり返した後、乾燥、粉砕して調製した、純度99.8%の含水結晶α,α−トレハロース粉末50質量部と、実施例5で得た粉末状のα−マルトシルα,α−トレハロース50質量部とを均質混合して、粉末混合物を得た。本品は、加工飲食品、化粧品、医薬部外品、医薬品、飼料、餌料、化学工業品を始めとする、ラジカル生成により、保存中に異臭の発生、褐変、変色、退色、硬化、分解、変性などの品質劣化や機能低下が生じ易い不飽和化合物を含有する組成物に含有させることにより、ラジカル生成を抑制し、安定に保つためのラジカル生成抑制剤として利用することができる。本品は、高純度のα−マルトシルα,α−トレハロース及びα,α−トレハロースで構成されているので、反応性が極めて低く、安定なので、特に、分子内にアミノ基を含み、還元性の糖とメーラード反応を起こし、その品質に劣化を来すような組成物に対して好適に使用できる。また、本品は、直接、或いは、シュガーエステルなどを添加して、造粒、さらには、打錠して、顆粒、錠剤の形態での利用も容易である。
<Radical production inhibitor>
Commercially available food-grade water-containing crystal α, α-trehalose (Hayashibara Shoji Co., Ltd., trade name “Treha”) was dissolved in water and heated to 60 ° C. and concentrated under reduced pressure to give a trehalose concentration of 75%. A solution was prepared and allowed to stand at room temperature to precipitate crystals, and the operation of washing the crystals with water was repeated twice, followed by drying and pulverization. Hydrous crystals α, α- with a purity of 99.8% were prepared. 50 parts by mass of trehalose powder and 50 parts by mass of the powdery α-maltosyl α, α-trehalose obtained in Example 5 were homogeneously mixed to obtain a powder mixture. This product is processed foods and drinks, cosmetics, quasi-drugs, pharmaceuticals, feeds, feeds, chemical industrial products, etc., generating radical odors during storage, browning, discoloration, fading, curing, decomposition, By containing it in a composition containing an unsaturated compound that easily undergoes quality degradation such as modification and functional degradation, it can be used as a radical generation inhibitor for suppressing radical generation and keeping it stable. This product is composed of high-purity α-maltosyl α, α-trehalose and α, α-trehalose, so it has extremely low reactivity and is stable. It can be suitably used for a composition that causes a Maillard reaction with sugar and deteriorates its quality. In addition, the product can be easily used in the form of granules or tablets by granulation or tableting directly or by adding a sugar ester or the like.
<魚肉練製品>
水晒ししたスケトウダラの生肉4,000質量部に対し、実施例12で調製した粉末状のラジカル生成抑制剤200質量部、クエン酸ナトリウム5質量部、アスコルビン酸2−グルコシド1質量部(株式会社林原商事販売、商品名「アスコフレッシュ」)を加えて、スリ身を製造し、−20℃で凍結して冷凍スリ身を製造した。冷凍スリ身を90日間−20℃で冷凍保存後に解凍し、グルタミン酸ナトリウム80質量部、馬鈴薯澱粉200質量部、氷水300質量部、トリポリリン酸ナトリウム8質量部、食塩120質量部及びマルチトール10質量部とを溶解しておいた水溶液100質量部を加えて擂漬し、約120gずつを定形して板付した。これらを、30分間で内部の品温が約80度になるように蒸し上げた。次いで、室温で放冷したのち、4℃で24時間放置して魚肉練製品を得た。ラジカル生成抑制剤は、スケトウダラの冷凍スリ身のタンパク質に対して優れた冷凍耐性を付与するため、冷凍保存後も、該冷凍スリ身の鮮度は十分に保持されており、それを原料とした本品は、風味良好、肌面が細やかで、艶やかな光沢を有していた。しかも、本品に含まれる脂質をはじめとする不飽和化合物の安定性が、α,α−トレハロースの糖質誘導体により高められているばかりでなく、ラジカル化した不飽和化合物の過酸化物によるタンパク質やアミノ酸の修飾、変性も抑制されるので、保存安定性にも優れているという特徴がある。
<Fish paste products>
200 parts by mass of a powdery radical production inhibitor prepared in Example 12, 5 parts by mass of sodium citrate, 1 part by mass of ascorbic acid 2-glucoside (in Hayashibara Co., Ltd.) Commercial sales, trade name “Asco Fresh”) was added to produce surimi and frozen at −20 ° C. to produce frozen surimi. The frozen surimi is thawed after refrigerated storage at -20 ° C. for 90 days, 80 parts by mass of sodium glutamate, 200 parts by mass of potato starch, 300 parts by mass of ice water, 8 parts by mass of sodium tripolyphosphate, 120 parts by mass of sodium salt and 10 parts by mass of maltitol 100 parts by mass of an aqueous solution in which the above was dissolved was added and pickled, and approximately 120 g each was shaped and attached to a plate. These were steamed so that the internal product temperature was about 80 degrees in 30 minutes. Next, after allowing to cool at room temperature, it was allowed to stand at 4 ° C. for 24 hours to obtain a fish paste product. Since the radical production inhibitor imparts excellent freezing tolerance to the protein of the frozen surimi of walleye pollack, the freshness of the frozen surimi is sufficiently preserved even after freezing. The product had a good flavor, a fine skin surface, and a glossy luster. In addition, the stability of unsaturated compounds such as lipids contained in this product is not only enhanced by α, α-trehalose saccharide derivatives, but also proteins by radicals of unsaturated compounds of peroxides. And modification and denaturation of amino acids are also suppressed, so that the storage stability is also excellent.
<生鮮魚介類の鮮度保持剤>
実施例12で調製した粉末状のラジカル生成抑制剤100質量部と、フィチン酸10質量部、グレープシードポリフェノール2質量部とを均一に混合し、粉末状の生鮮魚介類の鮮度保持剤を得た。本品は、α,α−トレハロースの糖質誘導体が、魚の油脂成分のラジカル生成を抑制することに加えて、α,α−トレハロースの糖質誘導体、α,α−トレハロース、グレープシードポリフェノール、有機酸、酵素処理ルチンが相乗的に作用して、魚肉の冷凍変性を抑制することから、生鮮魚介類及びその冷凍品の鮮度保持剤として、さらには、煮魚やその煮こごりの不快味や不快臭の改善剤としても好適である。
<Freshness preservation agent for fresh seafood>
100 parts by mass of the powdery radical production inhibitor prepared in Example 12, 10 parts by mass of phytic acid, and 2 parts by mass of grape seed polyphenol were uniformly mixed to obtain a freshness-preserving agent for powdered fresh seafood. . In this product, the carbohydrate derivative of α, α-trehalose suppresses radical generation of fish oil and fat components, in addition to carbohydrate derivatives of α, α-trehalose, α, α-trehalose, grape seed polyphenol, organic Since acid and enzyme-treated rutin act synergistically to suppress freezing and denaturation of fish meat, it can be used as a freshness-preserving agent for fresh seafood and its frozen products. It is also suitable as an improving agent.
本品400質量部を12Lの海水に溶解し、さらに、細かく砕いた市販の氷4kgを入れて冷却した。この水溶液に、漁港で水揚げした直後のアジ5kgを、浸漬処理し、10時間後に取り出して、体表及び鰓の状態を観察した。このアジは、α,α−トレハロースの糖質誘導体、α,α−トレハロース、グレープシードポリフェノール、有機酸、酵素処理ルチンが相乗的に作用して、ラジカルの生成を抑制し、脂質などの変性が抑制されることから、水揚げ直後と変わらない外観を呈していた。さらに、これを密封容器に入れて、−20℃の冷凍庫で10日間保存後、解凍してその状態を観察したところ、アジの体表は全く変化が起きておらず新鮮な状態を保っていた。 400 parts by mass of this product was dissolved in 12 L of seawater, and 4 kg of finely crushed commercial ice was added and cooled. 5 kg of horse mackerel immediately after landing at the fishing port was immersed in this aqueous solution, taken out after 10 hours, and observed on the body surface and the state of corals. This horse mackerel, α, α-trehalose carbohydrate derivative, α, α-trehalose, grape seed polyphenol, organic acid, enzyme-treated rutin acts synergistically to suppress the generation of radicals and denature lipids, etc. Since it was suppressed, it had the same appearance as immediately after landing. Furthermore, when this was put in a sealed container and stored for 10 days in a freezer at −20 ° C. and thawed and the state was observed, the body surface of the horse mackerel had not changed at all and was kept fresh. .
<米飯>
水洗いして水切りした米300質量部に水を米の1.25倍量と実施例4の方法で調製した粉末状のラジカル生成抑制剤13.5質量部、ビタミンE0.1質量部を混合して浸漬後、家庭用炊飯器にて炊飯して米飯を得た。本品は、米飯中の脂質をはじめとする不飽和化合物の安定性がα,α−トレハロースの糖質誘導体により高められているばかりでなく、ラジカル化した不飽和化合物の過酸化物によるタンパク質やアミノ酸の修飾、変性も抑制されるので、不快な米糠臭の発生やビタミンEに由来する不快臭が抑制され比較的長期間炊飯直後の好ましい風味が保持されるという特徴がある。また、α,α−トレハロースの糖質誘導体は、澱粉の老化防止効果、タンパク質の冷蔵・冷凍変性防止効果を併せ持っているので、本品は、老化や冷凍変性の発生するチルド冷蔵用や冷凍保存用の米飯として有利に利用できる。
<Rice rice>
To 300 parts by mass of washed and drained rice, 1.25 times the amount of water and 13.5 parts by mass of a powdery radical production inhibitor prepared by the method of Example 4 and 0.1 part by mass of vitamin E were mixed. After soaking, rice was cooked in a household rice cooker to obtain cooked rice. This product not only enhances the stability of unsaturated compounds such as lipids in cooked rice with carbohydrate derivatives of α, α-trehalose, but also includes proteins and peroxides derived from radicals of unsaturated compounds. Since modification and modification of amino acids are also suppressed, unpleasant rice bran odor generation and unpleasant odor derived from vitamin E are suppressed, and a preferable flavor immediately after cooking is maintained for a relatively long time. In addition, α, α-trehalose saccharide derivatives have both starch aging prevention effects and protein refrigeration / freezing denaturation prevention effects. It can be advantageously used as cooked rice.
<パスタ>
実施例1の方法で得たラジカル抑制剤、α,α−トレハロース(株式会社林原商事販売、商品名「トレハ」)及びマルトース(株式会社林原商事販売、商品名「サンマルト」)を水に溶解し、それぞれを10%含有する処理液を調製した。市販のパスタを常法により茹でた直後の熱いままで、80℃に加熱したこの処理液10質量部に対して、その1質量部を、5分間浸漬し、処理液から引き上げ、処理液をよくきって、冷却しパスタを調製した。対照として、処理液に浸漬しない以外は、同じ条件でパスタを調製して、これらパスタを4℃で3日間保存し、その食味を比較しところ、処理液で処理したパスタは、α,α−トレハロースの糖質誘導体、α,α−トレハロース及びマルトースが、ラジカルの生成を抑制し油脂の酸化や変腐を抑制すると共に、澱粉の老化も抑制することから、着色や異臭の発生もなく、製造直後のパスタ本来の食感と味質をよく保持していた。これに対して、処理液で処理しなかった対照のパスタでは、ぱさぱさした食感で、異臭が発生し、食味が低下した。なお、処理液は、α,α−トレハロースの糖質誘導体、α,α−トレハロース及びマルトースを含む糖質を、固形分換算で30%含有しているものの、これらの糖質の大部分は、パスタ中に均質浸透しているため、その甘味が、パスタ自身の味質に影響を及ぼすことはなかった。
<Pasta>
The radical inhibitor obtained by the method of Example 1, α, α-trehalose (Hayashibara Shoji Co., Ltd., trade name “Treha”) and maltose (Hayashibara Shoji Co., Ltd., trade name “Sanmalto”) were dissolved in water. A treatment solution containing 10% of each was prepared. Immediately after boiling commercially available pasta, 10 parts by mass of this treatment liquid heated to 80 ° C. while being hot, 1 part by mass is immersed for 5 minutes, pulled up from the treatment liquid, and the treatment liquid is well After cooling, the pasta was prepared. As a control, pasta was prepared under the same conditions except that it was not immersed in the treatment liquid, and the pasta was stored at 4 ° C. for 3 days, and the taste was compared. The sugar derivative of trehalose, α, α-trehalose and maltose inhibits the generation of radicals and the oxidation and transformation of fats and oils, and also suppresses starch aging, so there is no coloration or odor. The original texture and taste of pasta were maintained well. On the other hand, in the control pasta that was not treated with the treatment liquid, an unpleasant odor was generated with a crispy texture, and the taste was lowered. In addition, although the treatment liquid contains 30% of carbohydrates including α, α-trehalose carbohydrate derivatives, α, α-trehalose and maltose in terms of solid content, most of these carbohydrates are The sweetness did not affect the taste quality of the pasta because it penetrated homogeneously in the pasta.
<粉末油脂>
大豆サラダ油100質量部及びレシチン1質量部に水10質量部を室温で混合した後、これに実施例2の方法で得た粉末状のラジカル生成抑制剤100質量部を混合して粉末化し、篩にかけて粉末油脂を得た。本品における不飽和化合物は、α,α−トレハロースの糖質誘導体によりラジカルの生成及びラジカル生成の進行が抑制され、又、α,α−トレハロースが不飽和化合物と会合物を形成することによって、その安定性が高められているうえ、種々の食品素材とともに配合された際に、その配合される食品素材における不飽和化合物の安定化をも達成することができ、また、食品素材がタンパク質やアミノ酸を含有するものにあっては、ラジカル化した不飽和化合物の過酸化物によるタンパク質やアミノ酸の修飾、変性も抑制されるので、マヨネーズ、ドレッシングなどの調味材料、高カロリー経管栄養剤、配合飼料などに有利に利用できる。
<Powder oil and fat>
After mixing 100 parts by mass of soybean salad oil and 1 part by mass of lecithin with 10 parts by mass of water at room temperature, 100 parts by mass of the powdery radical production inhibitor obtained by the method of Example 2 was mixed with this, and pulverized. To obtain powdered fats and oils. The unsaturated compound in this product is a radical derivative of α, α-trehalose that suppresses the generation of radicals and the progress of radical generation, and α, α-trehalose forms an association with the unsaturated compound, In addition to its enhanced stability, when blended with various food ingredients, it can also stabilize unsaturated compounds in the blended food ingredients. In the case of foods that contain flavours, protein and amino acid modification and denaturation by peroxides of radicalized unsaturated compounds are also suppressed, so seasoning materials such as mayonnaise and dressings, high-calorie tube feedings, mixed feed It can be used to advantage.
<粉末牛乳>
生鮮乳200質量部に、α,α−トレハロースの糖質誘導体含有シラップ(株式会社林原商事販売、商品名『ハローデックス』)2質量部とデキストリン(三和澱粉工業株式会社販売、商品名『サンデックス』#100)8質量部とを加えて攪拌、溶解し、これを常法により噴霧乾燥して、粉末牛乳を得た。本品は、α,α−トレハロースの糖質誘導体によりラジカル生成が抑制されるので、比較的長期間生鮮乳の好ましい風味が保持される。また、この粉末牛乳は、α,α−トレハロースの糖質誘導体とデキストリンとを粉末化基剤として使用しているので、α,α−トレハロースの糖質誘導体のみを粉末化基剤として使用した場合に比して吸湿性が低く、デキストリンのみ粉末化基剤として使用した場合に比して、水や湯への溶解性が高いという特徴を有している。
<Powdered milk>
200 parts by mass of fresh milk, 2 parts by mass of syrup containing α, α-trehalose saccharide derivative (trade name “Hellodex”, trade name “Hellodex”) and dextrin (Sanwa Starch Co., Ltd., trade name “Sun”) Dex "# 100) 8 parts by mass was added, stirred and dissolved, and spray-dried by a conventional method to obtain powdered milk. Since the radical production of the product is suppressed by the carbohydrate derivative of α, α-trehalose, the preferable flavor of fresh milk is maintained for a relatively long period of time. In addition, this powdered milk uses α, α-trehalose saccharide derivatives and dextrin as powdered bases, so when only α, α-trehalose saccharide derivatives are used as powdered bases. Compared to the case of using dextrin alone as a powdered base, it has the characteristics of high solubility in water and hot water.
<サラダドレッシング>
水40.8質量部、蒸留ホワイトビネガー20質量部、植物油15質量部、砂糖5質量部、食塩2質量部、ガーリックパウダー1.0質量部、タマネギパウダー0.7質量部、グランドホワイトペッパー0.1質量部、キサンタンガム0.3質量部、ソルビン酸カリウム0.1質量部、実施例2の方法で得た粉末状のラジカル生成抑制剤15質量部を混合してサラダドレッシングを調製した。本品は、α,α−トレハロースの糖質誘導体によりラジカル生成が抑制されるので、油性成分の劣化や、ガーリックパウダー、タマネギパウダー、グランドホワイトペッパーなどの風味の劣化が抑制されるので、長期間、その品質が安定に保持される。
また、本品は、α,α−トレハロースの糖質誘導体及び環状四糖により、ビネガーの酢酸による刺激性が低減されるので、まろやかな美味しいドレッシングである。
<Salad dressing>
40.8 parts by weight of water, 20 parts by weight of distilled white vinegar, 15 parts by weight of vegetable oil, 5 parts by weight of sugar, 2 parts by weight of salt, 1.0 part by weight of garlic powder, 0.7 parts by weight of onion powder, A salad dressing was prepared by mixing 1 part by mass, 0.3 part by mass of xanthan gum, 0.1 part by mass of potassium sorbate, and 15 parts by mass of a powdery radical production inhibitor obtained by the method of Example 2. Since this product suppresses radical generation by the carbohydrate derivative of α, α-trehalose, it suppresses deterioration of oily components and flavors such as garlic powder, onion powder, ground white pepper, etc. , Its quality is kept stable.
In addition, this product is a mellow and delicious dressing because the irritation of vinegar by acetic acid is reduced by the carbohydrate derivative of α, α-trehalose and cyclic tetrasaccharide.
<クリーム>
シア分別脂(融点38℃)80部と菜種ヤシ油(融点35℃)20部との混合油脂35質量部、大豆レシチン(HLB3)0.3質量部、モノグリセリン脂肪酸エステル (HLB3)0.03質量部、ヘキサグリセリンペンタエステル(HLB4)0.15質量部、水60質量部、脱脂粉乳4質量部、リン酸のアルカリ金属塩0.1質量部を使用し、常法により、予備乳化を行い、70kg/cm2の加圧条件で均質化後、145℃、数秒程度の超高温加熱滅菌処理し、70kg/cm2の加圧条件にて再均質化した後、冷却し、約24時間エージングを行い、起泡性乳化物を調製した。この起泡性乳化物100質量部に対して、実施例3の方法で得た粉末状のラジカル生成抑制剤8質量部を加えて、ケンウッドミキサーを使用して、2分45秒間ホイップして、オーバーラン75% のクリームを調製した。本品は、ラジカル生成が抑制されるので、風味の劣化が抑制されており、5〜20℃で7日間保存後のもの、或いは、−20℃に14日間凍結保存後解凍したものは、いずれも、保形性、風味、口溶けがよく、また、冷凍保存時にも、ひび割れも認められなかった。
<Cream>
Mixed oil and fat of 80 parts of shea fractionated fat (melting point 38 ° C.) and 20 parts of rapeseed coconut oil (melting point 35 ° C.), 0.3 part by weight of soybean lecithin (HLB3), monoglycerin fatty acid ester (HLB3) 0.03 Preliminary emulsification is carried out in a conventional manner using parts by mass, 0.15 parts by mass of hexaglycerin pentaester (HLB4), 60 parts by mass of water, 4 parts by mass of skim milk powder, and 0.1 parts by mass of an alkali metal salt of phosphoric acid. , Homogenized under a pressure of 70 kg / cm 2 , sterilized by heating at 145 ° C. for several seconds, re-homogenized under a pressure of 70 kg / cm 2 , cooled, and aged for about 24 hours And a foamable emulsion was prepared. To 100 parts by mass of this foamable emulsion, 8 parts by mass of the powdery radical production inhibitor obtained by the method of Example 3 was added and whipped using a Kenwood mixer for 2 minutes and 45 seconds. A 75% overrun cream was prepared. Since this product has radical generation suppressed, flavor deterioration is suppressed, and after storage at 5-20 ° C for 7 days, or after thawing after freezing at -20 ° C for 14 days, However, the shape-retaining property, flavor and meltability in the mouth were good, and no cracks were observed even when stored frozen.
<マヨネーズ>
卵1個分の卵黄、サラダ油140ml、実施例2の方法で得た粉末状のラジカル生成抑制剤1g、国際公開WO 02/10361号明細書に開示された環状四糖5含水結晶1g、塩少々、胡椒少々を使用して、常法によりマヨネーズを調製した。本品は、α,α−トレハロースの糖質誘導体及び環状四糖によりラジカル生成が抑制されて、油性成分の劣化が抑制されるので、長期間、その品質が安定に保持される。
<Mayonnaise>
Egg yolk for 1 egg, 140 ml of salad oil, 1 g of powdery radical production inhibitor obtained by the method of Example 2, 1 g of cyclic tetrasaccharide 5 hydrous crystals disclosed in International Publication WO 02/10361, a little salt A mayonnaise was prepared by a conventional method using a little pepper. This product is stable in quality for a long period of time because radical generation is suppressed by the carbohydrate derivative of α, α-trehalose and cyclic tetrasaccharide, and deterioration of the oil component is suppressed.
<カット野菜>
カットしたレタスを次亜鉛塩素酸ナトリウムの90ppm水溶液に10分間浸漬して殺菌した後、実施例13の方法で得たラジカル生成抑制剤1%と食塩1%を含有し、クエン酸でpHを3.2に調整した水溶液に3分間浸漬してカット野菜を調製した。本品はα−トレハロースの糖質誘導体及びα,α−トレハロースによりラジカル生成が抑制されて、長期間、その鮮度が安定に保持される。
<Cut vegetables>
The cut lettuce was sterilized by immersing it in a 90 ppm aqueous solution of sodium hypochlorite for 10 minutes, and then containing 1% of the radical formation inhibitor obtained by the method of Example 13 and 1% of sodium chloride, and the pH was adjusted to 3 with citric acid. Cut vegetables were prepared by immersing in an aqueous solution adjusted to 2 for 3 minutes. In this product, radical generation is suppressed by α-trehalose carbohydrate derivative and α, α-trehalose, and its freshness is stably maintained for a long time.
<可食性フィルム>
プルラン(商品名「PI−20」、株式会社林原商事販売)30質量部、水70質量部、及び実施例2の方法で得た粉末状のラジカル生成抑制剤1.5質量部を加えて完全に溶解した。この溶解液100質量部に対して、カラギーナン1質量部及びレシチン0.1質量部を加えて溶解混合し、均一な溶液とした。これを、常法にしたがって、ポリエステルフィルム上に流延し、引取速度3m/分で、厚さ0.03mmのフィルムとし、90℃の熱風で乾燥させて製品とした。本品は、プルランのみを使用したフィルムとは違って、水系で速溶せず、徐々に溶解、崩壊する可食性フィルムであり、しかも、本品に含まれる不飽和化合物の安定性がα,α−トレハロースの糖質誘導体により高められているので、保存安定性にも優れているという特長がある。従って、本品はオブラートなどと同様に、食品分野や医薬品分野などで有利に利用できる。
<Edible film>
Pullulan (trade name “PI-20”, Hayashibara Shoji Sales Co., Ltd.) 30 parts by weight, water 70 parts by weight, and 1.5 parts by weight of the powdery radical generation inhibitor obtained by the method of Example 2 were completely added. Dissolved in. To 100 parts by mass of this solution, 1 part by mass of carrageenan and 0.1 part by mass of lecithin were added and dissolved and mixed to obtain a uniform solution. This was cast on a polyester film according to a conventional method to obtain a film having a take-up speed of 3 m / min and a thickness of 0.03 mm, and dried with hot air at 90 ° C. to obtain a product. Unlike the film that uses only pullulan, this product is an edible film that dissolves and disintegrates gradually without dissolving quickly in water, and the stability of unsaturated compounds contained in this product is -Since it is enhanced by a carbohydrate derivative of trehalose, it has the advantage of excellent storage stability. Therefore, this product can be advantageously used in the food and pharmaceutical fields as well as the wafers.
<焙煎アーモンド>
精選したアーモンド100質量部を常法により焙煎し、この高温のアーモンドを撹拌しつつ、実施例8の方法で得たシラップ状のラジカル生成抑制剤(水素添加していない)を予め水で希釈して20%水溶液としたもの3質量部をできるだけ均一に噴霧混合し、次いで、食塩粉末をまぶして焙煎アーモンドを得た。本品は風味の優れた焙煎アーモンドであり、脂質のラジカル生成が抑制されることから、その保存安定性に優れており、そのまま食すことも、或いは、製菓・製パンや調理用の材料としても好適である。
<Roasted almond>
100 parts by mass of carefully selected almonds are roasted by a conventional method, and while stirring the high-temperature almonds, the syrup-like radical formation inhibitor (not hydrogenated) obtained by the method of Example 8 is diluted with water in advance. Then, 3 parts by mass of a 20% aqueous solution was sprayed and mixed as uniformly as possible, and then salted powder was applied to obtain roasted almonds. This product is a roasted almond with excellent flavor, and because it suppresses the generation of lipid radicals, it has excellent storage stability and can be eaten as it is, or as a material for confectionery, bread making and cooking Is also suitable.
<茶飲料>
緑茶(煎茶)3質量部を熱水180質量部に浸出し、この浸出液に、アスコルビン酸、実施例1の方法で得たラジカル生成抑制剤、カテキン、糖転移ヘスペリジン(株式会社林原商事販売、商品名「林原ヘスペリジンS」)及びβ−サイクロデキストリンを、各々最終濃度が0.05%(w/v)、2%(w/v)、1.5%(w/v)、1%(w/v)及び0.1%(w/v)となるように添加して溶解し、除菌した後、500ml容プラスチック製透明ボトルに充填し、ボトル入り緑茶飲料を調製した。本品は、α,α−トレハロースの糖質誘導体及びサイクロデキストリンが、ラジカル生成を抑制すると共に、カテキンの渋味や苦味をマスクし、アスコルビン酸の褐変も抑制することから、長期間保存しても、褐変や異臭の発生もない、まろやかで風味の良い、飲みやすい茶飲料である。また、本品は、糖転移ヘスペリジンを含有しているので、体内の脂質調節の目的で飲用することもできる。
<Tea drink>
3 parts by mass of green tea (sencha) was leached into 180 parts by mass of hot water, and ascorbic acid, a radical production inhibitor obtained by the method of Example 1, catechin, and sugar-transferred hesperidin (sales of Hayashibara Corporation, merchandise) Name “Hayashibara Hesperidin S”) and β-cyclodextrin, final concentrations of 0.05% (w / v), 2% (w / v), 1.5% (w / v), 1% (w / V) and 0.1% (w / v) were added and dissolved, sterilized, and then filled into a 500 ml plastic transparent bottle to prepare a bottled green tea beverage. This product is preserved for a long time because the carbohydrate derivatives of α, α-trehalose and cyclodextrin suppress radical generation, mask the astringency and bitterness of catechins, and suppress browning of ascorbic acid. However, it is a mellow, savory and easy-to-drink tea beverage that does not cause browning or off-flavour. Moreover, since this product contains transglycosyl hesperidin, it can be taken for the purpose of regulating lipids in the body.
<中華まんじゅう>
豚肉20質量部、豚脂5質量部、タマネギ35質量部、シイタケ3質量部、タケノコ2質量部、澱粉3質量部、パン粉4質量部、実施例1の方法で得たシラップ状のラジカル生成抑制剤3質量部、醤油4質量部、砂糖4質量部、食塩0.7質量部、ごま油0.7質量部、生姜0.7質量部、ニンニク0.2質量部、ポークエキス3質量部、胡椒0.1質量部、うま味調味料0.5質量部、水を加えて全量を125質量部としたものを、常法により、熱調理したものを具材として調製した。これを、生イースト2.5質量部を水44質量部に溶き、強力粉30質量部、薄力粉70質量部、砂糖15質量部、実施例1で調製したシラップ状のラジカル生成抑制剤2質量部、食塩1.3質量部およびベーキングパウダー0.6質量部を加え、攪拌機で混合した後、ラード5質量部を加えさらに混合して、常法により調製した皮部生地で包み、常法により、38℃で40分間発酵後、15分間蒸して中華まんじゅうを調製した。本品はムチムチした食感の皮とジューシーな具からなる美味しい中華まんじゅうであり、冷凍、冷蔵、チルド条件で保存しても、調製直後の美味しさがよく保持されていた。
<Chinese Manju>
20 parts by mass of pork, 5 parts by mass of pork fat, 35 parts by mass of onion, 3 parts by mass of shiitake, 2 parts by mass of bamboo shoot, 3 parts by mass of starch, 4 parts by mass of bread crumb, and suppression of syrup-like radical production obtained by the method of Example 1 3 parts by weight, 4 parts by weight soy sauce, 4 parts by weight sugar, 0.7 parts by weight salt, 0.7 parts by weight sesame oil, 0.7 parts by weight ginger, 0.2 parts by weight garlic, 3 parts by weight pork extract, pepper 0.1 parts by mass, 0.5 parts by mass of umami seasoning, and water were added to make a total of 125 parts by mass. This is obtained by dissolving 2.5 parts by weight of raw yeast in 44 parts by weight of water, 30 parts by weight of strong flour, 70 parts by weight of weak flour, 15 parts by weight of sugar, 2 parts by weight of the syrup-like radical production inhibitor prepared in Example 1, Add 1.3 parts by weight of sodium chloride and 0.6 parts by weight of baking powder, mix with a stirrer, add 5 parts by weight of lard, further mix and wrap in the skin dough prepared by a conventional method. After fermentation at 40 ° C. for 40 minutes, Chinese steamed bun was prepared by steaming for 15 minutes. This product is a delicious Chinese bun with a crisp textured skin and juicy ingredients. Even when stored under chilled, chilled or chilled conditions, the deliciousness immediately after preparation was well preserved.
<ぎょうざ>
小麦粉16質量部、タピオカ加工澱粉4質量部、粉状の小麦蛋白0.2質量部、粉状の大豆蛋白0.1質量部、食塩0.2質量部、静菌剤0.1質量部をよく混合した後、水6.4質量部を加えて攪拌し、次いで、実施例1の方法で得たラジカル生成抑制剤3質量部を投入して混合し、これに、固形状乳化油脂1質量部を投入し、混合して生地を作成した。次いで得られたこの生地を、厚さ0.8mm程度にのばして、1枚の質量が約6gの餃子の皮を得た。この餃子の皮6gに餃子類の具15gを包み込み、成形した生餃子を蒸し器に入れ15分間、100℃前後で蒸し、次に、急速冷凍を60分間行い、冷凍餃子とした。これらの冷凍餃子を樹脂製袋に入れ、脱気して密封した上で箱詰めにして−20℃で保存した。本品を30日間冷凍保存後、解凍し、蒸し焼きして焼き餃子(製品)とし、さらに常温(20℃前後)で1日置いた。これを電子レンジで再加熱して食したところ冷凍、蒸し焼き、常温による保管、電子レンジ再加熱という餃子の皮の硬化や脂質の劣化が起こりやすいプロセスを経たにもかかわらず、脂質の劣化や、不快味、不快臭の発生もなく、また、皮は硬化することなく、耳まで柔らかい状態であった。
<Gyoza>
16 parts by weight of flour, 4 parts by weight of tapioca processed starch, 0.2 parts by weight of powdered wheat protein, 0.1 parts by weight of powdered soy protein, 0.2 parts by weight of salt, 0.1 parts by weight of bacteriostatic agent After mixing well, 6.4 parts by mass of water was added and stirred, and then 3 parts by mass of the radical generation inhibitor obtained by the method of Example 1 was added and mixed. The dough was made by mixing and mixing. Next, the obtained dough was stretched to a thickness of about 0.8 mm to obtain a dumpling skin having a mass of about 6 g. 15 g of dumplings were wrapped in 6 g of this dumpling skin, and the formed raw dumplings were placed in a steamer and steamed at around 100 ° C. for 15 minutes, and then rapidly frozen for 60 minutes to obtain frozen dumplings. These frozen dumplings were put in a resin bag, degassed and sealed, then boxed and stored at -20 ° C. This product was stored frozen for 30 days, thawed, steamed and baked to make a baked dumpling (product), and then placed at room temperature (around 20 ° C.) for 1 day. When this was reheated in a microwave oven and ate, it was frozen, steamed, stored at room temperature, and after a process that tends to cause hardening of the dumpling skin and lipid deterioration such as reheating of the microwave oven, fat deterioration, There was no occurrence of unpleasant taste and unpleasant odor, and the skin did not harden and was soft to the ears.
<脂肪含有乳剤>
精製大豆油100gに精製大豆レシチン12g及びグリセリン25gを加え、湯浴で加温し、ポリトロンホモジナイザーで乳化を行った後、ミクロンフルイダイザーを使用して、さらに乳化した。得られた乳化液に予め、実施例9の方法で得た粉末状のラジカル生成抑制剤(水素添加していない)80gを溶解した水溶液250mlを加え、さらに蒸留水を加えて、全液量を1,000mlに調整した。次いで、炭酸水素ナトリウムを加えて、pHを7.2に調整し、メンブランフィルターで濾過後、濾液を250mlのバイアルに充填し、120℃で20分間高圧蒸気滅菌を行い脂肪乳剤を得た。本品は、α,α−トレハロースの糖質誘導体によりラジカル生成が抑制されるので、ブドウ糖などの糖の使用時に問題となるギ酸をはじめとする有機酸の発生や、生体に有害な遊離脂肪酸の生成が抑制されており、長期に安定な、脂肪乳剤であり、そのままで、或いは、アミノ酸やビタミン類などを添加して、経口或いは非経口的な栄養補給に有利に利用できる。
<Fat containing emulsion>
12 g of purified soybean lecithin and 25 g of glycerin were added to 100 g of purified soybean oil, heated in a hot water bath, emulsified with a polytron homogenizer, and further emulsified using a micron fluidizer. In advance, 250 ml of an aqueous solution in which 80 g of a powdery radical production inhibitor (not hydrogenated) obtained by the method of Example 9 was dissolved was added to the obtained emulsion and distilled water was further added. Adjusted to 1,000 ml. Next, sodium bicarbonate was added to adjust the pH to 7.2, and after filtration through a membrane filter, the filtrate was filled into a 250 ml vial and autoclaved at 120 ° C. for 20 minutes to obtain a fat emulsion. This product has α, α-trehalose saccharide derivatives to suppress radical generation, so it can generate organic acids such as formic acid, which is a problem when using sugars such as glucose, and free fatty acids harmful to the body. It is a fat emulsion that is suppressed in production and stable for a long period of time, and can be advantageously used as it is or by adding amino acids, vitamins, or the like for oral or parenteral nutrition.
<香料>
水100gにHLB15のショ糖脂肪酸エステル5g、実施例4の方法で調製した粉末状のラジカル生成抑制剤75gを加えて溶解し、85〜90℃で15分間加熱殺菌した。この溶液を約40℃に冷却後ホモミキサーで撹拌しながら、レモンオイル10gを混合して乳化液を得た。本品は、さらに、噴霧乾燥などの方法で乾燥することにより、容易に粉末香料とすることができる。本品及び本品を粉末化したレモンオイル香料は、いずれも長期保存による劣化臭の発生がなく良好な香気・香味を保持していた。
<Fragrance>
To 100 g of water, 5 g of sucrose fatty acid ester of HLB15 and 75 g of a powdery radical production inhibitor prepared by the method of Example 4 were added and dissolved, and sterilized by heating at 85 to 90 ° C. for 15 minutes. The solution was cooled to about 40 ° C. and then stirred with a homomixer, and 10 g of lemon oil was mixed to obtain an emulsion. This product can be easily made into a powder flavor by drying by a method such as spray drying. Both this product and the lemon oil fragrance made by pulverizing this product did not generate a deteriorated odor due to long-term storage and maintained a good aroma and flavor.
<ビタミンD錠剤>
ビタミンDとしてビタミンD3(コレカルシフェロール、和光純薬株式会社製)をエタノール(試薬特級、片山化学株式会社販売)に溶解し、ビタミンD3を3%濃度含むエタノール溶液1.5mlに、実施例3の方法で得た粉末状のラジカル生成抑制剤10gに添加し、減圧乾燥後、粉末化して、α,α−トレハロースの糖質誘導体を含有するビタミンD3製剤粉末を調製した。この粉末約0.3gを採り、打錠機で200kg/cm2、2分間加圧して、ビタミンD3錠剤を調製した。本品は、長期保存によるビタミンDの劣化が少ない、保存安定性に優れているビタミンD3製剤である。
<Vitamin D tablets>
Vitamin D 3 (cholecalciferol, manufactured by Wako Pure Chemical Industries, Ltd.) is dissolved in ethanol (special grade reagent, sold by Katayama Chemical Co., Ltd.) as vitamin D, and 1.5 ml of ethanol solution containing 3% vitamin D 3 is used. It was added to a powdery radical inhibitor 10g obtained in example 3 of the method, after drying under reduced pressure, and powdered, alpha, to prepare vitamin D 3 formulations powder containing saccharide derivatives of α- trehalose. About 0.3 g of this powder was taken and pressurized with a tableting machine at 200 kg / cm 2 for 2 minutes to prepare vitamin D 3 tablets. The product has less degradation of vitamin D due to long-term storage, a vitamin D 3 formulations have excellent storage stability.
<洗顔フォーム>
下記の構成処方に基づき、常法により、その全量を75〜85℃で加熱溶解した後、徐々に室温まで攪拌冷却し、目的の洗顔フォームを得た。本品は、α,α−トレハロースの糖質誘導体を含有しているので、変色や異臭の発生が抑制され、しかも、クリーミィな泡立ちで、すっきりした洗浄感を有し、洗い上がり時はシットリとした感じが持続する洗顔フォームである。なお、以下の実施例33〜実施例48における各原料成分の配合量は、いずれも質量部を意味する。
N−アシル−L−グルタミン酸ナトリウム 20
N−ヤシ油脂肪酸/硬化牛脂肪酸アシル−L−グルタ
ミン酸ナトリウム 2
パーム核油脂肪酸ジエタノールアミド 1
ポリオキシエチレンヤシ油ソルビタン(20E.O.) 5
1,3−ブチレングリコール 4
プロピレングリコール 27
モノステアリン酸ポリエチレングリコール 1
実施例7の方法で得た粉末状のラジカル生成抑制剤 2
チョウジエキス 0.5
パラオキシ安息香酸エステル 0.3
精製水を加えて全量を100とする。
<Face-wash form>
Based on the following constitutional formulation, the whole amount was heated and dissolved at 75 to 85 ° C. by a conventional method, and then gradually stirred and cooled to room temperature to obtain the desired facial cleansing foam. Since this product contains a carbohydrate derivative of α, α-trehalose, discoloration and off-flavor generation are suppressed, and it has a clean feeling with creamy foaming. It is a face-washing foam that lasts. In addition, the compounding quantity of each raw material component in the following Examples 33-48 means all parts by mass.
Sodium N-acyl-L-glutamate 20
N-coconut oil fatty acid / cured beef fatty acid acyl-L-glutamate sodium 2
Palm kernel oil fatty acid diethanolamide 1
Polyoxyethylene palm oil sorbitan (20E.O.) 5
1,3-butylene glycol 4
Propylene glycol 27
Polyethylene glycol monostearate 1
Powdery radical production inhibitor obtained by the method of Example 7 2
Clove extract 0.5
P-Hydroxybenzoate ester 0.3
Purified water is added to bring the total volume to 100.
<口紅>
以下に示す構成処方に基づき、常法により、そのA成分を混合して、85℃で攪拌溶解したものに、B成分の各成分をヒマシ油の一部に加えローラーで処理したものを加えて均一に分散した。これを、モールド型に流し込み急冷し、スティック状とし、目的の口紅を得た。本品は、α,α−トレハロースの糖質誘導体を含有しているので、変色や異臭の発生が抑制され、しかも、滑らかなのびで、化粧仕上がりがよく、保湿性があり、潤った唇状態を保つことのできる口紅である。
<A成分>
ヒマシ油 25
2−エチルヘキサン酸セチル 14.5
ラノリン 11
イソプロピルミリスチン酸エステル 10
キャンデリラロウ 9
パラフィン 8
ミツロウ 5
カルナウバロウ 5
フラバンジェノール 0.5
パラオキシ安息香酸プロピル 適量
香料 適量
<B成分>
実施例7の方法で得た粉末状のラジカル生成抑制剤 4
酸化チタン 6
赤色202号 0.6
赤色201号 0.2
赤色223号 0.2
<Lipstick>
Based on the composition recipe shown below, add the component A mixed in a conventional manner, stir and dissolve at 85 ° C., add the components of component B to a portion of castor oil and treat with a roller. Evenly dispersed. This was poured into a mold and rapidly cooled to form a stick to obtain the desired lipstick. This product contains a saccharide derivative of α, α-trehalose, which prevents discoloration and off-flavour, and has a smooth, smooth finish, good moisturizing properties, moisturizing lips A lipstick that can keep you safe.
<A component>
Castor oil 25
Cetyl 2-ethylhexanoate 14.5
Lanolin 11
Isopropyl myristic acid ester 10
Candelilla Row 9
Paraffin 8
Beeswax 5
Carnauba wax 5
Flavangenol 0.5
Propyl paraoxybenzoate Appropriate amount Perfume Appropriate amount <Component B>
Powdered radical production inhibitor obtained by the method of Example 7 4
Titanium oxide 6
Red No. 202 0.6
Red No. 201 0.2
Red 223 0.2
<アイシャドー>
以下に示す構成処方に基づき、常法により、そのA成分をヘンシェルミキサーで混合し、これに均一に加熱溶解したB成分を加え、混合粉砕し、中皿に圧縮成型し、アイシャドーを得た。本品は、α,α−トレハロースの糖質誘導体を含有しているので、変色や異臭の発生が抑制され、しかも、密着性と化粧仕上がり感が良く、塗布した瞼から目尻は保湿感が得られる、使用感の良いアイシャドーである。
<A成分>
シリコン処理タルク 27
シリコン処理酸化チタン 9
チッ化ホウ素 9
シリコン処理(タルク・ケイフッ化K)焼成物 9
シコパール・ピンク(BASF社販売) 9
実施例3の方法で得た粉末状のラジカル生成抑制剤 8.5
カテキン 0.5
メチルパラベン 1
<B成分>
ジメチコン 5
ジオクタン酸ネオペンチルグリコール 1
スクワラン(植物性) 4
トコフェロール 0.01
プロピルパラベン 0.01
<Eye shadow>
Based on the composition formula shown below, the A component was mixed with a Henschel mixer by a conventional method, and the B component that was uniformly heated and dissolved was added thereto, mixed and pulverized, and compression molded into an inner dish to obtain an eye shadow. . Since this product contains a carbohydrate derivative of α, α-trehalose, discoloration and off-flavor generation are suppressed, and the adhesion and makeup feel are good. It is a good eye shadow that can be used.
<A component>
Silicon processing talc 27
Silicon-treated titanium oxide 9
Boron nitride 9
Baked product of silicon treatment (talc and silicic fluoride K) 9
Coco Pearl Pink (sales by BASF) 9
Powdery radical production inhibitor obtained by the method of Example 3 8.5
Catechin 0.5
Methylparaben 1
<B component>
Dimethicone 5
Neopentyl glycol dioctanoate 1
Squalane (vegetable) 4
Tocopherol 0.01
Propylparaben 0.01
<化粧下地>
下記に示す配合処方に基づき、常法により、そのB成分を加熱溶解したものの中にC成分を添加・分散後、別の容器で加熱・溶解したA成分を添加・乳化して充分に均一混合して、室温まで攪拌冷却し、目的の化粧下地を得た。本品は、α,α−トレハロースの糖質誘導体を含有しているので、変色や異臭の発生が抑制され、しかも、ファンデーションとの密着性がよく、化粧崩れしにくく、更に、シットリとした感触が持続し、良好な使用感を有する化粧下地である。また、ニキビやアトピー性の疾患を有する肌や、化粧品に過敏な肌の場合でも、炎症性の反応が抑制されるので、これらの疾患の増悪を懸念することなく使用することができる。
<A成分>
精製水 48
1,3−ブチレングリコール 2
グリセリン 1
実施例7の方法で得た粉末状のラジカル生成抑制剤 1.5
エラグ酸 0.5
モンモリロナイト 0.5
プルラン(株式会社林原商事販売、商品名「プルラン
PI−20」) 0.1
ヘキサメタリン酸ナトリウム 0.05
エチレンジアミン4酢酸ナトリウム 0.05
水酸化ナトリウム 0.1
<B成分>
ステアリン酸 1
パルミチン酸 1
イソステアリルパルミテート 3
ワセリン 1
ジメチルポリシロキサン(6CS) 10
流動パラフィン 10
POEグリセリルモノステアレート 1
グリセリルモノステアレート 1
酸化防止剤 0.05
防腐剤 0.2
香料 適量
<C成分>
酸化チタン 4
セリサイト 8
黄酸化鉄 0.1
微粒子酸化チタン 5
チタン酸コバルト 0.7
<Makeup base>
Based on the formulation shown below, add and disperse the C component in the B component heated and dissolved in a conventional manner, then add and emulsify the A component heated and dissolved in another container and mix thoroughly. Then, the solution was stirred and cooled to room temperature to obtain the desired makeup base. Since this product contains a saccharide derivative of α, α-trehalose, discoloration and off-flavor generation are suppressed, it has good adhesion to the foundation, is not easily disintegrated, and has a soft feel. Is a makeup base that lasts and has a good feeling of use. In addition, even in the case of skin having acne or atopic disease, or skin sensitive to cosmetics, the inflammatory reaction is suppressed, so that it can be used without worrying about exacerbation of these diseases.
<A component>
Purified water 48
1,3-butylene glycol 2
Glycerin 1
Powdery radical production inhibitor obtained by the method of Example 7 1.5
Ellagic acid 0.5
Montmorillonite 0.5
Pullulan (Hayashibara Trading Co., Ltd., trade name "Pullulan PI-20") 0.1
Sodium hexametaphosphate 0.05
Ethylenediaminetetraacetate sodium 0.05
Sodium hydroxide 0.1
<B component>
Stearic acid 1
Palmitic acid 1
Isostearyl palmitate 3
Vaseline 1
Dimethylpolysiloxane (6CS) 10
Liquid paraffin 10
POE glyceryl monostearate 1
Glyceryl monostearate 1
Antioxidant 0.05
Preservative 0.2
Perfume appropriate amount <C component>
Titanium oxide 4
Sericite 8
Yellow iron oxide 0.1
Fine particle titanium oxide 5
Cobalt titanate 0.7
<乳液>
以下に示す配合処方に基づき、常法により乳液を調製した。本品は、α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、はりのあるみずみずしい肌の維持をはじめ、皮膚刺激やかゆみの予防、美白、シミ、ソバカス、日焼け等の色素沈着症、或いは、皮膚の老化の治療用、予防用等に有利に使用できる。しかも、ニキビやアトピー性の疾患を有する肌や、化粧品に過敏な肌の場合でも、炎症性の反応が抑制されるので、これらの疾患の増悪を懸念することなく使用することができる。
ステアリン酸 2.5
セタノール 1.5
ワセリン 5
流動パラフィン 10
ポリオキシエチレン(10モル)オレート 2
プロピルパラベン 0.1
酢酸dl−α−トコフェロール 0.5
香料 0.2
ポリエチレングリコール(1500) 3
トリエタノールアミン 1
糖蜜エキス 0.5
L−アスコルビン酸2−グルコシド(林原生物化学研
究所株式会社販売、商品名「AA2G」) 2
α,α−トレハロースの糖質誘導体含有シラップ(株式
会社林原生物化学研究所販売、商品名「トルナーレ」) 2.5
国際公開WO 02/10361号明細書の実施例A−2
に開示された環状四糖含有シラップを水素添加したシ
ラップ(株式会社林原生物化学研究所製造) 0.5
脱イオン水を加えて全量を100とする。
<Emulsion>
An emulsion was prepared by a conventional method based on the formulation shown below. Since this product contains a carbohydrate derivative of α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, it can be advantageously used for the maintenance of bruise and fresh skin, the prevention of skin irritation and itching, pigmentation such as whitening, spots, buckwheat, sunburn, and the treatment and prevention of skin aging. Moreover, even in the case of skin with acne or atopic disease, or skin sensitive to cosmetics, the inflammatory reaction is suppressed, so that it can be used without worrying about exacerbation of these diseases.
Stearic acid 2.5
Cetanol 1.5
Vaseline 5
Liquid paraffin 10
Polyoxyethylene (10 mol) oleate 2
Propylparaben 0.1
Dl-α-tocopherol acetate 0.5
Fragrance 0.2
Polyethylene glycol (1500) 3
Triethanolamine 1
Molasses extract 0.5
L-ascorbic acid 2-glucoside (sold by Hayashibara Biochemical Research Co., Ltd., trade name “AA2G”) 2
Syrup containing carbohydrate derivatives of α, α-trehalose (sales company Hayashibara Biochemicals, Inc., trade name “Tornare”) 2.5
Example A-2 of WO 02/10361
Syrup hydrogenated from the cyclic tetrasaccharide-containing syrup disclosed in (manufactured by Hayashibara Biochemical Research Co., Ltd.) 0.5
Add deionized water to bring the total volume to 100.
<化粧水>
以下に示す配合処方に基づき、常法により、化粧水を調製した。本品は、α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、はりのあるみずみずしい肌の維持をはじめ、皮膚刺激やかゆみの予防、美白、シミ、ソバカス、日焼け等の色素沈着症、或いは、皮膚の老化の治療用、予防用等に有利に使用できる。しかも、ニキビやアトピー性の疾患を有する肌や、化粧品に過敏な肌の場合でも、炎症性の反応が抑制されるので、これらの疾患の増悪を懸念することなく使用することができる。
実施例6の方法で得たラジカル生成抑制剤 0.5
クエン酸 0.1
クエン酸ナトリウム 0.3
グリセロール 2
エタノール 5
チオタウリン 1
感光素201号 0.0001
エチルパラベン 0.1
精製水を適量加えて、全量を100とする。
<Lotion>
A lotion was prepared by a conventional method based on the formulation shown below. Since this product contains a carbohydrate derivative of α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, it can be advantageously used for the maintenance of bruise and fresh skin, the prevention of skin irritation and itching, pigmentation such as whitening, spots, buckwheat, sunburn, and the treatment and prevention of skin aging. Moreover, even in the case of skin with acne or atopic disease, or skin sensitive to cosmetics, the inflammatory reaction is suppressed, so that it can be used without worrying about exacerbation of these diseases.
Radical formation inhibitor obtained by the method of Example 6 0.5
Citric acid 0.1
Sodium citrate 0.3
Glycerol 2
Ethanol 5
Thiotaurine 1
Photosensitive element 201 0.0001
Ethylparaben 0.1
An appropriate amount of purified water is added to make the total amount 100.
<化粧水型スプレー>
以下に示す配合処方に基づき、無水エタノールの下記の成分を溶解後、ろ過して化粧水型スプレーの原液を調製した。これの1質量部をエアゾール容器に充填後、液体プロパンガス1質量部を充填して、化粧水型スプレーを調製した。本品は、α,α−−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、はりのあるみずみずしい肌の維持をはじめ、皮膚刺激やかゆみの予防、ニキビの抑制、美白、シミ、ソバカス、日焼け等の色素沈着症、或いは、皮膚の老化の治療、予防、体臭の抑制などに有利に使用できる。
パラフェノールスルホン酸亜鉛 2
無水エタノール 92.3
塩化ベンザルコニウム液(48%) 0.2
1,3−ブチレングリコール 2
実施例6の方法で得たラジカル生成抑制剤 1.5
ミリスチン酸イソプロピル 2
アスコルビン酸2−グルコシド(株式会社林原生物
化学研究所販売、「AA2G」) 0.8
アルブチン 0.5
香料 適量
精製水を適量加えて、全量を100とする。
<Toner lotion spray>
Based on the formulation shown below, the following components of absolute ethanol were dissolved, followed by filtration to prepare a lotion spray stock solution. After 1 part by mass of this was filled in an aerosol container, 1 part by mass of liquid propane gas was filled to prepare a lotion type spray. Since this product contains a carbohydrate derivative of α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long period of time. In addition, maintenance of bruise and fresh skin, prevention of skin irritation and itching, suppression of acne, pigmentation of whitening, spots, buckwheat, sunburn, etc., treatment of skin aging, prevention, suppression of body odor, etc. Can be advantageously used.
Zinc paraphenol sulfonate 2
Absolute ethanol 92.3
Benzalkonium chloride solution (48%) 0.2
1,3-butylene glycol 2
Radical production inhibitor obtained by the method of Example 1.5 1.5
Isopropyl myristate 2
Ascorbic acid 2-glucoside (Hayashibara Biochemical Laboratories, Inc., “AA2G”) 0.8
Arbutin 0.5
Fragrance Appropriate amount Purified water is added in an appropriate amount to make the total amount 100.
<ローション>
以下に示す配合処方に基づき、常法により、ローションを調製した。本品は、α,α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、はりのあるみずみずしい肌の維持をはじめ、皮膚刺激やかゆみの予防、ニキビの抑制、美白、シミ、ソバカス、日焼け等の色素沈着症、或いは、皮膚の老化の治療、予防、体臭の抑制などに有利に使用できる。
実施例6の方法で得たラジカル生成抑制剤 10
グリチルリチン酸ジカリウム 0.05
エタノール 10
1,3−ブチレングリコール 5
糖転移ルチン(株式会社林原生物化学研究所販売、商品名
「アルファグルコシルルチン」) 1
感光素201号 0.005
ポリオキシエチレン(60)硬化ひまし油 1
香料 適量
精製水を適量加えて、全量を100とする。
<Lotion>
A lotion was prepared by a conventional method based on the formulation shown below. Since this product contains a carbohydrate derivative of α, α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, maintenance of bruise and fresh skin, prevention of skin irritation and itching, suppression of acne, pigmentation of whitening, spots, buckwheat, sunburn, etc., treatment of skin aging, prevention, suppression of body odor, etc. Can be advantageously used.
Radical production inhibitor obtained by the method of Example 6 10
Dipotassium glycyrrhizinate 0.05
Ethanol 10
1,3-butylene glycol 5
Glucose transfer rutin (sales by Hayashibara Biochemical Laboratories, Inc., trade name "alpha glucosyl rutin") 1
Photosensitive Element 201 0.005
Polyoxyethylene (60) hydrogenated castor oil 1
Perfume Appropriate amount Purified water is added in an appropriate amount to make the total amount 100.
<ローション>
以下に示す配合処方に基づき、常法により、ローションを調製した。本品は、α,α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、はりのあるみずみずしい肌の維持をはじめ、皮膚刺激やかゆみの予防、ニキビ、美白、シミ、ソバカス、日焼け等の色素沈着症、皮膚の老化の治療、予防や体臭の抑制などに有利に使用できる。
実施例6の方法で得たラジカル生成抑制剤 10
アルミニウムクロロハイドレート 10
エタノール 50
1,3−ブチレングリコール 3
アルブチン 0.5
塩化ベンザルコニウム 0.2
ポリオキシエチレン(40)硬化ひまし油 0.5
香料 0.1
精製水を適量加えて、全量を100とする。
<Lotion>
A lotion was prepared by a conventional method based on the formulation shown below. Since this product contains a carbohydrate derivative of α, α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, it is useful for the maintenance of bruise and fresh skin, prevention of skin irritation and itching, pigmentation such as acne, whitening, spots, buckwheat and sunburn, treatment of skin aging, prevention and suppression of body odor. it can.
Radical production inhibitor obtained by the method of Example 6 10
Aluminum chlorohydrate 10
Ethanol 50
1,3-butylene glycol 3
Arbutin 0.5
Benzalkonium chloride 0.2
Polyoxyethylene (40) hydrogenated castor oil 0.5
Fragrance 0.1
An appropriate amount of purified water is added to make the total amount 100.
<化粧用クリーム>
以下に示す配合処方に基づき、常法により、A成分を加熱溶解し、これにB成分を加え、ホモゲナイザーにかけ乳化して撹拌混合して化粧用クリームを製造した。本品は、α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、はりのあるみずみずしい肌の維持をはじめ、皮膚刺激やかゆみの予防、ニキビ、美白、シミ、ソバカス、日焼け等の色素沈着症、或いは、皮膚の老化の治療、予防等に有利に使用できる。
<A成分>
モノステアリン酸ポリオキシエチレングリコール 2
自己乳化型モノステアリン酸グリセリル 5
ベヘニルアルコール 1
エイコサテトラエン酸 2
流動パラフィン 5
トリオクタン酸グリセリル 10
防腐剤 適量
<B成分>
実施例6の方法で得たラジカル生成抑制剤 2
dl−乳酸ナトリウム 5
1,3−ブチレングリコール 5
ニンジンエキス 1
シソエキス 1
香料 適量
精製水を加えて全量を100とする。
<Cosmetic cream>
Based on the formulation shown below, the component A was heated and dissolved by a conventional method, the component B was added thereto, emulsified with a homogenizer, stirred and mixed to produce a cosmetic cream. Since this product contains a carbohydrate derivative of α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, it can be advantageously used for the maintenance of bruise and fresh skin, prevention of skin irritation and itching, pigmentation such as acne, whitening, spots, buckwheat, sunburn, and skin aging.
<A component>
Monostearic acid polyoxyethylene glycol 2
Self-emulsifying glyceryl monostearate 5
Behenyl alcohol 1
Eicosatetraenoic acid 2
Liquid paraffin 5
Glyceryl trioctanoate 10
Preservative appropriate amount <B component>
Radical formation inhibitor obtained by the method of Example 6 2
dl-sodium lactate 5
1,3-butylene glycol 5
Carrot extract 1
Perilla extract 1
Perfume appropriate amount Purified water is added to make the total amount 100.
<ヘアトニック>
以下に示す配合処方に基づき、常法により、ヘアトニックを調製した。本品は、α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、本品は、使用後も頭皮がベタ付くこともなく、毛髪のセット力にも優れた、使用感に優れたヘアトニックである。また、使用後は頭髪の櫛の通りもよくなった。また、ニキビやアトピー性の疾患を有する肌や、化粧品に過敏な体質の場合でも、炎症性の反応が抑制されるので、これらの疾患の増悪を懸念することなく使用することができる。
エタノール 50
ポリオキシエチレン(8モル)オレエート 1.5
ヒノキチオール 0.1
感光素301号 0.01
α,α−トレハロースの糖質誘導体含有シラップ(株式
会社林原生物化学研究所販売、商品名「トルナーレ」) 7
α−グリコシルグリチルリチン粉末(株式会社林原生
物化学研究所製造) 3
アイエキス(水抽出) 0.5
エチルパラベン 0.1
香料 0.05
精製水を適量加えて全量を100とする。
<Hair tonic>
Based on the formulation shown below, a hair tonic was prepared by a conventional method. Since this product contains a carbohydrate derivative of α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, this product is a hair tonic with excellent usability, with no sticky scalp even after use, excellent hair setting power. In addition, the comb of the hair improved after use. In addition, even in the case of skin having acne or atopic disease or a constitution sensitive to cosmetics, the inflammatory reaction is suppressed, so that it can be used without worrying about exacerbation of these diseases.
Ethanol 50
Polyoxyethylene (8 mol) oleate 1.5
Hinokitiol 0.1
Photosensitive element 301 0.01
Syrup containing saccharide derivatives of α, α-trehalose (sales company Hayashibara Biochemicals Co., Ltd., trade name “Tornale”) 7
α-Glycosylglycyrrhizin powder (manufactured by Hayashibara Biochemical Research Institute) 3
Eye extract (water extraction) 0.5
Ethylparaben 0.1
Fragrance 0.05
An appropriate amount of purified water is added to make the total amount 100.
<ヘアダイ>
以下に示す配合処方に基づき、常法により、ジェルタイプのヘアダイ(染毛剤)を調製した。本品は、α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、本品は、皮膚に対する刺激性が低減されており、しかも、使用後も頭皮がベタ付くこともなく、毛髪のセット力にも優れた、使用感に優れたヘアダイである。また、使用後は頭髪の櫛の通りもよくなるだけでなく、ニキビやアトピー性の疾患を有する肌や、化粧品に過敏な体質の場合でも、炎症性の反応が抑制されるので、これらの疾患の増悪を懸念することなく使用することができる。
酸性染料 1
ベンジルアルコール 6
イソプロピルアルコール 18
実施例1の方法で得たシラップ状のラジカル生成抑制剤 3
アントシアニジン 0.5
クエン酸 0.3
キサンタンガム 1
精製水を加えて100とする。
<Hair dye>
Based on the formulation shown below, a gel-type hair dye (hair dye) was prepared by a conventional method. Since this product contains a carbohydrate derivative of α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, this product is a hair dye that has reduced irritation to the skin, does not have a sticky scalp even after use, has excellent hair setting power, and has an excellent feeling of use. In addition, after use, not only the comb of the hair will improve, but also the skin with acne and atopic diseases, and even if it is a constitution sensitive to cosmetics, the inflammatory reaction is suppressed, so these diseases Can be used without worrying about exacerbations.
Acid dye 1
Benzyl alcohol 6
Isopropyl alcohol 18
Syrup-like radical production inhibitor obtained by the method of Example 1 3
Anthocyanidin 0.5
Citric acid 0.3
Xanthan gum 1
Purified water is added to make 100.
<パーマネントウェーブ用剤>
以下に示す配合処方に基づき、常法により、パーマネントウェーブ剤を調製した。本品は、α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、本品は、皮膚に対する刺激性が低減されており、しかも、使用後も頭皮がベタ付くこともなく、毛髪のセット力にも優れた、使用感に優れたパーマネントウェーブ剤である。また、使用後は頭髪の櫛の通りもよくなるだけでなく、ニキビやアトピー性の疾患を有する肌や、化粧品に過敏な体質の場合でも、炎症性の反応が抑制されるので、これらの疾患の増悪を懸念することなく使用することができる。
チオグリコール酸アンモニウム(50%水溶液) 10
アンモニア水(28%) 3
塩化ステアリルトリメチルアンモニウム 0.1
実施例1の方法で得たシラップ状のラジカル生成抑制剤 1.5
プロピレングリコール 5
糖転移ヘスペリジン(東洋精糖株式会社販売、商品名
「αGヘスペリジン」) 1
エデト酸塩 適量
香料 適量
精製水を加えて100とする(チオグリコール酸アンモニウム、アンモニア水
は最後に混合する。)。
<Permanent Wave Agent>
Based on the formulation shown below, a permanent wave agent was prepared by a conventional method. Since this product contains a carbohydrate derivative of α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, this product is a permanent wave agent with reduced skin irritation, no stickiness of the scalp even after use, excellent hair setting, and excellent usability. In addition, after use, not only the comb of the hair will improve, but also the skin with acne and atopic diseases, and even if it is a constitution sensitive to cosmetics, the inflammatory reaction is suppressed, so these diseases Can be used without worrying about exacerbations.
Ammonium thioglycolate (50% aqueous solution) 10
Ammonia water (28%) 3
Stearyltrimethylammonium chloride 0.1
Syrup-like radical production inhibitor obtained by the method of Example 1 1.5
Propylene glycol 5
Glycosylated hesperidin (Toyo Seika Co., Ltd., trade name
“ΑG Hesperidin” 1)
Edetic acid salt Appropriate amount Fragrance Appropriate amount Purified water is added to make 100 (ammonium thioglycolate and aqueous ammonia are mixed at the end).
<歯磨き>
以下に示す構成処方に基づき、常法により、そのA成分を加熱混合して均一にした後、B成分、C成分を順次添加、攪拌して均一にし、攪拌冷却して、目的の歯磨きを得た。本品は、α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、本品は、口腔内の炎症作用を有すると共に、泡立ちがよく、すっきりした洗浄後感で、歯垢もきれいに除去することのできる歯磨きである。
<A成分>
酢酸トコフェロール 0.1
グリチルリチン酸ジカリウム 0.5
精製水 25
グリセリン 10
α,α−トレハロースの糖質誘導体含有シラップ(株式
会社林原生物化学研究所販売、商品名「トルナーレ」) 30
糖転移ルチン(東洋精糖株式会社販売、商品名「αG
ルチン」) 0.5
アイエキス(水抽出、株式会社林原生物化学研究所販売、
商品名「藍ルーロス」) 1.5
カラギーナン 0.5
耐塩性カルボキシメチルセルロースナトリウム 0.3
香料 適量
<B成分>
第2リン酸カルシウム 20
ハイドロキシアパタイト 5
炭酸カルシウム 5
<C成分>
ラウリル硫酸ナトリウム 1.5
精製水を適量加えて全量を100とする。
<Toothpaste>
Based on the composition formula shown below, the A component is heated and mixed in a conventional manner to make it uniform, then the B component and C component are added sequentially, stirred and uniformed, and stirred and cooled to obtain the desired toothpaste. It was. Since this product contains a carbohydrate derivative of α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, this product is a toothpaste that has an inflammatory action in the oral cavity, has good foaming, and has a clean feeling after washing, and can also remove plaque cleanly.
<A component>
Tocopherol acetate 0.1
Dipotassium glycyrrhizinate 0.5
Purified water 25
Glycerin 10
Syrup containing carbohydrate derivative of α, α-trehalose (sales company Hayashibara Biochemical Research Co., Ltd., trade name “Tornare”) 30
Glucose transfer rutin (sold by Toyo Seika Co., Ltd., trade name “αG
Rutin ") 0.5
Eye extract (water extraction, Hayashibara Biochemical Laboratories Inc. sales,
Product name “Ai Luros”) 1.5
Carrageenan 0.5
Salt-resistant sodium carboxymethylcellulose 0.3
Perfume appropriate amount <B component>
Dicalcium phosphate 20
Hydroxyapatite 5
Calcium carbonate 5
<C component>
Sodium lauryl sulfate 1.5
An appropriate amount of purified water is added to make the total amount 100.
<入浴剤>
以下に示す配合処方に基づき、常法により、全量を均一に混合した後、打錠して入浴剤を製造した。本品は、α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、変色や異臭の発生もなく、その品質が長期間安定に保持される。また、本品は、体臭の抑制作用を有すると共に、入浴後も肌がベタ付くこともなく、使用感に優れた浴用剤である。
硫酸ナトリウム 44
炭酸水素ナトリウム 14
炭酸ナトリウム 7
コハク酸 21
国際公開WO 02/10361号明細書に開示され
た環状四糖5含水結晶(株式会社林原生物化学研
究所製造) 5
α,α−トレハロースの糖質誘導体含有シラップ(株式
会社林原生物化学研究所販売、商品名「トルナーレ」) 3
L−アスコルビン酸2−グルコシド(林原生物化学研
究所株式会社販売、商品名「AA2G」) 0.5
滑沢剤 適量
色素 適量
香料 適量
<Bath agent>
Based on the formulation shown below, the whole amount was uniformly mixed by a conventional method, and then tableted to produce a bath preparation. Since this product contains a carbohydrate derivative of α, α-trehalose, radical generation is suppressed, and there is no discoloration or off-flavor, and the quality is stably maintained for a long time. In addition, this product is a bath preparation with an excellent feeling of use because it has an action of suppressing body odor and the skin does not become sticky after bathing.
Sodium sulfate 44
Sodium bicarbonate 14
Sodium carbonate 7
Succinic acid 21
Cyclic tetrasaccharide 5-hydrated crystal (manufactured by Hayashibara Biochemical Laboratories Co., Ltd.) disclosed in WO 02/10361
Syrup containing saccharide derivatives of α, α-trehalose (sales company Hayashibara Biochemicals Co., Ltd., trade name “Tornale”) 3
L-ascorbic acid 2-glucoside (Hayashibara Biochemical Lab.
Research Institute Co., Ltd., trade name “AA2G”) 0.5
Lubricant appropriate amount Pigment appropriate amount Fragrance appropriate amount
<化粧用石けん>
以下に示す配合処方に基づき、常法により、化粧用石けんを調製した。本品は、α,α−トレハロースの糖質誘導体を含有しているので、ラジカル生成が抑制されて、石鹸の基剤、乳化作用を有する物質、香料、色素等の酸化、分解が抑制され褐変、変色、異臭の発生等が長期間抑制されるので、その品質が長期間安定に保持される。また、本品は、体臭の抑制作用を有すると共に、使用後も肌がかさつくこともなく、使用感に優れた石けんである。
質量比4対1の牛脂及びヤシ油を通常のけん化・塩析
法に供して得たニートソープ 95.5
実施例6の方法で得たラジカル生成抑制剤 0.5
含水結晶α,α−トレハロース(株式会社林原生物
学研究所販売、商品名「化粧品用トレハロース」) 1
L−アスコルビン酸2−グルコシド(林原生物化学研
究所株式会社販売、商品名「AA2G」) 0.5
白糖 0.5
糖転移ナリンジン(株式会社林原生物化学研究所製造) 0.5
マルチトール 1
感光素201号 0.001
香料 適量
<Toilet soap>
Based on the formulation shown below, a cosmetic soap was prepared by a conventional method. This product contains a carbohydrate derivative of α, α-trehalose, so radical generation is suppressed, and soap base, emulsifying substances, fragrances, pigments, etc. are oxidized and decomposed, and browned. Since the occurrence of discoloration, off-flavor, etc. is suppressed for a long time, the quality is stably maintained for a long time. In addition, this product has a body odor suppressing action, and does not become skiny after use, and is a soap with excellent usability.
Neat soap 95.5 obtained by subjecting beef tallow and coconut oil in a mass ratio of 4 to 1 to conventional saponification and salting-out methods.
Radical formation inhibitor obtained by the method of Example 6 0.5
Hydrous crystals α, α-trehalose (sales by Hayashibara Biological Research Co., Ltd., trade name “trehalose for cosmetics”) 1
L-ascorbic acid 2-glucoside (Hayashibara Biochemical Lab.
Research Institute Co., Ltd., trade name “AA2G”) 0.5
Sucrose 0.5
Glycosylnarindin (manufactured by Hayashibara Biochemical Research Institute) 0.5
Maltitol 1
Photosensitive element 201 0.001
Perfume
<点眼剤>
実施例5の方法で得たラジカル生成抑制剤4.5質量部、塩化ナトリウム0.4質量部、塩化カリウム0.15質量部、リン酸2水素ナトリウム0.2質量部、硼砂0.15質量部、アスコルビン酸2−グルコシド(株式会社林原生物化学研究所販売、商品名「AA2G」)0.1質量部を滅菌精製水に溶解し、全量を100mlとして、公知の方法により無菌製剤を調製して点眼剤を調製した。pHは7.3に調整した。本品は、ラジカル生成抑制剤に含有されるα,α−トレハロースの糖質誘導体が眼の炎症を抑制するとともに、α,α−トレハロースが眼の粘膜を乾燥から保護する効果を発揮し、しかも、アスコルビン酸2−グルコシドが、酵素的により徐々に分解されてビタミンCの持続的な給源となることから、本点眼剤は、眼の疲労の回復や、アレルギー性の眼の炎症やドライアイ、飛蚊症などの眼性疾患の予防或いは治療に有利に使用できる。また、これら眼性疾患の治療及び/又は予防用の、眼の洗浄液や灌流液、更には、移植用角膜の保存液などに利用することも随意である。
<Eye drops>
4.5 parts by mass of the radical production inhibitor obtained by the method of Example 5, 0.4 parts by mass of sodium chloride, 0.15 parts by mass of potassium chloride, 0.2 parts by mass of sodium dihydrogen phosphate, 0.15 parts by mass of borax Part of ascorbic acid 2-glucoside (trade name “AA2G” sold by Hayashibara Biochemical Laboratories, Inc.) is dissolved in sterilized purified water to make a total volume of 100 ml, and a sterile preparation is prepared by a known method. An eye drop was prepared. The pH was adjusted to 7.3. In this product, the carbohydrate derivative of α, α-trehalose contained in the radical production inhibitor suppresses inflammation of the eye, and α, α-trehalose demonstrates the effect of protecting the eye mucosa from drying. Since ascorbic acid 2-glucoside is gradually degraded enzymatically and becomes a continuous source of vitamin C, the eye drops are used to restore eye fatigue, allergic eye inflammation and dry eye, It can be advantageously used for prevention or treatment of ophthalmic diseases such as flying mosquitoes. Further, it is also optional to use it as an eye washing solution or perfusion solution for the treatment and / or prevention of these ophthalmic diseases, and also as a preservation solution for transplanted cornea.
<外傷治療用軟膏>
実施例2の方法で得た粉末状のラジカル生成抑制剤500質量部に、感光素101号0.02質量部を添加混合後、更に10%プルラン水溶液200質量部を加えて混合し、適度の伸び、付着性を有する外傷治療用軟膏を得た。本品は創傷面に直接塗るか、ガーゼなどに塗るなどして患部に使用することにより、切傷、擦り傷、火傷、水虫などの外傷を治療することができる。また、本品は、α,α−トレハロースの糖質誘導体が、感光素101号のラジカル生成を抑制して製剤を安定化すると共に、ラジカル生成に起因する患部の炎症を抑制するので、その治療期間が短縮され、創面もきれいに回復することができる。
<Treatment ointment>
After adding and mixing 0.02 part by weight of Photosensitive Element 101 to 500 parts by weight of the powdery radical generation inhibitor obtained by the method of Example 2, 200 parts by weight of 10% pullulan aqueous solution was further added and mixed. An ointment for treating wounds having elongation and adhesion was obtained. This product can be used to treat wounds such as cuts, abrasions, burns and athlete's foot by applying it directly to the wound surface or gauze. In addition, in this product, the carbohydrate derivative of α, α-trehalose suppresses the radical generation of Photosensitive No. 101 and stabilizes the preparation, and also suppresses the inflammation of the affected area due to the radical generation. The period is shortened and the wound surface can be restored cleanly.
<インターフェロン−α含有坐剤>
インターフェロン−α製剤(大塚製薬株式会社販売、商品名「オーアイエフOIF注射用1,000万単位」)を0.1mlの蒸留水に溶解し、その0.1質量部を、実施例3の方法で得た粉末状のラジカル生成抑制剤1質量部と、予め40℃に加温溶解した油脂性基剤のファーマゾル9質量部と混合し、これを型に流し、冷却してインターフェロン−α含有坐剤を得た。本品1gは、インターフェロン活性100万単位を含有している。本品は、インターフェロン−αが安定化された坐剤であり、ヘルペスウイルス感染症、肝炎、悪性新生物をはじめとするインターフェロン−α感受性疾患の治療に有利に利用できる。
<Interferon-α containing suppository>
An interferon-α preparation (sold by Otsuka Pharmaceutical Co., Ltd., trade name “10 million units for OIF OIF injection”) was dissolved in 0.1 ml of distilled water, and 0.1 part by mass thereof was treated by the method of Example 3. 1 part by mass of the obtained powdery radical generation inhibitor and 9 parts by mass of an oleaginous pharmasol dissolved in advance at 40 ° C. were mixed, poured into a mold, cooled, and interferon-α-containing suppository. Got. 1 g of this product contains 1 million units of interferon activity. This product is a suppository in which interferon-α is stabilized, and can be advantageously used for treatment of interferon-α-sensitive diseases such as herpes virus infection, hepatitis, and malignant neoplasm.
<酵素剤>
微生物由来の乳酸脱水素酵素(東洋紡株式会社製造、フナコシ株式会社販売、429単位/mg)4mgを10mlの脱イオン水に溶解した酵素剤の水溶液0.3mlと、脱イオン水に実施例4の方法で得たラジカル生成抑制剤を3.5%となるように溶解した水溶液0.3mlを凍結乾燥用ガラス容器(液溜まり部の直径10mm、高さ50mm)内で穏やかに撹拌、混合後、常法により凍結乾燥して、乳酸脱水素酵素の粉末標品を調製した。本品は、α,α−トレハロースの糖質誘導体により、凍結乾燥時の冷凍、乾燥変性が抑制されるために、製造時の活性に酵素活性が減少することもなく、また、室温、冷蔵、或いは冷凍保存でも活性は長期間安定に保持される。さらに、本品の水溶液を約4乃至約−1℃で冷蔵保存、或いは、それを凍結して保存した場合にも、その酵素活性は長期間安定に保持することが可能である。
<Enzyme agent>
Lactic acid dehydrogenase derived from microorganisms (manufactured by Toyobo Co., Ltd., sold by Funakoshi Co., Ltd., 429 units / mg) 0.3 ml of an aqueous solution of an enzyme prepared by dissolving 4 mg in 10 ml of deionized water; After gently stirring and mixing 0.3 ml of an aqueous solution in which the radical production inhibitor obtained by the method was dissolved to 3.5% in a glass container for freeze-drying (diameter of the liquid reservoir 10 mm, height 50 mm), A powder preparation of lactate dehydrogenase was prepared by lyophilization by a conventional method. This product is a saccharide derivative of α, α-trehalose, so that freezing and drying denaturation during lyophilization are suppressed, so that the enzyme activity does not decrease to the activity at the time of manufacture, and room temperature, refrigeration, Alternatively, the activity is stably maintained for a long time even in frozen storage. Furthermore, even when the aqueous solution of this product is stored refrigerated at about 4 to about −1 ° C. or frozen and stored, the enzyme activity can be stably maintained for a long period of time.
<凍結乾燥補体製剤>
モルモットから血液を採取後、血清画分を分離し、その1質量部に対して、予め実施例5の方法で得たラジカル生成抑制剤1質量部を生理食塩水(商品名「大塚生食注」、大塚製薬工場製造)9質量部に溶解しておいた溶液1質量部を加え、均質になるように撹拌溶解し、0.2mlずつ2ml容の管瓶に分注し、常法に従って、最終到達温度25℃の乾燥条件で、凍結乾燥した。本品は、本品に含まれる脂質をはじめとする不飽和化合物の安定性がα,α−トレハロースの糖質誘導体により高められているため、血清中の不飽和化合物のラジカル化により生成する過酸化物による補体の修飾、変性が抑制されるので、補体の持つ一連の酵素反応系やその他の生理活性は、冷蔵或いは室温で長期保存した場合にも安定に保持されるという特徴がある。しかも、α,α−トレハロースの糖質誘導体は、凍結及び/又は乾燥による変性からタンパク質を保護するために、凍結乾燥時の補体活性の低下も抑制されるので、本品は、高品質の臨床診断、或いは、免疫学の試験用の試薬として有利に利用できる。
<Freeze-dried complement preparation>
After collecting blood from the guinea pig, the serum fraction is separated, and 1 part by mass of the radical production inhibitor obtained in advance by the method of Example 5 is added to physiological saline (trade name “Otsuka raw food injection”). , Manufactured by Otsuka Pharmaceutical Factory) Add 1 part by weight of the solution dissolved in 9 parts by weight, stir and dissolve to homogeneity, dispense 0.2 ml into a 2 ml tube bottle, It was freeze-dried under the drying conditions at an ultimate temperature of 25 ° C. In this product, the stability of unsaturated compounds such as lipids contained in this product is enhanced by the carbohydrate derivatives of α, α-trehalose, so that excess products generated by radicalization of unsaturated compounds in serum are produced. Since the modification and denaturation of complement by oxides are suppressed, a series of enzyme reaction systems and other physiological activities possessed by complement are characterized by being stably maintained even when stored for a long time at refrigeration or at room temperature. . Moreover, the α, α-trehalose carbohydrate derivative protects proteins from denaturation due to freezing and / or drying, so that the decrease in complement activity during lyophilization is also suppressed. It can be advantageously used as a reagent for clinical diagnosis or immunological test.
<塩化ビニル樹脂>
塩化ビニル樹脂100質量部、テトラヒドロフラン500質量部、ステアリン酸バリウム0.001質量部、ステアリン酸亜鉛0.001質量部に実施例3の方法で得たラジカル生成抑制剤0.6質量部を添加して、均質になるように混合し、更に、180℃に加温して、5分間混練し、厚さ0.5mmのシートを作成した。本品は、添加したα,α−トレハロースの糖質誘導体により紫外線などに起因するラジカル生成が抑制されるため、耐光性に優れた塩化ビニル樹脂である。また、本品はα,α−トレハロースの糖質誘導体を添加することにより、その耐熱性も向上することから、α,α−トレハロースの糖質誘導体は、樹脂の安定化剤として好適であることが判明した。
<Vinyl chloride resin>
Add 0.6 parts by mass of the radical generation inhibitor obtained by the method of Example 3 to 100 parts by mass of vinyl chloride resin, 500 parts by mass of tetrahydrofuran, 0.001 part by mass of barium stearate, and 0.001 part by mass of zinc stearate. Then, they were mixed so as to be homogeneous, further heated to 180 ° C. and kneaded for 5 minutes to prepare a sheet having a thickness of 0.5 mm. This product is a vinyl chloride resin with excellent light resistance, because the added α, α-trehalose saccharide derivative suppresses radical generation caused by ultraviolet rays and the like. In addition, the addition of an α, α-trehalose sugar derivative improves the heat resistance of this product, so the α, α-trehalose sugar derivative is suitable as a resin stabilizer. There was found.
<塗料>
ポリエステル樹脂100質量部、β−ヒドロキシアルキルアミド3.3質量部、炭酸カルシウム11質量部、実施例8の方法で得た粉末状のラジカル生成抑制剤3質量部、ベンゾイン1質量部、レベリング剤2質量部、二酸化チタン33質量部、カーボンブラック0.3質量部、トリポリリン酸二水素アルミニウム8質量部を、常法により、混合攪拌して塗料を調製した。本品は、ラジカル生成が抑制されているので、長期間光沢が保持される耐久性に優れた塗料である。また、塗料塗布時の付着性がよく、塗装性にも優れている。
<Paint>
100 parts by mass of polyester resin, 3.3 parts by mass of β-hydroxyalkylamide, 11 parts by mass of calcium carbonate, 3 parts by mass of a powdery radical generation inhibitor obtained by the method of Example 8, 1 part by mass of benzoin, leveling agent 2 A paint was prepared by mixing and stirring mass parts, 33 parts by mass of titanium dioxide, 0.3 part by mass of carbon black, and 8 parts by mass of aluminum dihydrogen tripolyphosphate by a conventional method. This product is a highly durable paint that retains its gloss for a long time because radical generation is suppressed. Moreover, the adhesion at the time of coating the paint is good and the paintability is also excellent.
<塗料>
水性樹脂の製造反応容器にイソフタル酸203質量部、ペンタエリスリトール235質量部、アマニ油脂肪酸301質量部、安息香酸380質量部、ジブチル錫オキサイド2質量部及びキシレン3質量0部を入れ、窒素雰囲気下で撹拌しながら240℃に加熱し、樹脂酸価が2.5になるまで6.5時間反応を行なって理論水酸基価7.2、樹脂固形分100%、ガードナー粘度(75%n−ブチルセロソルブ溶液)Z3−のアルキド樹脂を得た。次いで別の反応容器においてイソフタル酸189質量部、ペンタエリスリトール234質量部、アマニ油脂肪酸299質量部、安息香酸397質量部、ジブチル錫オキサイド2部及びキシレン30質量部を入れ、窒素雰囲気下で撹拌しながら240℃に加熱し、樹脂酸価が2.5になるまで6.5時間反応を行なった。該アルキド樹脂は理論水酸基価7.2である。ひきつづき温度を200℃まで下げて、無水マレイン酸28部を加え、200℃で3時間マレイン化反応を行い、樹脂固形分100%、樹脂酸価29.9、ガードナー粘度(75%n−ブチルセロソルブ溶液)Z5+のマレイン化アルキド樹脂を得た。上記アルキド樹脂とマレイン化アルキド樹脂とをそれぞれ500質量部ずつ反応容器に入れ、窒素雰囲気下で撹拌しながら200℃に加熱し、2時間反応を行なった。反応終了後140℃に下げ、同温度において、脱イオン水6質量部を反応容器に加え開環反応を1時間行なった。次にn−ブチルセロソルブ330質量部を加え、樹脂固形分75%、樹脂酸価13.3、ガードナー粘度(60%n−ブチルセロソルブ溶液)V+ の水分散用樹脂とし、これをトリエチルアミン1.0当量で中和し、脱イオン水を加えて乳化分散し、固形分52%のアルキドエマルジョンを得た。水性セルロース系誘導体の調整水57質量部とブチルセロソルブ21質量部の混合液に、旭化成工業社製水性セルロース誘導体「WHH」(カルボキシメチルセルロースの硝酸エステル、固形分50%)20質量部をディスパーで撹拌しながら添加し、徐々にトリエチルアミンを質量2部加えることで10%水性セルロース溶液(B)を得た。これらとは別に、撹拌混合容器に、脱イオン水90質量部と「ナトラゾール330」(アクアロン社製、ヒドロキシエチルセルロース)0.6質量部及び「ノプコスパース44C」(サンノプコ社製、分散剤)2.35質量部を加え、残渣がないように撹拌、溶解させた。該溶液に「BYK−024」(ビー・ワイ・ケー・ケミー社製、消泡剤)0.3質量部を加え、ディスパーで高速撹拌しながら、チタン白20.3質量部、タルク51.7質量部、クレー51.7質量部、特開平7−291987号公報の実験A−2に開示された方法で調製した含水結晶α−マルトトリオシルα,α−トレハロース45質量部を添加した。さらにこれを卓上サンドミルを用いて5分間分散し、固形分65%の顔料ペーストを得た。別の撹拌混合容器に、上記で得た顔料ペースト262質量部を、さらに上記で得たアルキドエマルジョン76.3質量部、アクリルエマルジョン72.9質量部を順次撹拌下に添加した後、水性セルロース溶液300質量部を撹拌下に添加し、さらに1時間撹拌した。この混合液をアンモニア水でpH8として塗料を得た。本品は、ラジカル生成が抑制されるため、耐久性に優れた塗料で、プライマー/サーフェーサーとして使用することができる。また、本品は、乾燥性、研磨作業性に、付着性に優れている。
<Paint>
In a reaction vessel for producing an aqueous resin, 203 parts by mass of isophthalic acid, 235 parts by mass of pentaerythritol, 301 parts by mass of linseed oil fatty acid, 380 parts by mass of benzoic acid, 2 parts by mass of dibutyltin oxide, and 3 parts by mass of xylene were placed in a nitrogen atmosphere. The mixture was heated to 240 ° C. with stirring at 6.5 ° C. and reacted for 6.5 hours until the resin acid value reached 2.5 to give a theoretical hydroxyl value of 7.2, a resin solid content of 100%, a Gardner viscosity (75% n-butyl cellosolve solution). ) A Z3-alkyd resin was obtained. In another reaction vessel, 189 parts by mass of isophthalic acid, 234 parts by mass of pentaerythritol, 299 parts by mass of linseed oil fatty acid, 397 parts by mass of benzoic acid, 2 parts of dibutyltin oxide and 30 parts by mass of xylene were added and stirred under a nitrogen atmosphere. The mixture was then heated to 240 ° C. and reacted for 6.5 hours until the resin acid value reached 2.5. The alkyd resin has a theoretical hydroxyl value of 7.2. Subsequently, the temperature was lowered to 200 ° C., 28 parts of maleic anhydride was added, and the maleation reaction was performed at 200 ° C. for 3 hours. The resin solid content was 100%, the resin acid value was 29.9, and the Gardner viscosity (75% n-butyl cellosolve solution). ) A maleated alkyd resin of Z5 + was obtained. 500 parts by mass of each of the alkyd resin and maleated alkyd resin were placed in a reaction vessel, heated to 200 ° C. with stirring under a nitrogen atmosphere, and reacted for 2 hours. After completion of the reaction, the temperature was lowered to 140 ° C., and at the same temperature, 6 parts by mass of deionized water was added to the reaction vessel, and the ring-opening reaction was carried out for 1 hour. Next, 330 parts by mass of n-butyl cellosolve was added to obtain a resin for water dispersion having a resin solid content of 75%, a resin acid value of 13.3, and a Gardner viscosity (60% n-butyl cellosolve solution) V +. Neutralized, deionized water was added and emulsified and dispersed to obtain an alkyd emulsion having a solid content of 52%. 20 parts by weight of an aqueous cellulose derivative “WHH” (carboxymethylcellulose nitrate, solid content 50%) manufactured by Asahi Kasei Kogyo Co., Ltd. was mixed with a mixed liquid of 57 parts by weight of water-based cellulose derivative and 21 parts by weight of butyl cellosolve. Then, 2 parts by mass of triethylamine was gradually added to obtain a 10% aqueous cellulose solution (B). Separately, 90 parts by mass of deionized water, 0.6 part by mass of “Natrazol 330” (Aqualon, hydroxyethylcellulose) and “Nopcosper 44C” (manufactured by San Nopco, dispersant) 2.35 are added to the stirring and mixing container. Mass parts were added and stirred and dissolved so that there was no residue. To this solution was added 0.3 part by weight of “BYK-024” (manufactured by BK Chemie Co., Ltd., antifoaming agent), and while stirring at high speed with a disper, 20.3 parts by weight of titanium white, 51.7% of talc. Mass parts, 51.7 parts by mass of clay, and 45 parts by mass of hydrous crystal α-maltotriosyl α, α-trehalose prepared by the method disclosed in Experiment A-2 of JP-A-7-291987 were added. Further, this was dispersed for 5 minutes using a desktop sand mill to obtain a pigment paste having a solid content of 65%. To another stirring and mixing vessel, 262 parts by mass of the pigment paste obtained above, 76.3 parts by mass of the alkyd emulsion obtained above and 72.9 parts by mass of the acrylic emulsion were sequentially added with stirring, and then an aqueous cellulose solution. 300 parts by mass were added with stirring, and the mixture was further stirred for 1 hour. The mixture was adjusted to pH 8 with aqueous ammonia to obtain a paint. Since this product suppresses radical generation, it is a paint with excellent durability and can be used as a primer / surfacer. Moreover, this product is excellent in drying property, polishing workability, and adhesion.
<コーティング剤>
ハイドランHW−970(大日本インキ化学工業(株)製アルキレンオキサイド鎖を有するポリウレタンの水性分散液、平均粒子径0.2ミクロン)45質量部とエチレン変性ポリビニルアルコール(重合度1700、けん化度98.0%、エチレン変性量6.0mol%)の15%水溶液を固形分換算50質量部配合、実施例1の方法で得たシラップ状のラジカル生成抑制剤1質量部を混合し、水性コーティング剤およびインキジェット用記録剤を得た。本品は、ラジカル生成が抑制されているので、これを使用したインクや印刷物は耐久性に優れている。また、本品は、塗布時の付着性にも優れている。
<Coating agent>
Hydran HW-970 (Dainippon Ink & Chemicals, Inc., polyurethane aqueous dispersion having an alkylene oxide chain, average particle size 0.2 microns) 45 parts by mass and ethylene-modified polyvinyl alcohol (polymerization degree 1700, saponification degree 98. 0%, ethylene modification amount 6.0 mol%) 15% aqueous solution was mixed with 50 parts by mass in terms of solid content, 1 part by mass of the syrup-like radical production inhibitor obtained by the method of Example 1 was mixed, and an aqueous coating agent and A recording agent for ink jet was obtained. Since this product has suppressed radical generation, ink and printed matter using this product are excellent in durability. In addition, this product is excellent in adhesion at the time of application.
<コーティング剤>
疎水性シリカ(日本アエロジル社販売、製品番号「RX300」)1.5質量部、アミノ変性シリコーン(東レ・ダウコーニング・シリコーン社販売、製品番号「BY16−849」)0.005質量部、特開平7−291987号公報の実験A−2に開示された方法で調製した含水結晶α−マルトトリオシルα,α−トレハロースを、100℃で一晩減圧乾燥して得た無水結晶α−マルトトリオシルα,α−トレハロース0.5質量部にイソパラフィン(出光石油化学社販売、商品名「IPPソルベント2028」)を加えて全量を100質量部とし、この混合物を、超音波洗浄器を用いて90分間分散して、撥水コーティング剤を調製した。本品は、ラジカル生成が抑制されているので、耐久性に優れている。また、本品は、塗布時の付着性にも優れている。
<Coating agent>
Hydrophobic silica (sales by Nippon Aerosil Co., Ltd., product number “RX300”) 1.5 parts by mass, amino-modified silicone (sales by Toray Dow Corning Silicone Co., Ltd., product number “BY16-849”) 0.005 parts by mass, Anhydrous crystal α-maltotriosyl obtained by drying the hydrous crystal α-maltotriosyl α, α-trehalose prepared by the method disclosed in Experiment A-2 of Japanese Patent Publication No. 7-291987 at 100 ° C. overnight under reduced pressure. Isoparaffin (sold by Idemitsu Petrochemical Co., Ltd., trade name “IPP Solvent 2028”) is added to 0.5 part by mass of α, α-trehalose to make a total amount of 100 parts by mass, and this mixture is mixed for 90 minutes using an ultrasonic cleaner. Dispersed to prepare a water repellent coating agent. This product has excellent durability because radical generation is suppressed. In addition, this product is excellent in adhesion at the time of application.
本発明は、ラジカルの生成、ラジカルの生成により不飽和化合物の分解が進行すること、さらには、不飽和化合物の過酸化物による脂質、タンパク質などの修飾、変性をも抑制するために、グルコースを構成糖とする非還元性糖質であるα,α−トレハロースの糖質誘導体が、ラジカルの生成抑制作用が強いことを見出し、ラジカル生成が起こる前、又は、起きている有機の不飽和化合物を含む反応系に上記のα,α−トレハロースの糖質誘導体、又は、これを含有する糖質を有効成分とするラジカル生成抑制剤を配合させることで、不飽和化合物からのラジカル生成を抑制し、さらには、発生した過酸化物によるタンパク質、脂質、核酸関連物質などの修飾、変性をも抑制するものである。しかも、α,α−トレハロースの糖質誘導体、又は、これを含有する糖質は、食品として安全で、且つ、非常に安定であることから、本発明によるα,α−トレハロースの糖質誘導体、又は、これを含有する糖質を配合するラジカル生成抑制剤の利用分野は、飲食品分野、農林水産分野(飼料、餌料、ペットフードなどの家畜、家禽、ペット、養殖魚、養殖甲殻類などの餌を含む)、化粧品分野、医薬部外品、医薬品分野を含めて、日用品分野、化学工業分野、染料分野、塗料分野、建材分野、香料分野、化学薬品分野、合成繊維分野、色素分野、感光色素分野、光記録媒体分野など多岐にわたる。本発明は、かくも顕著な作用効果を奏する発明であり、産業上の貢献度が誠に多大な意義ある発明である。 In order to suppress the generation of radicals, the decomposition of unsaturated compounds by the generation of radicals, and the modification and denaturation of lipids and proteins due to unsaturated compound peroxides, The carbohydrate derivative of α, α-trehalose, which is a non-reducing carbohydrate used as a constituent sugar, has been found to have a strong radical generation inhibitory action, and before the generation of radicals occurs, Incorporating the above-mentioned α, α-trehalose saccharide derivative or a radical generation inhibitor containing a saccharide containing this into the active reaction system, the radical generation from the unsaturated compound is suppressed, Furthermore, the modification and denaturation of proteins, lipids, nucleic acid-related substances and the like caused by the generated peroxide are also suppressed. Moreover, since the carbohydrate derivative of α, α-trehalose or a carbohydrate containing it is safe and very stable as food, the carbohydrate derivative of α, α-trehalose according to the present invention, Or, the fields of application of radical production inhibitors containing carbohydrates containing this include food and drink, agriculture, forestry and fisheries (feed, feed, pet food and other livestock, poultry, pets, cultured fish, cultured crustaceans, etc. Including food), cosmetics field, quasi-drugs, pharmaceutical field, daily necessities field, chemical industry field, dye field, paint field, building materials field, perfume field, chemical field, synthetic fiber field, dye field, photosensitive Wide range of fields such as dyes and optical recording media. The present invention is an invention that exhibits such remarkable operational effects, and is an invention that has a significant industrial contribution.
Claims (26)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005351866A JP2006188672A (en) | 2004-12-06 | 2005-12-06 | Radical formation inhibitor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004352163 | 2004-12-06 | ||
JP2005351866A JP2006188672A (en) | 2004-12-06 | 2005-12-06 | Radical formation inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006188672A true JP2006188672A (en) | 2006-07-20 |
JP2006188672A5 JP2006188672A5 (en) | 2009-01-08 |
Family
ID=36796159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005351866A Withdrawn JP2006188672A (en) | 2004-12-06 | 2005-12-06 | Radical formation inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006188672A (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006132310A1 (en) * | 2005-06-08 | 2006-12-14 | Cellex K.K. | Liquid for preventing tissue adhesion and method of preventing tissue adhesion |
WO2007097357A1 (en) | 2006-02-22 | 2007-08-30 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Volatile sulfide production inhibitor and method for inhibiting the production of volatile sulfide using the inhibitor |
WO2007114091A1 (en) * | 2006-03-31 | 2007-10-11 | Fuji Oil Company, Limited | Aging inhibitor for starch to be used in noodle, noodle using the same and process for producing the same |
WO2008143135A1 (en) * | 2007-05-15 | 2008-11-27 | Nippon Starch Chemical Co., Ltd. | Hair cosmetic comprising composition containing cationized trehalose derivative |
JP2009072184A (en) * | 2007-08-28 | 2009-04-09 | Sanei Gen Ffi Inc | Agent for suppressing formation of benzene and method for suppressing formation of benzene |
JP2010241743A (en) * | 2009-04-07 | 2010-10-28 | Noevir Co Ltd | Skin care preparation |
JP2011098901A (en) * | 2009-11-05 | 2011-05-19 | Noevir Co Ltd | Skin care preparation for acne |
JP2011140471A (en) * | 2010-01-08 | 2011-07-21 | Mandom Corp | Activity inhibitor and activity-inhibiting method for trpa1, and skin care preparation for external use |
JP2012025706A (en) * | 2010-07-26 | 2012-02-09 | National Institute Of Advanced Industrial Science & Technology | Antioxidant and use thereof |
CN102960437A (en) * | 2012-11-23 | 2013-03-13 | 苏州科技学院 | Environment-friendly healthy red bayberry preservative and preservation technology |
JP2013213001A (en) * | 2012-03-30 | 2013-10-17 | Arimento Kogyo Kk | Oxidation-controlling composition and solid oral agent or solid food |
GB2505248A (en) * | 2012-08-24 | 2014-02-26 | Citrox Biosciences Ltd | Bioflavonoid-coated polymeric material |
KR101560857B1 (en) | 2008-08-19 | 2015-10-19 | 미노루 칸노 | Raw materials, methods and fruits and vegetables pertaining to sugar content improvement, sugar component adjustment or flavor adjustment |
CN106852396A (en) * | 2015-12-08 | 2017-06-16 | 上海泓宝绿色水产股份有限公司 | A kind of aquatic livestock liver-care preparations and its preparation and application |
US9878840B2 (en) | 2012-08-24 | 2018-01-30 | Citrox Biosciences Limited | Bioflavonoid coated materials |
CN108157744A (en) * | 2018-01-02 | 2018-06-15 | 青岛农业大学 | Antistaling agent |
JP2021070661A (en) * | 2019-10-31 | 2021-05-06 | 晴義 山田 | Composition for inhibiting tslp gene expression, for inhibiting il-33 gene expression, or for promoting filaggrin production |
WO2021210648A1 (en) * | 2020-04-17 | 2021-10-21 | Next21 Kabushiki Kaisha | Medicine containing trehalose or trehalose derivative and nasal spray |
CN115413707A (en) * | 2022-10-14 | 2022-12-02 | 广东李金柚农业科技有限公司 | Anti-browning agent for fruits and vegetables as well as preparation method and application method of anti-browning agent |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004020552A1 (en) * | 2002-08-30 | 2004-03-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof |
WO2004056216A1 (en) * | 2002-12-19 | 2004-07-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method of inhibiting water content variation of composition and use thereof |
-
2005
- 2005-12-06 JP JP2005351866A patent/JP2006188672A/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004020552A1 (en) * | 2002-08-30 | 2004-03-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof |
WO2004056216A1 (en) * | 2002-12-19 | 2004-07-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method of inhibiting water content variation of composition and use thereof |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006132310A1 (en) * | 2005-06-08 | 2006-12-14 | Cellex K.K. | Liquid for preventing tissue adhesion and method of preventing tissue adhesion |
US9155751B2 (en) | 2005-06-08 | 2015-10-13 | The University Of Tokyo | Solution for tissue adhesion prevention and method for tissue adhesion prevention |
WO2007097357A1 (en) | 2006-02-22 | 2007-08-30 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Volatile sulfide production inhibitor and method for inhibiting the production of volatile sulfide using the inhibitor |
EP2000036A2 (en) * | 2006-02-22 | 2008-12-10 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Volatile sulfide production inhibitor and method for inhibiting the production of volatile sulfide using the inhibitor |
US8343951B2 (en) | 2006-02-22 | 2013-01-01 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Volatile sulfide production inhibitor and method for inhibiting the production of volatile sulfide using the inhibitor |
EP2000036A4 (en) * | 2006-02-22 | 2012-01-18 | Hayashibara Biochem Lab | VOLATILE SULFIDE PRODUCTION INHIBITOR AND METHOD FOR INHIBITING VOLATILE SULFIDE PRODUCTION USING THE SAME |
WO2007114091A1 (en) * | 2006-03-31 | 2007-10-11 | Fuji Oil Company, Limited | Aging inhibitor for starch to be used in noodle, noodle using the same and process for producing the same |
JP5029602B2 (en) * | 2006-03-31 | 2012-09-19 | 不二製油株式会社 | Starch aging inhibitor for noodles, noodles using the same, and method for producing the same |
WO2008143135A1 (en) * | 2007-05-15 | 2008-11-27 | Nippon Starch Chemical Co., Ltd. | Hair cosmetic comprising composition containing cationized trehalose derivative |
JP5427032B2 (en) * | 2007-05-15 | 2014-02-26 | 日澱化學株式会社 | Hair cosmetic comprising a composition containing a cationized trehalose derivative |
JP2009072184A (en) * | 2007-08-28 | 2009-04-09 | Sanei Gen Ffi Inc | Agent for suppressing formation of benzene and method for suppressing formation of benzene |
KR101560857B1 (en) | 2008-08-19 | 2015-10-19 | 미노루 칸노 | Raw materials, methods and fruits and vegetables pertaining to sugar content improvement, sugar component adjustment or flavor adjustment |
JP2010241743A (en) * | 2009-04-07 | 2010-10-28 | Noevir Co Ltd | Skin care preparation |
JP2011098901A (en) * | 2009-11-05 | 2011-05-19 | Noevir Co Ltd | Skin care preparation for acne |
JP2011140471A (en) * | 2010-01-08 | 2011-07-21 | Mandom Corp | Activity inhibitor and activity-inhibiting method for trpa1, and skin care preparation for external use |
JP2012025706A (en) * | 2010-07-26 | 2012-02-09 | National Institute Of Advanced Industrial Science & Technology | Antioxidant and use thereof |
JP2013213001A (en) * | 2012-03-30 | 2013-10-17 | Arimento Kogyo Kk | Oxidation-controlling composition and solid oral agent or solid food |
US10791735B2 (en) | 2012-08-24 | 2020-10-06 | Citrox Biosciences Limited | Bioflavonoid coated materials |
GB2505248B (en) * | 2012-08-24 | 2017-04-12 | Citrox Biosciences Ltd | Bioflavonoid coated materials |
US9878840B2 (en) | 2012-08-24 | 2018-01-30 | Citrox Biosciences Limited | Bioflavonoid coated materials |
US11578050B2 (en) | 2012-08-24 | 2023-02-14 | Citrox Biosciences Limited | Bioflavonoid coated materials |
GB2505248A (en) * | 2012-08-24 | 2014-02-26 | Citrox Biosciences Ltd | Bioflavonoid-coated polymeric material |
CN102960437A (en) * | 2012-11-23 | 2013-03-13 | 苏州科技学院 | Environment-friendly healthy red bayberry preservative and preservation technology |
CN106852396A (en) * | 2015-12-08 | 2017-06-16 | 上海泓宝绿色水产股份有限公司 | A kind of aquatic livestock liver-care preparations and its preparation and application |
CN108157744B (en) * | 2018-01-02 | 2021-04-23 | 青岛农业大学 | preserver |
CN108157744A (en) * | 2018-01-02 | 2018-06-15 | 青岛农业大学 | Antistaling agent |
JP2021070661A (en) * | 2019-10-31 | 2021-05-06 | 晴義 山田 | Composition for inhibiting tslp gene expression, for inhibiting il-33 gene expression, or for promoting filaggrin production |
JP7396585B2 (en) | 2019-10-31 | 2023-12-12 | 晴義 山田 | Composition for suppressing TSLP gene expression, suppressing IL-33 gene expression, or promoting filaggrin production |
WO2021210648A1 (en) * | 2020-04-17 | 2021-10-21 | Next21 Kabushiki Kaisha | Medicine containing trehalose or trehalose derivative and nasal spray |
CN115397433A (en) * | 2020-04-17 | 2022-11-25 | 21世纪国际新技术株式会社 | Medicine and nasal spray containing trehalose or trehalose derivatives |
CN115413707A (en) * | 2022-10-14 | 2022-12-02 | 广东李金柚农业科技有限公司 | Anti-browning agent for fruits and vegetables as well as preparation method and application method of anti-browning agent |
CN115413707B (en) * | 2022-10-14 | 2024-05-24 | 广东李金柚农业科技有限公司 | Anti-browning agent for fruits and vegetables, and preparation method and application method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5654731B2 (en) | Cyanobacteria extract powder, method for producing the same, and use of Cyanobacteria extract powder | |
JP5007471B2 (en) | Functional powder | |
JP2006188672A (en) | Radical formation inhibitor | |
JP2019203033A (en) | External composition for skin for antiaging, and production method thereof | |
US20100280231A1 (en) | Whitening agent comprising equol or its saccharide derivative as an effective ingredient | |
JP5479891B2 (en) | Novel royal jelly fraction, its production method and use | |
JP4658348B2 (en) | Collagen production promoter, collagenase inhibitor, fibroblast proliferation agent, elastase inhibitor, estrogen-like agent, and skin cosmetics | |
WO2004060077A1 (en) | Method of reducing unpleasant taste and/or unpleasant odor | |
JP2004131431A (en) | Composition for preventing or ameliorating ultraviolet damage | |
WO2004020552A1 (en) | Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof | |
JP2008074816A (en) | In vivo antioxidant | |
JPWO2009048120A1 (en) | Astaxanthin-containing water-soluble composition | |
JP2001316240A (en) | Collagen production promoter, estrogenic agent, skin cosmetic and food for beauty | |
JP4573611B2 (en) | Aureobasidium culture | |
JP3827581B2 (en) | Skin cosmetics and beauty food and drink | |
EP2990035B1 (en) | 1,5-anhydro-d-glucitol-containing collagen production accelerator | |
JP2007056035A (en) | Differentiation inhibiting agent for normal keratinized human epithelium cell | |
JP2010037287A (en) | Composition containing reduced coenzyme q and n-acetylglucosamine | |
JP2010189368A (en) | Liquid external preparation for skin | |
JP4084726B2 (en) | Collagen synthesis promoter, fibroblast proliferation promoter, cyclic AMP phosphodiesterase inhibitor, tyrosinase inhibitor, platelet aggregation inhibitor, cosmetics and food and drink. | |
JP3806015B2 (en) | Skin preparations and foods and drinks | |
JP4202638B2 (en) | Collagen production promoter, elastase inhibitor, collagenase inhibitor and anti-aging skin cosmetic | |
JP2009108019A (en) | External preparation for skin for enhancing ultraviolet resistivity | |
JP3806014B2 (en) | Skin preparations and foods and drinks | |
JP2003246721A (en) | Whitening cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081118 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081118 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100506 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100525 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20100716 |